
<html lang="en"     class="pb-page"  data-request-id="4ad5ed37-1d3e-45af-b5be-9c92ef1c731a"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2016.59.issue-13;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.6b00571"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Development of Novel Alkoxyisoxazoles as Sigma-1 Receptor Antagonists with Antinociceptive Efficacy" /></meta><meta name="dc.Creator" content="Hao  Sun" /></meta><meta name="dc.Creator" content="Min  Shi" /></meta><meta name="dc.Creator" content="Wei  Zhang" /></meta><meta name="dc.Creator" content="Yue-Ming  Zheng" /></meta><meta name="dc.Creator" content="Ya-Zhou  Xu" /></meta><meta name="dc.Creator" content="Jun-Jie  Shi" /></meta><meta name="dc.Creator" content="Ting  Liu" /></meta><meta name="dc.Creator" content="Hendra  Gunosewoyo" /></meta><meta name="dc.Creator" content="Tao  Pang" /></meta><meta name="dc.Creator" content="Zhao-Bing  Gao" /></meta><meta name="dc.Creator" content="Fan  Yang" /></meta><meta name="dc.Creator" content="Jie  Tang" /></meta><meta name="dc.Creator" content="Li-Fang  Yu" /></meta><meta name="dc.Description" content="A novel series of sigma (σ) receptor ligands based on an alkoxyisoxazole scaffold has been designed and synthesized. Preliminary receptor binding assays identified highly potent (Ki &lt; 1 nM) and sel..." /></meta><meta name="Description" content="A novel series of sigma (σ) receptor ligands based on an alkoxyisoxazole scaffold has been designed and synthesized. Preliminary receptor binding assays identified highly potent (Ki &lt; 1 nM) and sel..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 30, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b00571" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00571" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b00571" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00571" /></link>
        
    
    

<title>Development of Novel Alkoxyisoxazoles as Sigma-1 Receptor Antagonists with Antinociceptive Efficacy | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b00571" /></meta><meta property="og:title" content="Development of Novel Alkoxyisoxazoles as Sigma-1 Receptor Antagonists with Antinociceptive Efficacy" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/large/jm-2016-00571g_0010.jpeg" /></meta><meta property="og:description" content="A novel series of sigma (σ) receptor ligands based on an alkoxyisoxazole scaffold has been designed and synthesized. Preliminary receptor binding assays identified highly potent (Ki &lt; 1 nM) and selective σ1 ligands devoid of binding interactions with the monoamine transporters DAT, NET, and SERT. In particular, compound 53 was shown to possess significant antinociceptive activity in the mouse formalin-induced inflammation pain model when administered intraperitoneally at 40 and 80 mg/kg. Initial pharmacokinetics evaluation indicated an excellent brain exposure following oral dosing in mice, suggesting that further investigation into the use of alkoxyisoxazoles as σ1 ligands for antinociception is warranted. This study supports the notion that selective σ1 antagonism could be a useful strategy in the development of novel antipain therapy." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b00571"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b00571">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b00571&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b00571&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b00571&amp;href=/doi/10.1021/acs.jmedchem.6b00571" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 13</span><span class="cit-fg-pageRange">, 6329-6343</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/13" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b00544" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b00591" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Development of Novel Alkoxyisoxazoles as Sigma-1 Receptor Antagonists with Antinociceptive Efficacy</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hao++Sun">Hao Sun</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Min++Shi">Min Shi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wei++Zhang">Wei Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yue-Ming++Zheng">Yue-Ming Zheng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ya-Zhou++Xu">Ya-Zhou Xu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jun-Jie++Shi">Jun-Jie Shi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ting++Liu">Ting Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hendra++Gunosewoyo">Hendra Gunosewoyo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tao++Pang">Tao Pang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhao-Bing++Gao">Zhao-Bing Gao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fan++Yang">Fan Yang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jie++Tang">Jie Tang</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Li-Fang++Yu">Li-Fang Yu</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University, 3663 North Zhongshan Road, Shanghai 200062, China</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Hai Ke Road, Shanghai 201203, China</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Jiangsu Key Laboratory of Drug Screening, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">School of Pharmacy, Faculty of Health Sciences, Curtin University, Bentley, Perth, Western Australia 6102, Australia</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Shanghai Key Laboratory of Green Chemistry and Chemical Process, School of Chemistry and Molecular Engineering, East China Normal University, 3663 North Zhongshan Road, Shanghai 200062, China</span></div><div class="corresp-info"><strong>*</strong>For J.T.: phone, +86-21-62232764; E-mail, <a href="/cdn-cgi/l/email-protection#513b25303f36113239343c7f34323f247f3435247f323f"><span class="__cf_email__" data-cfemail="fb918f9a959cbb98939e96d59e98958ed59e9f8ed59895">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>For L.-F.Y.: phone, +86-021-62231385; E-mail, <a href="/cdn-cgi/l/email-protection#711d170804310210055f14121f045f1415045f121f"><span class="__cf_email__" data-cfemail="3458524d41744755401a51575a411a5150411a575a">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00571&amp;href=/doi/10.1021%2Facs.jmedchem.6b00571" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 13</span><span class="cit-pageRange">, 6329–6343</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 16, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>14 April 2016</li><li><span class="item_label"><b>Published</b> online</span>30 June 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 July 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b00571" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00571</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6329%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DHao%2BSun%252C%2BMin%2BShi%252C%2BWei%2BZhang%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D13%26contentID%3Dacs.jmedchem.6b00571%26title%3DDevelopment%2Bof%2BNovel%2BAlkoxyisoxazoles%2Bas%2BSigma-1%2BReceptor%2BAntagonists%2Bwith%2BAntinociceptive%2BEfficacy%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6343%26publicationDate%3DJuly%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b00571"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1205</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">16</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b00571" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Development of Novel Alkoxyisoxazoles as Sigma-1 Receptor Antagonists with Antinociceptive Efficacy&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Hao&quot;,&quot;last_name&quot;:&quot;Sun&quot;},{&quot;first_name&quot;:&quot;Min&quot;,&quot;last_name&quot;:&quot;Shi&quot;},{&quot;first_name&quot;:&quot;Wei&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Yue-Ming&quot;,&quot;last_name&quot;:&quot;Zheng&quot;},{&quot;first_name&quot;:&quot;Ya-Zhou&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Jun-Jie&quot;,&quot;last_name&quot;:&quot;Shi&quot;},{&quot;first_name&quot;:&quot;Ting&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Hendra&quot;,&quot;last_name&quot;:&quot;Gunosewoyo&quot;},{&quot;first_name&quot;:&quot;Tao&quot;,&quot;last_name&quot;:&quot;Pang&quot;},{&quot;first_name&quot;:&quot;Zhao-Bing&quot;,&quot;last_name&quot;:&quot;Gao&quot;},{&quot;first_name&quot;:&quot;Fan&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Jie&quot;,&quot;last_name&quot;:&quot;Tang&quot;},{&quot;first_name&quot;:&quot;Li-Fang&quot;,&quot;last_name&quot;:&quot;Yu&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;30&quot;,&quot;issue&quot;:&quot;13&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;6329-6343&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b00571&quot;},&quot;abstract&quot;:&quot;A novel series of sigma (σ) receptor ligands based on an alkoxyisoxazole scaffold has been designed and synthesized. Preliminary receptor binding assays identified highly potent (Ki &lt; 1 nM) and selective σ1 ligands devoid of binding interactions with the monoamine transporters DAT, NET, and SERT. In particular, compound 53 was shown to possess significant antinociceptive activity in the mouse formalin-induced inflammation pain model when administered intraperitoneally at 40 and 80 mg/kg. Initial pharmacokinetics evaluation indicated an excellent brain exposure following oral dosing in mice, suggesting that further investigation into the use of alkoxyisoxazoles as σ1 ligands for antinociception is warranted. This study supports the notion that selective σ1 antagonism could be a useful strategy in the development of novel antipain therapy.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00571&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00571" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00571&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00571" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00571&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00571" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00571&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00571&amp;href=/doi/10.1021/acs.jmedchem.6b00571" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b00571" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b00571" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b00571%26sid%3Dliteratum%253Aachs%26pmid%3D27309376%26genre%3Darticle%26aulast%3DSun%26date%3D2016%26atitle%3DDevelopment%2Bof%2BNovel%2BAlkoxyisoxazoles%2Bas%2BSigma-1%2BReceptor%2BAntagonists%2Bwith%2BAntinociceptive%2BEfficacy%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D13%26spage%3D6329%26epage%3D6343%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291352" title="Screening assays">Screening assays</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/13" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/jmcmar.2016.59.issue-13/20160714/jmcmar.2016.59.issue-13.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/medium/jm-2016-00571g_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/large/jm-2016-00571g_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00571&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A novel series of sigma (σ) receptor ligands based on an alkoxyisoxazole scaffold has been designed and synthesized. Preliminary receptor binding assays identified highly potent (<i>K</i><sub>i</sub> < 1 nM) and selective σ1 ligands devoid of binding interactions with the monoamine transporters DAT, NET, and SERT. In particular, compound <b>53</b> was shown to possess significant antinociceptive activity in the mouse formalin-induced inflammation pain model when administered intraperitoneally at 40 and 80 mg/kg. Initial pharmacokinetics evaluation indicated an excellent brain exposure following oral dosing in mice, suggesting that further investigation into the use of alkoxyisoxazoles as σ1 ligands for antinociception is warranted. This study supports the notion that selective σ1 antagonism could be a useful strategy in the development of novel antipain therapy.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88003" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88003" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Sigma (σ) receptors belong to a unique class of receptors that is distinct from the opioid and <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate/phencyclidine (NMDA/PCP) receptors. Initially classified as an opioid receptor subtype by Martin in 1976<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> and subsequently confused with the PCP binding site of NMDA receptor, σ receptors are nowadays referred to as central nervous system (CNS) proteins with no homology to known G-protein coupled receptors but are capable of influencing opioid actions. Two types of σ receptors have been identified, namely σ1 (25–29 kDa) and σ2 (18–22 kDa), both of which have been implicated in the pathophysiology of various neurological disorders<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> and cancer,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> respectively.</div><div class="NLM_p">The cloned σ1 receptor<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> encodes for a protein of 223 amino acids with two transmembrane domains located at the mitochondrial-associated endoplasmic reticulum membrane (MAM)<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> and regulates endoplasmic reticulum (ER)–mitochondrion calcium signaling and cell survival.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Sigma 1 receptor ligands trigger the translocation of σ1 receptor from the MAM to other parts of the cell, thereby modulating the activities of various ion channels, receptors, or kinases, thus affecting each stage of neuronal transmission. Su et al. reported that σ1 receptors modulate inositol 1,4,5-trisphosphate (IP<sub>3</sub>) function by forming a trimeric complex with IP<sub>3</sub> receptor and its inhibitory protein ankyrin B.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Acute binding of σ1 receptor agonist was found to remove ankyrin B from IP<sub>3</sub> receptor, thereby enhancing the calcium release from ER into the cytosol in NG-108 cells. Moreover, σ1 receptor agonists are likely to exert their effects by dissociating σ1 receptor chaperones from binding-immunoglobulin protein (BiP).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> This is in contrast to the σ1 receptor antagonists which do not affect the σ1 receptor–BiP association and rather stabilize this complex. The σ2 receptor, on the other hand, has not yet been cloned but is known to be overexpressed in aggressive tumor cells. Unlike the σ1 receptor that readily translocates upon activation, σ2 receptor is localized within the progesterone receptor membrane component 1 (PGRMC1) protein known to be associated with cell proliferation.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The σ2 receptor is regarded as a reliable biomarker in oncology, as proliferating cancer cells are found to have a 10-fold higher density of σ2 receptor compared to the dormant cancer cells.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The progress toward understanding the precise function of σ receptors, however, has been hampered partly due to the lack of conclusive evidence on certain endogenous ligand(s) that selectively bind to these receptors. <i>N</i>,<i>N</i>-Dimethyltryptamine (DMT) was suggested to be a low potency endogenous ligand for the σ1 and σ2 receptors.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Other endogenous σ1 ligands, such as <span class="smallcaps smallerCapital">d</span>-erythro-sphingosine and sphinganine, have also been studied (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). (+)-Pentazocine (<b>1</b>) (<i>K</i><sub>i</sub> σ1 = 3.1 nM, <i>K</i><sub>i</sub> σ2 = 1542 nM) and DTG (<b>2</b>, 1,3-di-<i>o</i>-tolylguanidine, <i>K</i><sub>i</sub> σ1 = 15 nM, <i>K</i><sub>i</sub> σ2 = 28.4 nM) are now commonly used as the radioligand of choice to study the σ1 and σ2 receptor binding.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/medium/jm-2016-00571g_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/large/jm-2016-00571g_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Selected σ receptor ligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/large/jm-2016-00571g_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00571&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Recent clinical and preclinical findings suggested the implication of σ1 receptor in various CNS disorders. This is best demonstrated by reports on the use of various σ1 receptor antagonists in drug addiction,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> including alcohol, cocaine, and methamphetamine, as well as HIV-associated neurocognitive disorder and pain.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> Interestingly, σ1 receptor agonists are also reported to possess beneficial effects in neurodegenerative disorders,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> such as stroke,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Alzheimer’s disease,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> pseudobulbar affect,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and depression and anxiety disorders.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Of particular interest, a considerable body of evidence lends support to the hypothesis that antagonism of σ1 receptor results in antinociceptive effect. The σ1 receptor knockout mouse showed decreased pain responses in the formalin test and no mechanical hypersensitivity following capsaicin sensitization or sciatic nerve injury.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> The Pasternak group demonstrated that the σ1 receptor agonist (+)-pentazocine reduced the analgesic effect of the μ opiate morphine but not the inhibition of gastrointestinal transit.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The administration of the classical σ1 receptor antagonist haloperidol (<b>3</b>) and its metabolites resulted in antinociceptive effects in the mouse formalin test.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The most clinically advanced selective σ1 receptor antagonist based on a morpholinyl pyrazole scaffold S1RA (E-52862, <b>4</b>) is currently in phase II trials for treatments of diverse pain states.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Although inactive when administered alone, this compound enhanced the antinociceptive effect of morphine in mouse tail flick tests and thus was proposed as an opioid adjuvant, offering a novel approach in pain management.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Other recently reported selective σ1 receptor antagonists showing antinociceptive effects in animal models of pain include the 4-aminotriazole <b>5</b>, hexahydro-2<i>H</i>-pyrano[3,2-<i>c</i>]quinoline <b>6</b>, and 5-chloro-2-(4-chlorophenyl)-4-methyl-6-(3-(piperidin-1-yl)propoxy)pyrimidine <b>7</b>.<a onclick="showRef(event, 'ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26">(24-26)</a></div><div class="NLM_p last">During our previous campaign on potent and selective α4β2 partial agonists, compounds <b>8</b> and <b>9</b> were identified as novel selective σ1 ligands resulting from a comparative analysis of the pharmacophoric elements required for σ1 and nicotinic ligands.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Compounds <b>8</b> and <b>9</b> displayed high affinity for the σ1 receptor (<b>8</b>: <i>K</i><sub>I</sub> σ1 = 33 nM, <i>K</i><sub>i</sub> σ2 = 1472 nM; <b>9</b>: <i>K</i><sub>i</sub> σ1 = 4.1 nM, <i>K</i><sub>i</sub> σ2 = 1312 nM) in the National Institute of Mental Health—Psychoactive Drug Screening Program (NIMH-PDSP) broad screening panel of 42 common CNS neurotransmitter transporters and receptors, while possessing good to moderate affinity for DAT (<b>8</b>: <i>K</i><sub>i</sub> DAT = 24 nM; <b>9</b>: <i>K</i><sub>i</sub> DAT = 373 nM) and NET (<b>8</b>: <i>K</i><sub>i</sub> NET = 191 nM; <b>9</b>: <i>K</i><sub>i</sub> NET = 203 nM). Considering the good preliminary ADME-Tox profile and brain uptake for this series of compounds, current efforts are being undertaken to ultimately identify selective σ1 antagonists and assess their analgesic properties alone or in combination with clinically used opioids. Herein, we report the rational design and synthesis of isoxazole-based compounds as σ1 ligands. Highly potent and selective analogues devoid of binding interactions with DAT or NET are identified, with the pharmacokinetic properties and in vivo antinociceptive efficacy assessed for the best compound.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43133" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43133" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p">Analogues of alkoxyisoxazoles <b>8</b> and <b>9</b> were designed based on the following principles: (1) adherence with the σ1 receptor pharmacophore requirements, (2) improved selectivity over nicotinic receptors and monoamine transporters, and (3) access to compounds from readily available starting materials. We previously reported that 3-alkoxyisoxazoles, originally developed for α4β2 nicotinic acetylcholine receptors, could be readily switched upon slight chemical modifications to a scaffold that is selective for σ1 receptor.<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27, 28)</a> In this study, three regions of the isoxazoles based on the previously identified selective σ1 ligand compound <b>9</b> were selected for SAR investigation: the hydrophobic region, linker L, and the <i>N</i>-region (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>), keeping the core isoxazole intact.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/medium/jm-2016-00571g_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/large/jm-2016-00571g_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. σ1 receptor pharmacophore model and proposed match of substructures with pharmacophore elements for compounds <b>8</b>, <b>9</b>, <b>53</b>, and <b>54</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/large/jm-2016-00571g_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00571&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The 3-alkoxyisoxazoles <b>15</b>–<b>33</b> were synthesized starting from commercially available dimethyl 2-butynedioate (<b>10</b>) in 5–8 steps utilizing the synthetic routes shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Alkyne <b>10</b> and <i>N</i>-hydroxyurea underwent a [2 + 3] intermolecular cycloaddition to form isoxazole <b>11</b>, which was subsequently reacted with Boc-protected 2(<i>S</i>)-pyrrolidinylmethanol via Mitsunobu reaction to form ester <b>12</b>. Basic hydrolysis or lithium borohydride reduction of ester <b>12</b> furnished the acid <b>13</b> and primary alcohol <b>14</b>, respectively. Final compounds <b>15</b>–<b>17</b> were synthesized through condensation of acid <b>13</b> with phenol or indoline followed by deprotection of the Boc group. Alcohol <b>14</b> was initially converted to the iodide and subsequently reacted with benzenethiol or substituted phenols to form the thioether <b>18</b> and aromatic ethers <b>20</b>–<b>33</b>. Carbamate <b>19</b> was prepared by treatment of intermediate alcohol <b>14</b> with phenylisocyanate. After acidic deprotection, final compounds <b>18</b>–<b>33</b> were obtained as trifluoroacetates or hydrochlorides.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/medium/jm-2016-00571g_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/large/jm-2016-00571g_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/large/jm-2016-00571g_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00571&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>N</i>-hydroxyurea, 1,5-diazabicyclo[5.4.0]undec-5-ene, MeOH, 0 °C, then HCl; (b) 1-(<i>tert</i>-butoxycarbonyl)-2(<i>S</i>)-pyrrolidinylmethanol, diisopropyl azodicarboxylate, PPh<sub>3</sub>, THF, 0 °C to rt; (c) NaOH, THF, rt; (d) DCC, DMAP, phenol, CH<sub>2</sub>Cl<sub>2</sub>, rt; (e) TFA/CH<sub>2</sub>Cl<sub>2</sub>, rt, or HCl/EtOAc, rt; (f) EDC, DMAP, aniline or indoline, rt; (g) LiBH<sub>4</sub>, THF, 0 °C to rt; (h) I<sub>2</sub>, PPh<sub>3</sub>, imidazole, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt; (i) phenol, or naphthalen-2-ol, or substituted phenol, K<sub>2</sub>CO<sub>3</sub>, DMF, rt; (j) PhSH, K<sub>2</sub>CO<sub>3</sub>, DMF, rt; (k) PhNCO, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt.</p></p></figure><div class="NLM_p">Compounds <b>34</b>–<b>39</b> were synthesized in a similar manner to parent compound <b>9</b><a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27, 28)</a> from methyl 3-hydroxyisoxazole-5-carboxylate <b>11</b> with corresponding alcohols <b>40</b>–<b>43</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). The <i>N</i>-alkylated analogues <b>44</b>–<b>59</b> were synthesized via reductive amination with the corresponding aldehydes or ketones. All final compounds were purified by HPLC or recrystallization as trifluoroacetates or hydrochlorides, respectively.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/medium/jm-2016-00571g_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/large/jm-2016-00571g_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/large/jm-2016-00571g_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00571&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HCHO, CF<sub>3</sub>CH<sub>2</sub>OH, NaBH<sub>4</sub>, 40 °C; (b) aldehyde or ketone, Na(CN)BH<sub>3</sub>, CH<sub>3</sub>CO<sub>2</sub>H, CH<sub>3</sub>OH, rt; (c) (ClCH<sub>2</sub>CH<sub>2</sub>)<sub>2</sub>O, NaI, K<sub>2</sub>CO<sub>3</sub>, DMF.</p></p></figure><div class="NLM_p">Compounds <b>65</b>–<b>69</b> were synthesized by employing a similar strategy as described in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. 1,1-Dibromoformaldoxime <b>60</b> and <i>tert</i>-butyl acrylate <b>61</b> underwent intermolecular cycloaddition under basic conditions to form intermediate dihydroisoxazole <b>62</b>. Addition–elimination with the appropriate amine under basic conditions, followed by oxidation with iodine, afforded isoxazole <b>63</b>. This intermediate was reduced with lithium borohydride and reacted with iodine/triphenylphosphine to give halide <b>64</b>. Subsequent reaction with phenol in the presence of potassium carbonate and Boc deprotection gave the desired final compounds <b>65</b>–<b>69</b>.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/medium/jm-2016-00571g_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/large/jm-2016-00571g_0008.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/large/jm-2016-00571g_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00571&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) KHCO<sub>3</sub>, DMF, −10 °C to rt then 1 N HCl; (b) (i) <i>N-</i>Boc piperazine, <sup><i>t</i></sup>BuOH, Na<sub>2</sub>CO<sub>3</sub>, reflux, (ii) imidazole, I<sub>2</sub>, PhMe, 110 °C; (c) LiBH<sub>4</sub>, THF; (d) PPh<sub>3</sub>, imidazole, I<sub>2</sub>, rt; (e) phenol, K<sub>2</sub>CO<sub>3</sub>, DMF, rt; (f) HCl, EtOAc, rt.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> In Vitro Characterization: Radioligand Binding Studies<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></h3><div class="NLM_p">In vitro binding affinities of compounds <b>15</b>–<b>33</b> at σ1 and σ2 receptors were determined by the standard [<sup>3</sup>H]pentazocine and [<sup>3</sup>H]DTG binding assay with rat brain homogenate and P12 cells, respectively (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Keeping the pyrrolidine group intact on the 3-isoxazole position, we first looked at the effects of changing linker L from a methylene ether to an ester (compound <b>15</b>), amide (compounds <b>16</b> and <b>17</b>), thioether <b>18</b>, and carbamate <b>19</b>. Ester <b>15</b> turned out to be completely inactive at both σ1 and σ2 receptors, while the amide <b>16</b> had approximately 30-fold reduction on the affinity to σ1 receptor. Substituting the benzene ring for a bulkier indoline resulted in a 9-fold improvement in σ1 binding affinity (<b>16</b> vs <b>17</b>) but still 3-fold less potent compared to the original methylene ether <b>9</b>. Thioether or carbamate linkers (<b>18</b> and <b>19</b>) also resulted in a decrease in σ1 affinity (∼16–74-fold vs compound <b>9</b>), therefore prompting us to retain linker L as a methylene ether and investigate the effects of phenyl substitution (R<sup>1</sup>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Binding Affinities of 3-Alkoxyisoxazole Ligands at σ1 and σ2 Receptors<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/medium/jm-2016-00571g_0012.gif" alt="" id="GRAPHIC-d77e976-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/medium/jm-2016-00571g_0013.gif" alt="" id="GRAPHIC-d77e977-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">See <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. Radioligands: σ1, [<sup>3</sup>H]-(+)-pentazocine; σ2, [<sup>3</sup>H]DTG (ditolylguanidine).</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">The <i>K</i><sub>i</sub> values for compound <b>9</b> are cited from the literature.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">NA: not active, defined as <50% binding in the primary assay at 10 μM.</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">Log BB values were calculated from the Clark’s equation: Log BB = −0.0148 × PSA + 0.152 × CLogP + 0.139.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></p></div><div class="footnote" id="t1fn5"><sup>Table e</sup><p class="last">Data shown as average of <i>K</i><sub>i</sub> values from two measurements: 665 ± 29 and 1958 ± 392 nM.</p></div></div><div></div></div><div class="NLM_p">The hydrophobic region R<sup>1</sup> typically occupied by a benzene ring is generally deemed an important pharmacophoric element, as seen in most σ1 ligands.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> In our previous work, we demonstrated that replacing a benzene group at R<sup>1</sup> with small aliphatic groups, e.g., methyl and cyclopropylmethyl, was deleterious for σ1 affinity.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> A 5-chloropyridyl substitution also resulted in a less potent σ1 ligand (<i>K</i><sub>i</sub> σ1 103 nM, σ2 > 10000 nM). The next iteration of SAR studies was thus focused on assessing the effects of electron withdrawing group (EWG; F, Cl, Br, CF<sub>3</sub>) and electron donating group (EDG; OMe, Me) substituents on the benzene ring. A fluoro or chloro monosubstitution (compounds <b>20</b>–<b>25</b>) generally retained affinity at σ1 receptor, with no higher than a 3-fold decrease or increase relative to parent compound <b>9</b>. Unfortunately, this was accompanied by an unwanted improvement at σ2 receptor binding, with the single exception of 3-chloro-substituted compound <b>24</b> (<i>K</i><sub>i</sub> σ1 2.6 nM, σ2 > 10000 nM). Monobromo or monotrifluoromethyl substitution (compounds <b>26</b>–<b>29</b>) resulted in a very similar trend to those observed with monofluoro compounds. Introduction of a methoxy group at the 3- or 4-position resulted in 8-fold and 51-fold reduction, respectively, in σ1 affinity (compounds <b>30</b> and <b>31</b>). A 3-methyl susbstitution gave an equipotent compound to parent compound <b>9</b> in terms of σ1 affinity but a more potent binder at σ2 receptor (<i>K</i><sub>i</sub> σ2 341 nM). Substitution of the benzene ring with a sterically bulkier naphthalene yielded a more potent σ2 receptor binder and less potent affinity at σ1 (<i>K</i><sub>i</sub> σ1 37 nM, σ2 151 nM). In almost all of the tested analogues <b>20</b>–<b>33</b>, affinity at σ2 receptor was improved upon monosubstitution with an EWG or EDG, with the exception of 3-chloro-substituted compound <b>24</b> (<i>K</i><sub>i</sub> σ1 2.6 nM, σ2 > 10000 nM) and 3-methoxy-substituted compound <b>30</b> (<i>K</i><sub>i</sub> σ1 31 nM, σ2 > 10000 nM).</div><div class="NLM_p">Subsequent SAR studies were focused on assessing replacement of the nitrogen-containing group R<sup>2</sup>, keeping the linker L and hydrophobic group R<sup>1</sup> as methylene ether and benzene or 3-substituted benzene, respectively. Compound <b>34</b>, which is an <i>R</i>-enantiomer of the parent compound <b>9</b>, was found to be ∼10-fold less potent at the σ1 receptor and 3-fold more potent at the σ2 receptor. Replacement with 4-methylpiperidine or a ring-opened aminopropyl group resulted in deleterious effects on the σ1 affinity (compounds <b>35</b> and <b>37</b>), which could be explained by the nonideal positioning of the nitrogen according to the proposed pharmacophore model shown in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>, which consists of (1) a substituted basic nitrogen, and (2) primary and secondary hydrophobic regions at a distance of approximately 6–10 Å and 2.5–3.9 Å from the nitrogen atom.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> A shorter aminoethyl or <i>N</i>-methylaminoethyl substitution (compounds <b>36</b> and <b>38</b>) partially restored binding affinity at σ1 receptor, with σ1 <i>K</i><sub>i</sub> values of 64 and 81 nM, respectively, as the nitrogen fits better with the proposed pharmacophore. <i>N</i>-Ethylaminoethyl substitution (compound <b>39</b>) resulted in a significant increase of σ1 binding affinity (<i>K</i><sub>i</sub> = 3.7 nM), while weakly binding to the σ2 receptor with a <i>K</i><sub>i</sub> value of 975 nM.</div><div class="NLM_p">We next examined the effect of <i>N</i>-alkylation on the binding affinity profiles (<b>44</b>–<b>59</b>) (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). <i>N</i>-Methyl pyrrolidine/piperidine analogues generally slightly improved the binding affinity at σ1 receptor relative to the corresponding unsubstituted pyrrolidines/piperidine (<b>44</b> vs <b>9</b>, <b>45</b> vs <b>21</b>, <b>46</b> vs <b>24</b>, <b>47</b> vs <b>34</b>, <b>48</b> vs <b>35</b>). Compound <b>47</b> was a less potent binder at σ1 compared to its enantiomer compound <b>44</b>, suggesting the <i>S</i>-configuration of the pyrrolidine moiety is favored for σ1 binding. In contrast, further <i>N</i>-methylation of compounds <b>38</b> and <b>39</b> resulted in a significant decrease of binding affinity (<b>49</b> vs <b>38</b> and <b>50</b> vs <b>39</b>). Gratifyingly, bulkier cycloaliphatic substituents (compounds <b>51</b>–<b>54</b>) resulted in compounds with low single-digit nanomolar to subnanomolar <i>K</i><sub>i</sub> values at the σ1 receptor. The cyclopropyl analogue <b>53</b> was found to possess the most superior σ2/σ1 ratio, whereas the cyclohexyl analogue <b>54</b> was the most potent binder at σ1 receptor with a <i>K</i><sub>i</sub> value of 0.3 nM. 3-Fluoro or 3-chloro substitutions at the hydrophobic region R<sup>1</sup> for these two compounds (<b>55</b>–<b>58</b>) yielded compounds with very similar binding profiles. However, binding affinity to the σ2 receptor also increased with <i>K</i><sub>i</sub> values of less than 100 nM for the cyclopentyl and cyclohexyl compounds (compounds <b>52</b> and <b>54</b>). This observation is consistent with SAR findings in the 1-arylpyrazoles series of σ ligands in which only small cyclic amine analogues possessed sufficient selectivity for σ1 vs σ2 receptor.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> As the ethoxymorpholine group is favored in the 1-arylpyrazoles series, we attempted to attach the same appendage to our isoxazole-containing ligands, resulting in compound <b>59</b>. Unfortunately the potency was found to dramatically drop by 100-fold (<b>59</b> vs <b>9</b>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Binding Affinities of 22 Isoxazole Ligands at σ1 and σ2 Receptors<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/medium/jm-2016-00571g_0014.gif" alt="" id="GRAPHIC-d77e1323-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/medium/jm-2016-00571g_0015.gif" alt="" id="GRAPHIC-d77e1324-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">See <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. Radioligands: σ1, [<sup>3</sup>H]-(+)-pentazocine; σ2, [<sup>3</sup>H]DTG (ditolylguanidine).</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">The <i>K</i><sub>i</sub> values for <b>8</b> and <b>9</b> are cited from the literature.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">Not active, defined as <50% binding in the primary assay at 10 μM.</p></div><div class="footnote" id="t2fn4"><sup>Table d</sup><p class="last">Log BB values were calculated from the Clark’s equation: Log BB = −0.0148 × PSA + 0.152 × CLogP + 0.139.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></p></div><div class="footnote" id="t2fn5"><sup>Table e</sup><p class="last">Data shown as average of <i>K</i><sub>i</sub> values from two measurements: 1288 ± 128 and 1657 ± 329 nM.</p></div><div class="footnote" id="t2fn6"><sup>Table f</sup><p class="last">Data shown as average of <i>K</i><sub>i</sub> values from two measurements: 665 ± 29 and 1958 ± 392 nM.</p></div></div><div></div></div><div class="NLM_p">We also examined briefly the effects of replacing the 3-alkyoxy groups with cyclic amines as shown in compounds <b>65</b>–<b>69</b> (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). Piperazine-substituted analogue <b>65</b> had a very similar <i>K</i><sub>i</sub> value to the parent compound <b>9</b> at σ1 receptor but improved binding affinity to the σ2 receptor. 3-Chloro substitution at the hydrophobic region R<sup>1</sup> (compound <b>66</b>) resulted in a 7-fold decrease in σ1 affinity. <i>N</i>-Methylpiperazine substitution (compound <b>67</b>) gave a much less potent σ1 binder (<i>K</i><sub>i</sub> σ1 = 64 nM, <i>K</i><sub>i</sub> σ2 = 2202 nM). Morpholine, or piperidine substitution, was found to be deleterious for affinity at both σ receptors (<b>68</b> and <b>69</b>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Binding Affinities of 5 Isoxazole Ligands at σ1 and σ2 Receptors<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/medium/jm-2016-00571g_0009.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub>, σ1 (nM)</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub>, σ2 (nM)</th><th class="colsep0 rowsep0" align="center" char=".">Log BB<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center">7.0 ± 1.1</td><td class="colsep0 rowsep0" align="center">19.6 ± 2.2</td><td class="colsep0 rowsep0" align="char" char=".">0.124</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>65</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">5.3 ± 1.0</td><td class="colsep0 rowsep0" align="center">221 ± 30</td><td class="colsep0 rowsep0" align="char" char=".">–0.272</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>66</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="center">36.5 ± 3.3</td><td class="colsep0 rowsep0" align="center">687 ± 125</td><td class="colsep0 rowsep0" align="char" char=".">–0.142</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>67</b></td><td class="colsep0 rowsep0" align="left">NCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">63.9 ± 10.2</td><td class="colsep0 rowsep0" align="center">2202 ± 297</td><td class="colsep0 rowsep0" align="char" char=".">–0.054</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>68</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">NA<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">NA</td><td class="colsep0 rowsep0" align="char" char=".">–0.228</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>69</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">NA</td><td class="colsep0 rowsep0" align="center">NA</td><td class="colsep0 rowsep0" align="char" char=".">0.118</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">See <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. Radioligands: σ1, [<sup>3</sup>H]-(+)-pentazocine; σ2, [<sup>3</sup>H]DTG (ditolylguanidine).</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">NA: not active, defined as <50% binding in the primary assay at 10 μM.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">Log BB values were calculated from the Clark’s equation: Log BB = −0.0148 × PSA + 0.152 × CLogP + 0.139.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></p></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Selectivity Studies at Selected Neurotransmitter Transporters</h3><div class="NLM_p">A broad-range screening study was carried out previously for compounds <b>8</b> and <b>9</b> to determine their global selectivity profile among 42 other CNS neurotransmitter receptors and transporters, including serotonin receptors, dopamine receptors, GABA receptors, biogenic amine transporters, adrenergic receptors, muscarinic receptors, opioid receptors, and histamine receptors.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> We previously found that compounds <b>8</b> and <b>9</b> not only bind to σ1 receptor (<i>K</i><sub>i</sub> = 33 and 4.1 nM) but also showed moderate binding affinities at two of the biogenic amine transporters DAT (<i>K</i><sub>i</sub> = 24 and 373 nM) and NET (<i>K</i><sub>i</sub> = 191 and 203 nM), respectively. Gratifyingly, no appreciable binding was observed for DAT, NET, and SERT using a 10 μM concentration of compounds <b>53</b> and <b>54</b>, indicating that these two compounds have excellent selectivity for σ1 receptor over DAT, NAT, and SERT (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>.) The other three tested compounds, <b>20</b>, <b>23</b>, and <b>66</b>, were found to retain some binding affinities to at least one of the three transporters tested.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Binding Affinities of Selected Ligands at NET, DAT, and SERT<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub>, DAT (nM)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub>, NET (nM)</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub>, SERT (nM)</th><th class="colsep0 rowsep0" align="center" char="±"><i>K</i><sub>i</sub>, σ1 (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBR12909</td><td class="colsep0 rowsep0" align="center">8.8 ± 3.8</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="±"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">desipramine</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">2.5 ± 0.4</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="±"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">amitryptiline</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">5.4 ± 0.9</td><td class="colsep0 rowsep0" align="char" char="±"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="center">24 ± 0.95</td><td class="colsep0 rowsep0" align="center">191 ± 10</td><td class="colsep0 rowsep0" align="center">NA<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char="±">33 ± 5.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="center">373 ± 24</td><td class="colsep0 rowsep0" align="center">203 ± 12</td><td class="colsep0 rowsep0" align="center">NA</td><td class="colsep0 rowsep0" align="char" char="±">4.1 ± 0.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="center">NA</td><td class="colsep0 rowsep0" align="center">1082 ± 148</td><td class="colsep0 rowsep0" align="center">NA</td><td class="colsep0 rowsep0" align="char" char="±">6.1 ± 0.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="center">NA</td><td class="colsep0 rowsep0" align="center">2109 ± 289</td><td class="colsep0 rowsep0" align="center">2946</td><td class="colsep0 rowsep0" align="char" char="±">2.7 ± 0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b></td><td class="colsep0 rowsep0" align="center">NA</td><td class="colsep0 rowsep0" align="center">NA</td><td class="colsep0 rowsep0" align="center">NA</td><td class="colsep0 rowsep0" align="char" char="±">0.8 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="center">NA</td><td class="colsep0 rowsep0" align="center">NA</td><td class="colsep0 rowsep0" align="center">NA</td><td class="colsep0 rowsep0" align="char" char="±">0.3 ± 0.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>65</b></td><td class="colsep0 rowsep0" align="center">497 ± 297</td><td class="colsep0 rowsep0" align="center">163 ± 37</td><td class="colsep0 rowsep0" align="center">NA</td><td class="colsep0 rowsep0" align="char" char="±">5.3 ± 0.9</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">See <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. DAT, dopamine transporter; NET, norepinephrine transporter; SERT, serotonin transporter. radioligands: σ1, [<sup>3</sup>H]-(+)-pentazocine; σ2, [<sup>3</sup>H]DTG (ditolylguanidine); DAT, [<sup>3</sup>H]WIN35428; NET, [<sup>3</sup>H]nisoxetine; SERT, [<sup>3</sup>H]citalopram.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">The <i>K</i><sub>i</sub> values for <b>8</b>–<b>9</b> are cited from the literature.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">Not active, defined as <50% binding in the primary assay at 10 μM. <i>K</i><sub>i</sub> values were determined for those targets where the binding efficacy at 10 μM was greater than 50%.</p></div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Functional Profile</h3><div class="NLM_p last">To date, there is still an unmet need of high throughput functional assays that readily identify σ1 ligands as an agonist, partial agonist, or antagonist. Competition binding studies of the examined ligands with phenytoin, an allosteric modulator of σ1 receptor, have recently emerged as an accepted method<a onclick="showRef(event, 'ref26 ref33'); return false;" href="javascript:void(0);" class="ref ref26 ref33">(26, 33)</a> to differentiate σ1 agonists and antagonists.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> In this assay, phenytoin is believed to induce a conformational change in the receptor to shift the equilibrium toward the active state, thereby increasing the affinity of putative agonists but not of the antagonists.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Six selected compounds (<b>4</b>, <b>9</b>, <b>21</b>, <b>24</b>, <b>51</b>, and <b>53</b>) were subjected to this assay and found to bind less potently to the σ1 receptor in the presence of phenytoin, indicating that they behave as antagonists (see Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.6b00571/suppl_file/jm6b00571_si_001.pdf" class="ext-link">Table 1</a>).</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> In Vivo Analgesic Effects: Mouse Formalin Test</h3><div class="NLM_p">Compound <b>53</b> was further advanced to the in vivo analgesic studies given its in vitro potency, selectivity, functional profiles, as well as Log BB value. Antinociceptive efficacy was assessed using the mouse formalin test, a classic model in which formalin solution is injected to the hind paw of the mouse and a biphasic pain response is characterized by analyzing the behavior of licking and flinching of the affected hind paw.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35, 36)</a> The first phase (0–10 min) reflects mostly nociceptive pain whereas the second phase (11–45 min) represents the inflammatory responses. Traditional analgesics as well as σ1 receptor antagonists have been reported to attenuate the licking and flinching behavior. In this study, mice were administered compounds <b>53</b> (40 and 80 mg/kg ip) or selected σ1 antagonist <b>4</b> as a positive control (80 mg/kg ip) and the time spent licking the paw after injection was recorded as shown in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>. Drug administration produced a reduction of paw licking behavior in mouse, suggestive of an antinociceptive effect. Compound <b>53</b> (80 mg/kg) or <b>4</b> (80 mg/kg) significantly attenuated paw licking behavior in both phases in mice, while 40 mg/kg of compound <b>53</b> markedly reduced paw licking in phase II but not in phase I compared to the vehicle group.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/medium/jm-2016-00571g_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/large/jm-2016-00571g_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Analgesic effects of compound <b>53</b> and <b>4</b> in phase I (0–10 min) and phase II (11–45) of the mouse formalin test at the dose of 80 mg/kg. All drugs were administered intraperitoneally; each column and vertical line represents mean ± SEM of the values obtained in at least six animals. Statistically significant differences: * <i>p</i> < 0.05, ** <i>p</i> < 0.01, *** <i>p</i> < 0.001 vs vehicle using unpaired, two-tailed <i>t</i> test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/large/jm-2016-00571g_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00571&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Rotarod Test</h3><div class="NLM_p">The rotarod test is widely used to evaluate the motor coordination of rodents. In this study, we utilized this assay to rule out the possibility that the observed efficacy of compound <b>53</b> in the formalin test was due to the interference with motor coordination. As shown in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>, pretreatment with pregabalin (40 mg/kg) significantly decreased the rotarod latency of mice at 60, 90, and 120 min compared to the vehicle group. Compound <b>53</b> did not significantly alter the time mice remained on the rotarod at both 40 and 80 mg/kg, suggesting no interference with motor coordination.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/medium/jm-2016-00571g_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/large/jm-2016-00571g_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Dose response effect of <b>53</b> and pregabalin on rotarod test. Data obtained from the 8–10 mice per group and expressed as mean ± SEM latency (s) to fall down from the rod. Statistically significant differences: * <i>p</i> < 0.05, ** <i>p</i> < 0.01, *** <i>p</i> < 0.001 vs vehicle (two-way ANOVA followed by Bonferroni test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/large/jm-2016-00571g_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00571&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> In Vitro PAMPA Data</h3><div class="NLM_p last">The oral absorption of seven representative compounds was initially evaluated using parallel artificial membrane permeability assay (PAMPA), which is an in vitro model of passive, transcellular permeation widely used in the pharmaceutical industry. The in vitro permeability (<i>Pe</i>) of compounds <b>4</b>, <b>9</b>, <b>21</b>, <b>24</b>, <b>44</b>, <b>53</b>, and <b>65</b> and the control drugs verapamil and atenolol through a lipid extract of porcine brain was determined using PBS as the solvent. Compounds with a <i>Pe</i> above 4.0 × 10<sup>–6</sup> cm·s<sup>–1</sup> are considered possibly penetrating into the CNS by passive diffusion (CNS+), whereas compounds with <i>Pe</i> below 2.0 × 10<sup>–6</sup> cm·s<sup>–1</sup> are considered to be impenetrant (CNS−).<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Those with <i>Pe</i> values ranging from 2.0 × 10<sup>–6</sup> to 4.0 × 10<sup>–6</sup> cm·s<sup>–1</sup> are categorized as uncertain (CNS±). Compound <b>65</b> was found to possess the greatest permeability, with a <i>Pe</i> value of 7.36 × 10<sup>–6</sup> cm·s<sup>–1</sup> (SI, <a href="/doi/suppl/10.1021/acs.jmedchem.6b00571/suppl_file/jm6b00571_si_001.pdf" class="ext-link">Table 2</a>), while all the other tested compounds have <i>Pe</i> values between 2 × 10<sup>–6</sup> and 4 × 10<sup>–6</sup> cm·s<sup>–1</sup>, including compound <b>4</b>, which is currently in a phase II clinical trial.</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> In Vivo Pharmacokinetic Studies of Compound <b>53</b></h3><div class="NLM_p">To determine the ability of these alkoxyisoxazole compounds to penetrate the BBB, compound <b>53</b> was selected for in vivo pharmacokinetic studies in mouse. Compound <b>53</b> (40 mg/kg) was orally administered to KM mice before collection of plasma and brain samples at the following time points: 0.167, 0.5, 1, 2, 4, 6, and 8 h (<i>n</i> = 3/group). The concentrations of compound <b>53</b> in the brain and plasma samples were determined by a developed LC–MS/MS method. The plasma and brain oral half-lives of compound <b>53</b> were found to be 2.64 and 2.52 h, respectively (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>). The AUC<sub>0–∞</sub> values were 113 and 403 h·ng·g<sup>–1</sup> in the plasma and brain, respectively, with the brain/plasma ratio of 3.6. These data suggest that compound <b>53</b> is absorbed rapidly following oral administration and readily crosses the BBB.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Pharmacokinetic Parameters of <b>53</b> in KM Mice (40 mg/kg, po)</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">plasma PK parameters</th><th class="colsep0 rowsep0" align="center">plasma</th><th class="colsep0 rowsep0" align="center">brain PK parameters</th><th class="colsep0 rowsep0" align="center">brain</th><th class="colsep0 rowsep0" align="center" char=".">ratio (brain/plasma)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K</i><sub>el</sub>, h<sup>–1</sup></td><td class="colsep0 rowsep0" align="left">0.263</td><td class="colsep0 rowsep0" align="left"><i>K</i><sub>el</sub>, h<sup>–1</sup></td><td class="colsep0 rowsep0" align="left">0.276</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub>, h</td><td class="colsep0 rowsep0" align="left">2.64</td><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub>, h</td><td class="colsep0 rowsep0" align="left">2.52</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>max</sub>, h</td><td class="colsep0 rowsep0" align="left">0.167</td><td class="colsep0 rowsep0" align="left"><i>t</i><sub>max</sub>, h</td><td class="colsep0 rowsep0" align="left">0.167</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub>, ng·mL<sup>–1</sup></td><td class="colsep0 rowsep0" align="left">193</td><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub>, ng·g<sup>–1</sup></td><td class="colsep0 rowsep0" align="left">395</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0–8</sub>, h·ng·mL<sup>–1</sup></td><td class="colsep0 rowsep0" align="left">108</td><td class="colsep0 rowsep0" align="left">AUC<sub>0–8</sub>, h·ng·g<sup>–1</sup></td><td class="colsep0 rowsep0" align="left">373</td><td class="colsep0 rowsep0" align="char" char=".">3.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0-inf</sub>, h·ng·mL<sup>–1</sup></td><td class="colsep0 rowsep0" align="left">113</td><td class="colsep0 rowsep0" align="left">AUC<sub>0-inf</sub>, h·ng·g<sup>–1</sup></td><td class="colsep0 rowsep0" align="left">403</td><td class="colsep0 rowsep0" align="char" char=".">3.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUMC<sub>0–8</sub>, h·h·ng·mL<sup>–1</sup></td><td class="colsep0 rowsep0" align="left">91.5</td><td class="colsep0 rowsep0" align="left">AUMC<sub>0–8</sub>, h·h·ng·g<sup>–1</sup></td><td class="colsep0 rowsep0" align="left">578</td><td class="colsep0 rowsep0" align="char" char=".">6.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUMC<sub>0-inf</sub>, h·h·ng·mL<sup>–1</sup></td><td class="colsep0 rowsep0" align="left">157</td><td class="colsep0 rowsep0" align="left">AUMC<sub>0–inf</sub>, h·h·ng·g<sup>–1</sup></td><td class="colsep0 rowsep0" align="left">935</td><td class="colsep0 rowsep0" align="char" char=".">6.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MRT<sub>PO</sub>, h</td><td class="colsep0 rowsep0" align="left">1.39</td><td class="colsep0 rowsep0" align="left">MRT<sub>PO</sub>, h</td><td class="colsep0 rowsep0" align="left">2.32</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57010" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57010" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">A total of 46 compounds were designed and synthesized based on the previously identified alkoxyisoxazole scaffold as potent and selective σ1 receptor ligands. Binding assays at both σ1 and σ2 receptors revealed analogues with subnanomolar potencies at the σ1 receptor. Selected compounds were tested for their binding profiles at DAT, NET, and SERT transporters. Compound <b>53</b> was found to be the most promising compound overall given its in vitro binding profile, Log BB value, and permeability in PAMPA assay. Administration of σ1 antagonist <b>53</b> at 80 mg/kg (ip) was found to demonstrate statistically significant analgesic effects in mouse formalin test. Combined with the acceptable pharmacokinetic parameters and its excellent brain/plasma ratio, this study overall supports the notion of the use of σ1 antagonists for novel treatment in pain.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41354" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41354" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> General Methods</h3><div class="NLM_p last">Starting materials, reagents, and solvents were purchased from commercial suppliers and used without further purification unless otherwise stated. Anhydrous THF and CH<sub>2</sub>Cl<sub>2</sub> were obtained by distillation over sodium wire or CaH<sub>2</sub>, respectively. All nonaqueous reactions were run under a nitrogen atmosphere with exclusion of moisture from reagents, and all reaction vessels were oven-dried. The progress of reactions was monitored by TLC on SiO<sub>2</sub>. Spots were visualized by their quenching of the fluorescence of an indicator admixed to the SiO<sub>2</sub> layer or by dipping into KMnO<sub>4</sub> solution followed by heating. SiO<sub>2</sub> for column chromatography (CC) was of 200–300 mesh particle size, and an EtOAc/hexane mixture or gradient was used unless stated otherwise. <sup>1</sup>H NMR spectra were recorded at a spectrometer frequency of 400 MHz, and <sup>13</sup>C NMR spectra at 101 MHz. Chemical shifts are reported in δ (ppm) using the δ 0 signal of tetramethylsilane (TMS) as internal standard. High resolution mass spectra were performed using a Bruker ESI-TOF high-resolution mass spectrometer. Purities of final compounds (>98%) were established by analytical HPLC, which was carried out on an Agilent 1200 HPLC system with a ZORBAX Eclipse XDB-C18 column, with detection at 220 or 254 nm on a variable wavelength detector G1365D; flow rate = 1.4 mL/min; gradient of 0–100% methanol in water (both containing 0.05 vol % of TFA) in 25 min. Final products were purified by preparative HPLC (Beckman GOLD126P) under the following conditions: column, Atlantis T3 5 μm, 250 mm × 4.6 mm; flow, 3 mL/min; all solvents containing 0.05 vol % TFA; UV detection at 254 and 220 nm; gradient I: 8–100% MeOH in water in 30 min, 100% for 4 min, return to 8% in 20 min. The optical rotation experiments were performed using an Autopol VI polarimeter.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> General Procedure for the Reduction of Isoxazolecarboxylic Acid Esters to Alcohols (Method A)</h3><div class="NLM_p last">To a solution of isoxazolecarboxylic acid esters (0.8 mmol) in anhydrous THF (20 mL) was added LiBH<sub>4</sub> (4 mmol) with ice cooling under Ar. After stirring overnight at rt, saturated aqueous NH<sub>4</sub>Cl solution was added with ice cooling. Extraction with EtOAc (2 × 30 mL), drying over Na<sub>2</sub>SO<sub>4</sub>, followed by evaporation under vacuum afforded the residue which was further purified by flash chromatography to give the alcohol.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Procedure for the Esterification of Isoxazolecarboxylic Acid with Phenol or Alcohol (Method B)</h3><div class="NLM_p last">To a stirred solution of isoxazole-5-carboxylic acid (0.3 mmol) and phenol (or alcohol) (0.3 mmol) in 10 mL of CH<sub>2</sub>Cl<sub>2</sub> was added DCC (98 mg, 0.47 mmol) and DMAP (19.2 mg, 0.16 mmol) under N<sub>2</sub>. After stirring overnight at rt, the reaction mixture was evaporated under vacuum and the residue was purified by flash chromatography to give the ester product.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> General Procedure for the Deprotection of <i>N</i>-Boc-Amines to Afford HCl Salts (Method C)</h3><div class="NLM_p last">To a solution of the <i>N</i>-Boc protected precursor (1 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) was added HCl/EtOAc (4 mol/L, 2 mL) under N<sub>2</sub> with ice cooling. The mixture was stirred overnight at rt, after which the solvent was evaporated and the residue was triturated with diethyl ether (20 mL). The resultant solid was filtered off to give the HCl salt.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> General Procedure for the Deprotection of <i>N</i>-Boc-Amines to Afford TFA Salts (Method D)</h3><div class="NLM_p last">To a solution of the <i>N</i>-Boc protected precursor (1 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) was added TFA (0.5 mL) under N<sub>2</sub> with ice cooling. The mixture was stirred overnight at rt. After the solvent was evaporated, the residue was purified by preparative HPLC. Following evaporation under vacuum, the residue was dissolved in distilled water (about 2–3 mL) and the solution was lyophilized to obtain the TFA salt.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> General Procedure for the Amidation of Isoxazole-5-Carboxylic Acid (Method E)</h3><div class="NLM_p last">To a stirred solution of isoxazole-5-carboxylic acid (1.6 mmol) and amine (1.6 mmol) in 20 mL of CH<sub>2</sub>Cl<sub>2</sub> was added EDC·HCl (2.08 mmol) and 3-methylpyridine (2.24 mmol) under N<sub>2</sub>. After stirring overnight at rt, the reaction mixture was evaporated and the residue was purified by flash chromatography to give the amide product.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> General Procedure for the Preparation of Phenyl Ethers or Thioether from Iodides (Method F)</h3><div class="NLM_p last">To a stirred solution of an iodide (1 mmol) and phenol or thiophenol (2 mmol) in anhydrous DMF (4 mL) was added K<sub>2</sub>CO<sub>3</sub> (6 mmol) under N<sub>2</sub>. After stirring overnight at rt, saturated aqueous NH<sub>4</sub>Cl solution was added. The mixture was extracted with EtOAc (2 × 30 mL), and the combined organic phases were washed with water (3 × 20 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated. The residue was purified by flash chromatography to give the phenyl ether or thioether product.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> General Procedure for the Mitsunobu Reaction of Alcohol with Hydroxyisoxazole (11) to Afford Alkoxyisoxazoles (Method G)</h3><div class="NLM_p last">To a stirred solution of alcohol (1.2 mmol), <b>11</b> (2.0 mmol), and PPh<sub>3</sub> (2.0 mmol) in anhydrous THF (20 mL) was added diisopropyl azodicarboxylate (1.5 mmol) dropwise with ice cooling under N<sub>2</sub>. After stirring overnight at rt, the solvent was evaporated, and the residue was dissolved in EtOAc (30 mL). The solution was washed with water (20 mL) and brine (15 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under vacuum. The residue was purified by flash chromatography to give the alkoxyisoxazole product.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> General Procedure for the Preparation of Iodides from Alcohols (Method H)</h3><div class="NLM_p last">To a stirred solution of crude alcohol (0.7 mmol), imidazole (1.05 mmol), and PPh<sub>3</sub> (1.05 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was added I<sub>2</sub> (1.05 mmol) with ice cooling under N<sub>2</sub>. After stirring overnight at rt, the solvent was evaporated and the residue was purified by flash chromatography to give the iodide.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> General Procedure for the Preparation of <i>N</i>-Methyl Analogues from Primary or Secondary Amines (Method I)</h3><div class="NLM_p last">To a solution of primary or secondary amine (0.5 mmol) and HCHO (0.5 mL) in CF<sub>3</sub>CH<sub>2</sub>OH (5 mL) was added NaBH<sub>4</sub> (0.6 mmol) at 40 °C under N<sub>2</sub>. After stirring for 2 h at 40 °C, the solvent was evaporated and extracted with EtOAc (3 × 10 mL). The combined organic layers were washed with water (20 mL) and brine (15 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under vacuum. The residue was purified by flash chromatography. To a solution of the <i>N</i>-methyl compound in CH<sub>2</sub>Cl<sub>2</sub> (3 mL) was added HCl/EtOAc (4 mol/L, 1 mL) under N<sub>2</sub> with ice cooling. The mixture was stirred overnight at rt and the solvent evaporated to give the HCl salt.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> General Procedure for the Preparation of <i>N</i>-Alkyl Analogues from Secondary Amines (Method J)</h3><div class="NLM_p last">To a stirred solution of secondary amine (0.43 mmol), aldehyde or ketone (0.5 mmol), and acetic acid (0.05 mL) in CH<sub>3</sub>OH (10 mL) was added Na(CN)BH<sub>3</sub> (0.6 mmol) at rt under N<sub>2</sub>. After stirring overnight at rt, the solvent was evaporated and the residue was extracted with EtOAc (3 × 10 mL). The combined organic layers were washed with water (20 mL) and brine (15 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under vacuum. The residue was then purified by flash chromatography. To a solution of the <i>N</i>-alkyl compound in CH<sub>2</sub>Cl<sub>2</sub> (3 mL) was added HCl/EtOAc (4 mol/L, 1 mL) under N<sub>2</sub> with ice cooling. The mixture was stirred overnight at rt and the solvent evaporated to give the HCl salt.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Methyl (<i>S</i>)-3-((1-(<i>tert</i>-Butoxycarbonyl)pyrrolidin-2-yl)methoxy)isoxazole-5-carboxylate (<b>12</b>)</h3><div class="NLM_p last">This compound was obtained from 1-(<i>tert</i>-butoxycarbonyl)-2(<i>S</i>)-azetidinylmethanol and <b>11</b><a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> employing method G. White solid; yield 41%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.10 (s, 1H), 4.31–4.29 (m, 1H), 4.24–4.20 (m, 1H), 4.09–3.98 (m, 1H), 3.88 (s, 3H), 3.23–3.21 (m, 2H), 2.13–1.94 (m, 1H), 1.95–1.83 (m, 2H), 1.81–1.71 (m, 1H), 1.39 (s, 9H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 176.9, 171.8, 160.5, 157.1, 100.7, 80.1, 70.6, 56.1, 52.8, 46.4, 28.5, 23.6, 22.6.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> (<i>S</i>)-3-((1-(<i>tert</i>-Butoxycarbonyl)pyrrolidin-2-yl)methoxy)isoxazole-5-carboxylic Acid (<b>13</b>)</h3><div class="NLM_p last">To a stirred solution of <b>12</b> (326 mg, 1.0 mmol) in 10 mL THF was added NaOH (1 M, 4 mmol). After stirring for 4 h at rt, the pH of the solvent was adjusted to 1 with hydrochloric acid (1 M). The reaction mixture was extracted with EtOAc (2 × 30 mL), and the combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under vacuum. The residue was purified by flash chromatography to give the title compound as white solid in 87% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.95 (s, 1H), 6.54 (s, 1H), 4.33 (m, 1H), 4.16 (m, 2H), 3.46 (m, 2H), 1.98 (m, 2H), 1.91 (m, 2H), 1.48 (s, 9H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 171.5, 160.7, 158.2, 155.2, 100.7, 80.8, 60.6, 55.9, 41.9, 30.3, 28.5, 27.0.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>tert</i>-Butyl (<i>S</i>)-2-(((5-(Hydroxymethyl)isoxazol-3-yl)oxy)methyl)pyrrolidine-1-carboxylate (<b>14</b>)</h3><div class="NLM_p last">This compound was obtained from <b>12</b> employing method A. Colorless oil; yield 91%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 5.90 (s, 1H), 4.74 (m, 1H), 4.60 (s, 2H), 4.29 (m, 1H), 4.12 (m, 2H), 3.36 (m, 2H), 1.94 (m, 3H), 1.86 (m, 1H), 1.45 (s, 9H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 173.3, 171.7, 154.6, 92.8, 79.8, 69.8, 60.4, 56.8, 56.4, 46.6, 28.4, 22.9.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Phenyl (<i>S</i>)-3-(Pyrrolidin-2-ylmethoxy)isoxazole-5-carboxylate Hydrochloride (<b>15</b>)</h3><div class="NLM_p last">This compound was obtained from <b>13</b> and phenol in two steps employing methods B and C. White solid; yield 41%; purity 99.2%. [α]<sub>D</sub><sup>20</sup> + 18.23 (<i>c</i> = 0.13, MeOH). <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 7.47 (t, <i>J</i> = 8.0 Hz, 2H), 7.35 (t, <i>J</i> = 8.0 Hz, 1H), 7.23 (d, <i>J</i> = 8.0 Hz, 2H), 7.00 (s, 1H), 4.61 (dd, <i>J</i> = 12.0, 4.0 Hz, 1H), 4.53–4.31 (m, 1H), 4.07 (m, 1H), 3.34 (t, <i>J</i> = 8.0 Hz, 2H), 2.36–2.14 (m, 1H), 2.16–1.94 (m, 2H), 1.93–1.70 (m, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.1, 159.8, 154.6, 149.4, 129.8, 126.7, 121.5, 101.7, 69.3, 57.5, 45.4, 26.1, 23.3. HRMS (ESI): calcd for C<sub>15</sub>H<sub>16</sub>N<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 289.1183; found, 289.1207.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> (<i>S</i>)-<i>N</i>-Phenyl-3-(pyrrolidin-2-ylmethoxy)isoxazole-5-carboxamide Hydrochloride (<b>16</b>)</h3><div class="NLM_p last">This compound was obtained from <b>13</b> and aniline in two steps employing methods E and C. White solid; 52% yield; purity 98.6%. [α]<sub>D</sub><sup>20</sup> + 10.21 (<i>c</i> = 0.10, MeOH). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.74 (br s, 1H), 9.26 (br s, 1H), 8.90 (s, 1H), 7.75 (d, <i>J</i> = 8.0 Hz, 2H), 7.39 (t, <i>J</i> = 8.0 Hz, 2H), 7.17 (t, <i>J</i> = 6.0 Hz, 1H), 7.09 (s, 1H), 4.54 (dd, <i>J</i> = 12.0, 4.0 Hz, 1H), 4.47–4.32 (m, 1H), 4.14–3.83 (m, 1H), 3.24 (t, <i>J</i> = 8.0 Hz, 2H), 2.22–2.05 (m, 1H), 2.05–1.85 (m, 2H), 1.83–1.65 (m, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.0, 164.1, 153.8, 137.5, 128.8, 124.8, 120.7, 98.0, 69.0, 57.6, 45.4, 26.0, 23.3. HRMS (ESI): calcd for C<sub>15</sub>H<sub>18</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 288.1343; found, 288.1353.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> (<i>S</i>)-Indolin-1-yl(3-(pyrrolidin-2-ylmethoxy)isoxazol-5-yl)methanone Hydrochloride (<b>17</b>)</h3><div class="NLM_p last">This compound was obtained from <b>13</b> and indoline in two steps employing methods E and C. White solid; yield 78%; purity 99.0%. [α]<sub>D</sub><sup>20</sup> + 11.43 (<i>c</i> = 0.14, MeOH). <sup>1</sup>H NMR(400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.49 (br s, 2H), 8.12 (d, <i>J</i> = 8.0 Hz, 1H), 7.34 (d, <i>J</i> = 8.0 Hz, 1H), 7.25 (t, <i>J</i> = 8.0 Hz, 1H), 7.13 (t, <i>J</i> = 8.0 Hz, 1H), 7.01 (s, 1H), 4.57–4.43 (m, 2H), 4.36 (t, <i>J</i> = 8.0 Hz, 2H), 4.01–3.91 (m, 1H), 3.22 (m, 4H), 2.21–2.07 (m, 1H), 2.04–1.84 (m, 2H), 1.81–1.67 (m, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.7, 164.1, 154.6, 142.0, 132.8, 127.2, 125.1, 125.0, 116.9, 99.0, 68.9, 57.1, 49.1, 45.0, 27.9, 26.4, 23.2. HRMS (ESI): calcd for C<sub>17</sub>H<sub>20</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 314.1499; found, 314.1522.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> (<i>S</i>)-5-((Phenylthio)methyl)-3-(pyrrolidin-2-ylmethoxy)isoxazole Trifluoroacetate (<b>18</b>)</h3><div class="NLM_p last">This compound was obtained from <b>14</b> and benzenethiol in two steps employing methods F and D and gradient I. White solid; yield 24%; purity 98.4%. [α]<sub>D</sub><sup>20</sup> + 13.49 (<i>c</i> = 0.16, MeOH). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.25 (br s, 1H), 8.77 (s, 1H), 7.40 (d, <i>J</i> = 8.0 Hz, 2H), 7.34 (t, <i>J</i> = 8.0 Hz, 2H), 7.24 (t, <i>J</i> = 8.0 Hz, 1H), 6.11 (s, 1H), 4.40 (m, 1H), 4.36 (s, 2H), 4.30–4.19 (m, 1H), 3.88 (m, 1H), 3.19 (m, 2H), 2.16–2.01 (m, 1H), 2.02–1.78 (m, 2H), 1.78–1.57 (m, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ170.9, 170.6, 158.2 (TFA), 134.3, 129.1, 128.7, 126.6, 116.1 (TFA), 93.9, 68.3, 57.6, 45.3, 27.6, 26.0, 23.3. HRMS (ESI): calcd for C<sub>15</sub>H<sub>19</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup>, 291.1162; found, 291.1170.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (<i>S</i>)-(3-(Pyrrolidin-2-ylmethoxy)isoxazol-5-yl)methyl Phenylcarbamate Trifluoroacetate (<b>19</b>)</h3><div class="NLM_p last">To a stirred solution of alcohol <b>14</b> (0.8 mmol) and DMAP (1.5 mmol) in 20 mL of CH<sub>2</sub>Cl<sub>2</sub> was added isocyanatobenzene (1.0 mmol) under N<sub>2</sub>. After stirring for 5 h at rt, the reaction mixture was evaporated and the residue was purified by flash chromatography to give Boc-protected carbamate processor. The title compound was obtained by employing method D and gradient I. White solid; yield 40% in two steps; purity 99.0%. [α]<sub>D</sub><sup>20</sup> + 11.67 (<i>c</i> = 0.16, MeOH). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.92 (br s, 1H), 9.48 (br s, 1H), 8.98 (s, 1H), 7.46 (d, <i>J</i> = 8.0 Hz, 2H), 7.38–7.21 (m, 2H), 7.09–6.97 (m, 1H), 6.40 (s, 1H), 5.20 (s, 2H), 4.45 (dd, <i>J</i> = 12.0, 4.0 Hz, 1H), 4.33 (dd, <i>J</i> = 12.0, 8.0 Hz, 1H), 3.94 (m, 1H), 3.22 (s, 2H), 2.25–2.03 (m, 1H), 2.04–1.81 (m, 2H), 1.82–1.63 (m, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.8, 168.8, 158.3 (TFA), 152.5, 138.6, 128.8, 122.8,118.3, 115.2 (TFA), 95.2, 68.5, 57.5, 56.5, 45.2, 26.0, 23.3. HRMS (ESI): calcd for C<sub>16</sub>H<sub>20</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 318.1448; found, 318.1444.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> (<i>S</i>)-5-((2-Fluorophenoxy)methyl)-3-(pyrrolidin-2-ylmethoxy)isoxazole Hydrochloride (<b>20</b>)</h3><div class="NLM_p last">This compound was obtained from <b>14</b> and 2-fluorophenol in two steps employing methods F and C. White solid; yield 37%; purity 98.0%. [α]<sub>D</sub><sup>20</sup> + 13.32 (<i>c</i> = 0.16, MeOH). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.90 (br s, 1H), 9.39 (br s, 1H), 7.37–7.19 (m, 2H), 7.14 (m, 1H), 7.00 (m, 1H), 6.47 (s, 1H), 5.27 (s, 2H), 4.42 (m, 2H), 3.89 (m, 1H), 3.17 (m, 2H), 2.22–1.99 (m, 1H), 1.97–1.73 (m, 2H), 1.78–1.54 (m, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.8, 168.5, 151.7 (d, <i>J</i><sub>C–F</sub> = 248.0 Hz), 145.2 (d, <i>J</i><sub>C–F</sub> = 10.0 Hz) 124.8 (d, <i>J</i><sub>C–F</sub> = 4.0 Hz), 122.2 (d, <i>J</i><sub>C–F</sub> = 7.0 Hz), 116.2 (d, <i>J</i><sub>C–F</sub> = 19.2 Hz), 115.6, 95.8, 68.4, 61.3, 57.3, 44.9, 26.1, 23.2. HRMS (ESI): calcd for C<sub>15</sub>H<sub>17</sub>FN<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 293.1309; found, 293.1311.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (<i>S</i>)-5-((3-Fluorophenoxy)methyl)-3-(pyrrolidin-2-ylmethoxy)isoxazole Hydrochloride (<b>21</b>)</h3><div class="NLM_p last">This compound was obtained from <b>14</b> and 3-fluorophenol in two steps employing methods F and C. White solid; yield 36%; purity 97.8%. [α]<sub>D</sub><sup>20</sup> + 9.33 (<i>c</i> = 0.10, MeOH). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.45–7.05 (m, 1H), 6.78–6.58 (m, 3H), 5.99 (s, 1H), 5.00 (s, 2H), 4.39–4.24 (m, 1H), 4.22–4.15 (m, 1H), 3.71–3.56 (m, 1H), 3.16–2.95 (m, 2H), 2.02–1.94 (m, 1H), 1.93–1.76 (m, 2H), 1.70–1.52 (m, 1H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 171.8, 168.4, 163.0 (d, <i>J</i><sub>C–F</sub> = 136.2 Hz), 159.1 (d, <i>J</i><sub>C–F</sub> = 10.8 Hz), 130.6 (d, <i>J</i><sub>C–F</sub> = 9.9 Hz), 108.7(d, <i>J</i><sub>C–F</sub> = 11.1 Hz), 102.9 (d, <i>J</i><sub>C–F</sub> = 25.3 Hz), 95.3, 71.8, 61.8, 60.5, 57.2, 46.2, 27.6, 24.9. HRMS(ESI): calcd for C<sub>15</sub>H<sub>17</sub>FN<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 293.1309; found, 293.1311.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> (<i>S</i>)-5-((4-Fluorophenoxy)methyl)-3-(pyrrolidin-2-ylmethoxy)isoxazole Hydrochloride (<b>22</b>)</h3><div class="NLM_p last">This compound was obtained from <b>14</b> and 4-fluorophenol in two steps employing methods F and C. White solid; yield 36%; purity 98.1%. [α]<sub>D</sub><sup>20</sup> + 10.67 (<i>c</i> = 0.10, MeOH). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.77 (br s, 1H), 9.26 (br s, 1H), 7.17 (m, 2H), 7.10–7.01 (m, 2H), 6.44 (s, 1H), 5.18 (s, 2H), 4.48–4.31 (m, 2H), 3.89 (m, 1H), 3.19 (m, 2H), 2.09 (m, 1H), 2.00–1.79 (m, 2H), 1.71 (m, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.8, 169.1, 157.0 (d, <i>J</i><sub>C–F</sub> = 236.9 Hz), 153.7 (d, <i>J</i><sub>C–F</sub> = 2.0 Hz), 116.3 (d, <i>J</i><sub>C–F</sub> = 8.1 Hz), 115.9 (d, <i>J</i><sub>C–F</sub> = 23.2 Hz), 95.6, 68.5, 61.1, 57.4, 45.1, 26.2, 23.3. HRMS (ESI): calcd for C<sub>15</sub>H<sub>17</sub>FN<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 293.1309; found, 293.1311.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> (<i>S</i>)-5-((2-Chlorophenoxy)methyl)-3-(pyrrolidin-2-ylmethoxy)isoxazole Hydrochloride (<b>23</b>)</h3><div class="NLM_p last">This compound was obtained from <b>14</b> and 2-chlorophenol in two steps employing methods F and C. White solid; yield 71%; purity 98.4%. [α]<sub>D</sub><sup>20</sup> + 14.71 (<i>c</i> = 0.14, MeOH). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.57 (br s, 2H), 7.46 (d, <i>J</i> = 8.0 Hz, 1H), 7.33 (m, 2H), 7.02 (m, 1H), 6.48 (s, 1H), 5.31 (s, 2H), 4.60–4.36 (m, 2H), 4.15–3.77 (m, 1H), 3.19 (m, 2H), 2.20–2.04 (m, 1H), 2.01–1.81 (m, 2H), 1.79–1.60 (m, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.8, 168.6, 152.7, 130.2, 128.3, 122.5, 121.5, 114.4, 95.8, 68.4, 61.3, 57.3, 45.0, 26.1, 23.2. HRMS (ESI): calcd for C<sub>15</sub>H<sub>18</sub>ClN<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 309.1000; found, 309.1014.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> (<i>S</i>)-5-((3-Chlorophenoxy)methyl)-3-(pyrrolidin-2-ylmethoxy)isoxazole Trifluoroacetate (<b>24</b>)</h3><div class="NLM_p last">This compound was obtained from <b>14</b> and 3-chlorophenol in two steps employing methods F and D and gradient I. White solid; yield 51%; purity 98.1%. [α]<sub>D</sub><sup>20</sup> + 7.44 (<i>c</i> = 0.14, MeOH). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.49 (br s, 1H), 8.98 (s, 1H), 7.33 (t, <i>J</i> = 8.0 Hz, 1H), 7.14 (m, 1H), 7.09–6.97 (m, 2H), 6.44 (s, 1H), 5.24 (s, 2H), 4.44 (dd, <i>J</i> = 12.0, 4.0 Hz, 1H), 4.37–4.28 (m, 1H), 3.93 (m, 1H), 3.21 (m, 2H), 2.21–2.04 (m, 1H), 2.03–1.82 (m, 2H), 1.80–1.60 (m, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.8, 168.7, 160.9 (TFA), 158.3, 133.8, 131.0, 121.5, 115.4 (TFA), 114.9, 113.9, 95.6, 68.5, 60.8, 57.5, 45.2, 26.0, 23.3. HRMS (ESI): calcd for C<sub>15</sub>H<sub>18</sub>ClN<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 309.1000; found, 309.1014.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> (<i>S</i>)-5-((4-Chlorophenoxy)methyl)-3-(pyrrolidin-2-ylmethoxy)isoxazole Hydrochloride (<b>25</b>)</h3><div class="NLM_p last">This compound was obtained from <b>14</b> and 4-chlorophenol in two steps employing methods F and C. White solid yield 55%; purity 97.1%. [α]<sub>D</sub><sup>20</sup> + 5.95 (<i>c</i> = 0.14, MeOH). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.44 (s, 1H), 8.93 (s, 1H), 7.36 (d, <i>J</i> = 12.0 Hz, 2H), 7.07 (d, <i>J</i> = 8.0 Hz, 2H), 6.44 (s, 1H), 5.21 (s, 2H), 4.44 (dd, <i>J</i> = 12.0, 4.0 Hz, 1H), 4.33 (dd, <i>J</i> = 12.0, 8.0 Hz, 1H), 3.94 (m, 1H), 2.17–2.06 (m, 1H), 2.02–1.84 (m, 2H), 1.77–1.64 (m, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.8, 168.9, 156.2, 129.3, 125.2, 116.6, 95.5, 68.5, 60.8, 57.6, 45.3, 26.0, 23.3. HRMS (ESI): calcd for C<sub>15</sub>H<sub>18</sub>ClN<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 309.1000; found, 309.0996.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> (<i>S</i>)-5-((3-Bromophenoxy)methyl)-3-(pyrrolidin-2-ylmethoxy)isoxazole Hydrochloride (<b>26</b>)</h3><div class="NLM_p last">This compound was obtained from <b>14</b> and 3-bromophenol in two steps employing methods F and C. White solid; yield 40%; purity 98.0%. [α]<sub>D</sub><sup>20</sup> + 9.79 (<i>c</i> = 0.16, MeOH). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.60 (s, 1H), 9.11 (s, 1H), 7.35–7.24 (m, 2H), 7.19 (d, <i>J</i> = 8.0 Hz, 1H), 7.06 (d, <i>J</i> = 8.0 Hz, 1H), 6.47 (s, 1H), 5.25 (s, 2H), 4.44 (dd, <i>J</i> = 12.0, 4.0 Hz, 1H), 4.37 (dd, <i>J</i> = 12.0, 8.0 Hz 1H), 3.90 (m, 1H), 3.19 (m, 2H), 2.19–2.02 (m, 1H), 2.02–1.83 (m, 2H), 1.81–1.59 (m, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.7, 168.7, 158.2, 131.4, 124.4, 122.1, 117.5, 114.2, 95.6, 68.3, 60.6, 57.6, 45.2, 25.8, 23.2. HRMS (ESI): calcd for C<sub>15</sub>H<sub>18</sub>BrN<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 353.0495; found, 353.0516.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> (<i>S</i>)-5-((4-Bromophenoxy)methyl)-3-(pyrrolidin-2-ylmethoxy)isoxazole Hydrochloride (<b>27</b>)</h3><div class="NLM_p last">This compound was obtained from <b>14</b> and 4-bromophenol in two steps employing methods F and C. White solid; yield 34%; purity 98.2%. [α]<sub>D</sub><sup>20</sup> + 12.41 (<i>c</i> = 0.19, MeOH). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.96 (br s, 2H), 7.49 (d, <i>J</i> = 8.0 Hz, 2H), 7.02 (d, <i>J</i> = 8.0 Hz, 2H), 6.45 (s, 1H), 5.22 (s, 2H), 4.45 (dd, <i>J</i> = 12.0, 4.0 Hz, 1H), 4.32 (dd, <i>J</i> = 12.0, 8.0 Hz, 1H), 3.93 (m, 1H), 3.21 (t, <i>J</i> = 6.0 Hz, 1H), 2.18–2.05 (m, 1H), 2.02–1.83 (m, 2H), 1.82–1.61 (m, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.8, 168.8, 158.3 (TFA), 156.6, 132.2, 117.1, 115.6 (TFA), 113.0, 95.5, 68.5, 60.7, 57.6, 45.3, 26.0, 23.3. HRMS (ESI): calcd for C<sub>15</sub>H<sub>18</sub>BrN<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 353.0495; found, 353.0523.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> (<i>S</i>)-3-(Pyrrolidin-2-ylmethoxy)-5-((3-(trifluoromethyl)phenoxy)methyl)isoxazole Trifluoroacetate (<b>28</b>)</h3><div class="NLM_p last">This compound was obtained from <b>14</b> and 3-(trifluoromethyl)phenol in two steps employing methods F and D and gradient I. Pale-yellow liquid; yield 30%; purity 98.5%. [α]<sub>D</sub><sup>20</sup> + 13.96 (<i>c</i> = 0.16, MeOH). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.59 (br s, 1H), 9.06 (br s, 1H), 7.56 (t, <i>J</i> = 8.0 Hz, 1H), 7.37 (m, 2H), 6.47 (s, 1H), 5.32 (s, 2H), 4.45 (dd, <i>J</i> = 8.0, 4.0 Hz, 1H), 4.34 (dd, <i>J</i> = 10.0, 4.0 Hz, 1H), 3.96 (m, 1H), 3.23 (t, <i>J</i> = 6.0 Hz, 2H), 2.18–2.06 (m, 1H), 2.04–1.81 (m, 2H), 1.81–1.61 (m, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.8, 168.6, 158.6 (TFA), 157.7, 130.8, 130.2 (q, <i>J</i><sub>C–F</sub> = 31.6 Hz), 123.8 (q, <i>J</i><sub>C–F</sub> = 271.0 Hz), 119.0, 118.0 (q, <i>J</i><sub>C–F</sub> = 4.0 Hz), 115.6 (TFA), 111.4 (q, <i>J</i><sub>C–F</sub> = 4.0 Hz), 95.6, 68.4, 60.8, 57.5, 45.2, 26.0, 23.3. HRMS (ESI): calcd for C<sub>16</sub>H<sub>18</sub>F<sub>3</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 343.1264; found, 343.1281.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> (<i>S</i>)-3-(Pyrrolidin-2-ylmethoxy)-5-((4-(trifluoromethyl)phenoxy)methyl)isoxazole Trifluoroacetate (<b>29</b>)</h3><div class="NLM_p last">This compound was obtained from <b>14</b> and 4-(trifluoromethyl)phenol in two steps as white solid in 30% yield employing methods F and D and gradient I. Purity 95.6%. [α]<sub>D</sub><sup>20</sup> + 9.24 (<i>c</i> = 0.18, MeOH). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.40 (br s, 1H), 8.96 (br s, 1H), 7.69 (d, <i>J</i> = 8.0 Hz, 2H), 7.23 (d, <i>J</i> = 12.0 Hz, 2H), 6.48 (s, 1H), 5.32 (s, 2H), 4.45 (dd, <i>J</i> = 12.0, 4.0 Hz, 1H), 4.33 (dd, <i>J</i> = 12.0, 8.0 Hz, 1H), 3.94 (m, 1H), 3.22 (t, <i>J</i> = 8.0 Hz, 2H), 2.19–2.04 (m, 1H), 2.04–1.84 (m, 2H), 1.80–1.64 (m, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.8, 168.6, 163.5 (TFA), 160.2, 127.0 (q, <i>J</i><sub>C–F</sub> = 3.5 Hz), 122.8 (q, <i>J</i><sub>C–F</sub> = 264.4 Hz), 122.0 (q, <i>J</i><sub>C–F</sub> = 32.1 Hz), 116.0 (TFA), 115.3, 95.7, 68.5, 60.7, 57.6, 45.3, 26.0, 23.3. HRMS (ESI): calcd for C<sub>16</sub>H<sub>18</sub>F<sub>3</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 343.1264; found, 343.1296.</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> (<i>S</i>)-5-((3-Methoxyphenoxy)methyl)-3-(pyrrolidin-2-ylmethoxy)isoxazole Hydrochloride (<b>30</b>)</h3><div class="NLM_p last">This compound was obtained from <b>14</b> and 3-methoxyphenol in two steps employing methods F and C. Pale-brown solid; yield 33%; purity 95.6%. [α]<sub>D</sub><sup>20</sup> + 13.49 (<i>c</i> = 0.13, MeOH). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.02 (s, 1H), 9.54 (s, 1H), 7.20 (t, <i>J</i> = 8.0 Hz, 1H), 6.61 (d, <i>J</i> = 8.0 Hz, 2H), 6.56 (d, <i>J</i> = 8.0 Hz, 1H), 6.45 (s, 1H), 5.17 (s, 2H), 4.42 (d, <i>J</i> = 8.0 Hz, 2H), 3.98–3.82 (m, 1H), 3.72 (s, 3H), 3.17 (m, 2H), 2.15–2.03 (m, 1H), 1.99–1.82 (m, 2H), 1.77–1.61 (m, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.8, 169.0, 160.5, 158.6, 130.2, 107.1, 106.8, 101.1, 95.5, 68.4, 60.5, 57.3, 55.1, 44.8, 26.2, 23.2. HRMS (ESI): calcd for C<sub>16</sub>H<sub>21</sub>N<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 305.1496; found, 305.1517.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> (<i>S</i>)-5-((4-Methoxyphenoxy)methyl)-3-(pyrrolidin-2-ylmethoxy)isoxazole Hydrochloride (<b>31</b>)</h3><div class="NLM_p last">This compound was obtained from <b>14</b> and 4-methoxyphenol in two steps employing methods F and C. White solid; yield 55%; purity 98.8%. [α]<sub>D</sub><sup>20</sup> + 10.00 (<i>c</i> = 0.16, MeOH). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.40 (s, 1H), 8.94 (s, 1H), 6.97 (d, <i>J</i> = 12.0 Hz, 2H), 6.87 (d, <i>J</i> = 8.0 Hz, 2H), 6.41 (s, 1H), 5.12 (s, 2H), 4.44 (dd, <i>J</i> = 12.0, 4.0 Hz, 1H), 4.31 (dd, <i>J</i> = 12.0, 8.0 Hz, 1H), 3.94 (m, 1H), 3.70 (s, 3H), 3.21 (t, <i>J</i> = 8.0 Hz, 2H), 2.22–2.01 (m, 1H), 2.03–1.77 (m, 2H), 1.81–1.58 (m, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.7, 169.5, 153.9, 151.3, 115.8, 114.6, 95.2, 68.5, 61.1, 57.6, 55.3, 45.3, 26.1, 23.3. HRMS (ESI): calcd for C<sub>16</sub>H<sub>21</sub>N<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 305.1496; found, 305.1517.</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> (<i>S</i>)-3-(Pyrrolidin-2-ylmethoxy)-5-((m-tolyloxy)methyl)isoxazole Hydrochloride (<b>32</b>)</h3><div class="NLM_p last">This compound was obtained from <b>14</b> and 3-methylphenol in two steps employing methods F and C. White solid yield 41%; purity 96.7%. [α]<sub>D</sub><sup>20</sup> + 6.00 (<i>c</i> = 0.10, MeOH). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.36 (br s, 2H), 7.19 (t, <i>J</i> = 8.0 Hz, 1H), 6.83 (m, 3H), 6.43 (s, 1H), 5.17 (s, 2H), 4.52–4.30 (m, 2H), 4.01–3.76 (m, 1H), 3.20 (dd, <i>J</i> = 9.4, 5.2 Hz, 2H), 2.28 (s, 3H), 2.15–2.03 (m, 1H), 1.92 (m, 2H), 1.77–1.62 (m, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.8, 169.3, 157.1, 139.2, 129.2, 122.2, 115.2, 111.5, 95.2, 68.2, 60.2, 57.2, 44.9, 25.9, 22.9, 20.9. HRMS (ESI): calcd for C<sub>16</sub>H<sub>20</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 289.1556; found, 289.1547.</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> (<i>S</i>)-5-((Naphthalen-2-yloxy)methyl)-3-(pyrrolidin-2-ylmethoxy)isoxazole Trifluoroacetate (<b>33</b>)</h3><div class="NLM_p last">This compound was obtained from <b>14</b> and naphthalen-2-ol in two steps employing methods F and D and gradient I. White solid; yield 33%; purity 98.2%. [α]<sub>D</sub><sup>20</sup> + 7.33 (<i>c</i> = 0.10, MeOH). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.26 (br s, 1H), 8.82 (br s, 1H), 7.86 (dd, <i>J</i> = 8.0, 4.0 Hz, 1H), 7.81 (d, <i>J</i> = 8.0 Hz, 1H), 7.49 (m, 1H), 7.38 (t, <i>J</i> = 8.0 Hz, 1H), 7.23 (d, <i>J</i> = 8.0 Hz, 1H), 6.51 (s, 1H), 5.33 (s, 2H), 4.45 (dd, <i>J</i> = 12.0, 4.0 Hz, 1H), 4.32 (dd, <i>J</i> = 12.0, 8.0 Hz, 1H), 3.94 (m, 1H), 3.21 (t, <i>J</i> = 6.0 Hz, 2H), 2.11 (m, 1H), 2.03–1.79 (m, 1H), 1.71 (m, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.8, 169.1, 158.1 (TFA), 155.2, 134.0, 129.5, 128.8, 127.6, 126.8, 126.6, 124.0, 118.4, 113.7 (TFA), 107.5, 95.5, 68.5, 60.6, 57.6, 45.2, 25.9, 23.2. HRMS (ESI): calcd for C<sub>19</sub>H<sub>20</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 325.1565; found, 325.1547.</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> (<i>R</i>)-5-(Phenoxymethyl)-3-(pyrrolidin-2-ylmethoxy)isoxazole Hydrochloride (<b>34</b>)</h3><div class="NLM_p last">This compound was obtained from <b>41</b> and <b>11</b> in five steps employing methods G, A, H, F, and C. Pale-gray solid; yields of each step: 89% (G), 35% (A and H), 60% (F and C); purity 98.8%. [α]<sub>D</sub><sup>20</sup> −37.10 (<i>c</i> = 0.12, MeOH). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.32 (t, <i>J</i> = 8.0 Hz, 2H), 7.03 (d, <i>J</i> = 8.0 Hz, 2H), 6.99 (t, <i>J</i> = 6.0 Hz, 1H), 6.45 (s, 1H), 5.19 (s, 2H), 4.53–4.36 (m, 2H), 4.03–3.72 (m, 1H), 3.16 (m, 2H), 2.14–2.02 (m, 1H), 1.99–1.79 (m, 2H), 1.76–1.61 (m, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) 170.8, 169.1, 163.3 (TFA), 157.3, 129.6, 121.4, 115.3 (TFA), 114.7, 95.4, 68.7, 60.4, 57.2, 45.0, 26.3, 23.3. HRMS (ESI): calcd for C<sub>15</sub>H<sub>18</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 275.1390; found, 275.1411.</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 5-(Phenoxymethyl)-3-(piperidin-4-ylmethoxy)isoxazole Trifluoroacetate (<b>35</b>)</h3><div class="NLM_p last">This compound was obtained from <b>42</b> and <b>11</b> in five steps employing methods G, A, H, F, and D and gradient I. White solid; yields of each step: 85% (G), 53% (A and H), 55% (F and D); purity 97.2%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.59 (br s, 1H), 8.27 (s, 1H), 7.32 (t, <i>J</i> = 8.0 Hz, 2H), 7.02 (d, <i>J</i> = 8.0 Hz, 2H), 6.98 (d, <i>J</i> = 8.0 Hz, 1H), 6.38 (s, 1H), 5.16 (s, 2H), 4.09 (d, <i>J</i> = 4.0 Hz, 2H), 3.28 (m, 1H), 2.90 (t, <i>J</i> = 12.0 Hz, 2H), 2.09 (m, 1H), 1.87 (d, <i>J</i> = 12.0 Hz, 2H), 1.58–1.33 (m, 2H), 1.24 (m, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.3, 169.0, 162.3 (TFA) 157.4, 129.6, 121.4, 114.7, 111.9 (TFA) 95.3, 73.0, 60.5, 42.7, 32.8, 24.9. HRMS (ESI): calcd for C<sub>16</sub>H<sub>21</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 289.1547; found, 289.1567.</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 2-((5-(Phenoxymethyl)isoxazol-3-yl)oxy)ethan-1-amine Hydrochloride (<b>36</b>)</h3><div class="NLM_p last">This compound was obtained from <i>tert</i>-butyl (2-hydroxyethyl)carbamate and <b>11</b> in five steps employing methods G, A, H, F, and C. White solid; yield of each step: 60% (G), 43% (A and H), 30% (F and C) purity 95.3%. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 7.43–7.39 (m, 2H), 7.13 (d, <i>J</i> = 8.0 Hz, 1H), 7.10 (d, <i>J</i> = 8.0 Hz, 2H), 6.30 (s, 1H), 5.23 (s, 2H), 4.50 (t, <i>J</i> = 6.0 Hz, 2H), 3.47 (t, <i>J</i> = 6.0 Hz, 2H). <sup>13</sup>C NMR (101 MHz, D<sub>2</sub>O) δ 171.3, 169.6, 157.0, 129.9, 122.4, 115.2, 95.4, 66.1, 61.3, 38.6. HRMS (ESI): calcd for C<sub>12</sub>H<sub>14</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 235.1041; found, 235.1057.</div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 3-((5-(Phenoxymethyl)isoxazol-3-yl)oxy)propan-1-amine Hydrochloride (<b>37</b>)</h3><div class="NLM_p last">This compound was obtained from <i>tert</i>-butyl (3-hydroxypropyl)carbamate and <b>11</b> in five steps employing methods G, A, H, F, and C. White solid; yield of each steps: 90% (G), 50% (A and H), 30% (F and C); purity 98.4%. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 7.32 (t, <i>J</i> = 8.0 Hz, 2H), 7.04 (d, <i>J</i> = 8.0 Hz, 1H), 7.00 (d, <i>J</i> = 8.0 Hz, 2H), 6.16 (s, 1H), 5.12 (s, 2H), 4.26 (t, <i>J</i> = 4.0 Hz, 2H), 3.11 (t, <i>J</i> = 6.0 Hz, 2H), 2.15–1.96 (m, 2H). <sup>13</sup>C NMR (101 MHz, D<sub>2</sub>O) δ 171.7, 169.3, 157.0, 129.9, 122.4, 115.2, 95.4, 67.7, 61.3, 37.0, 26.2. HRMS (ESI): calcd for C<sub>13</sub>H<sub>16</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 249.1234; found, 249.1251.</div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> <i>N</i>-Methyl-2-((5-(phenoxymethyl)isoxazol-3-yl)oxy)ethan-1-amine Hydrochloride (<b>38</b>)</h3><div class="NLM_p last">This compound was obtained from <i>tert</i>-butyl (2-hydroxyethyl) (methyl)carbamate and <b>11</b> in five steps employing methods G, A, H, F, and C. White solid; yield of each steps: 60% (G), 60% (A and H), 70% (F and C); purity 99.6%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.06 (br s, 2H), 7.32 (t, <i>J</i> = 8.0 Hz, 2H), 7.03 (d, <i>J</i> = 8.0 Hz, 2H), 6.99 (t, <i>J</i> = 8.0 Hz, 1H), 6.42 (s, 1H), 5.19 (s, 2H), 4.46 (t, <i>J</i> = 4.0 Hz, 2H), 3.31–3.25 (m, 2H), 2.59 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.8, 169.2, 157.4, 129.6, 121.5, 114.7, 95.4, 65.4, 60.4, 46.9, 32.7. HRMS (ESI): calcd for C<sub>13</sub>H<sub>16</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 249.1234; found, 249.1250.</div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> <i>N</i>-Ethyl-2-((5-(phenoxymethyl)isoxazol-3-yl)oxy)ethan-1-amine Hydrochloride (<b>39</b>)</h3><div class="NLM_p last">This compound was obtained from <i>tert</i>-butyl ethyl(2-hydroxyethyl)carbamate and <b>11</b> in five steps employing methods G, A, H, F, and C. White solid; yield of each steps: 80% (G), 50% (A and H), 70% (F and C); purity 99.9%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.10 (br s, 2H), 7.32 (t, <i>J</i> = 8.0 Hz, 2H), 7.03 (d, <i>J</i> = 8.0 Hz, 2H), 6.99 (t, <i>J</i> = 8.0 Hz, 1H), 6.43 (s, 1H), 5.19 (s, 2H), 4.48 (t, <i>J</i> = 6.0 Hz, 2H), 3.13–2.89 (m, 2H), 2.52 (m, 2H), 1.21 (t, <i>J</i> = 8.0 Hz, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.8, 169.2, 157.4, 129.6, 121.4, 114.7, 95.4, 65.5, 60.5, 45.1, 42.3, 10.8. HRMS (ESI): calcd for C<sub>14</sub>H<sub>19</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 262.1390; found, 263.1392.</div></div><div id="sec4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> (<i>S</i>)-3-((1-Methylpyrrolidin-2-yl)methoxy)-5-(phenoxymethyl)isoxazole Hydrochloride (<b>44</b>)</h3><div class="NLM_p last">This compound was obtained from <b>9</b> employing method I. Pale-yellow liquid; yield 80%; purity 95.6%. [α]<sub>D</sub><sup>20</sup> + 43.75 (<i>c</i> = 0.10, MeOH). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.99 (br s, 1H), 7.32 (t, <i>J</i> = 8.0 Hz, 2H), 7.03 (d, <i>J</i> = 8.0 Hz, 2H), 6.99 (t, <i>J</i> = 8.0 Hz, 1H), 6.45 (s, 1H), 5.20 (s, 2H), 4.53 (dd, <i>J</i> = 12.0, 4.0 Hz, 1H), 4.44 (dd, <i>J</i> = 12.0, 8.0 Hz, 1H), 3.83 (m, 1H), 3.58 (m, 1H), 3.19–3.06 (m, 1H), 2.92 (s, 3H), 2.31–2.17 (m, 1H), 2.14–2.00 (m, 1H), 1.96–1.77 (m, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.7, 169.4, 157.4, 129.6, 121.5, 114.7, 95.3, 67.6, 66.4, 60.5, 56.5, 40.6, 26.1, 22.0. HRMS (ESI): calcd for C<sub>16</sub>H<sub>21</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 289.1547; found, 289.1566.</div></div><div id="sec4_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> (<i>S</i>)-5-((3-Fluorophenoxy)methyl)-3-((1-methylpyrrolidin-2-yl)methoxy)isoxazole Hydrochloride (<b>45</b>)</h3><div class="NLM_p last">This compound was obtained from <b>21</b> employing method I. White solid; yield 67%; purity 95.7%. [α]<sub>D</sub><sup>20</sup> + 2.33 (<i>c</i> = 0.10, MeOH). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.31–7.15 (m, 1H), 6.79–6.57 (m, 3H), 5.98 (s, 1H), 5.01 (s, 2H), 4.22 (m, 2H), 3.10 (m, 1H), 2.59 (m, 1H), 2.42 (s, 3H), 2.26 (m, 1H), 2.03–1.63 (m, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 172.0, 168.0, 163.6 (d, <i>J</i><sub>C–F</sub> = 247.5 Hz), 159.0 (d, <i>J</i><sub>C–F</sub> = 11.0 Hz), 130.5 (d, <i>J</i><sub>C–F</sub> = 9.1 Hz), 110.4, 108.7 (d, <i>J</i><sub>C–F</sub> = 21.2 Hz), 102.8 (d, <i>J</i><sub>C–F</sub> = 25.3 Hz), 95.3, 71.7, 64.0, 61.8, 57.7, 41.4, 28.3, 22.8. HRMS(ESI): calcd for C<sub>16</sub>H<sub>20</sub>FN<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 307.1452; found, 307.1467.</div></div><div id="sec4_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> (<i>S</i>)-5-((3-Chlorophenoxy)methyl)-3-((1-methylpyrrolidin-2-yl)methoxy)isoxazole Hydrochloride (<b>46</b>)</h3><div class="NLM_p last">This compound was obtained from <b>24</b> employing method I. Colorless oil; yield 49%; purity 97.5%. [α]<sub>D</sub><sup>20</sup> + 5.68 (<i>c</i> = 0.10, MeOH). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.19 (t, <i>J</i> = 8.0 Hz, 1H), 6.97 (d, <i>J</i> = 8.0 Hz, 1H), 6.92 (s, 1H), 6.81 (d, <i>J</i> = 8.0 Hz, 1H), 5.97 (s, 1H), 5.00 (s, 2H), 4.27–4.18 (m, 2H), 3.09 (t, <i>J</i> = 8.0 Hz, 1H), 2.61–2.56 (m, 1H), 2.41 (s, 3H), 2.26 (dd, <i>J</i> = 16.0, 8.0 Hz, 1H), 1.97–1.68 (m, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 171.8, 167.8, 158.0, 134.7, 130.3, 121.9, 115.3, 112.9, 95.1, 71.5, 63.8, 61.5, 59.2, 41.2, 27.8, 22.7. HRMS (ESI): calcd for C<sub>16</sub>H<sub>20</sub>ClN<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 323.1157; found, 323.1150.</div></div><div id="sec4_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> (<i>R</i>)-3-((1-Methylpyrrolidin-2-yl)methoxy)-5-(phenoxymethyl)isoxazole Hydrochloride (<b>47</b>)</h3><div class="NLM_p last">This compound was obtained from <b>34</b> employing method I. White solid; yield 77%; purity 98.6%. [α]<sub>D</sub><sup>20</sup> −20.31 (<i>c</i> = 0.32, MeOH). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.32 (t, <i>J</i> = 8.0 Hz, 2H), 7.02 (d, <i>J</i> = 8.0 Hz, 2H), 6.99 (t, <i>J</i> = 8.0 Hz, 1H), 6.38 (s, 1H), 5.16 (s, 2H), 4.15 (dd, <i>J</i> = 12.0, 8.0 Hz, 1H), 4.04 (dd, <i>J</i> = 12.0, 8.0 Hz, 1H), 2.99–2.87 (m, 1H), 2.61–2.52 (m, 1H), 2.32 (s, 3H), 2.18 (q, <i>J</i> = 8.6 Hz, 1H), 2.00–1.84 (m, 1H), 1.74–1.62 (m, 2H), 1.62–1.49 (m, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.5, 168.8, 157.4, 129.6, 121.4, 114.7, 95.3, 72.2, 63.2, 60.5, 56.9, 41.1, 28.0, 22.5. HRMS (ESI): calcd for C<sub>16</sub>H<sub>21</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 289.1547; found, 289.1556.</div></div><div id="sec4_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 3-((1-Methylpiperidin-4-yl)methoxy)-5-(phenoxymethyl)isoxazole Hydrochloride (<b>48</b>)</h3><div class="NLM_p last">This compound was obtained from <b>35</b> employing method I. White solid; yield 66%; purity 98.6%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.48 (br s, 1H), 7.32 (t, <i>J</i> = 8.0 Hz, 2H), 7.03 (d, <i>J</i> = 8.0 Hz, 2H), 7.01–6.92 (m, 1H), 6.40 (s, 1H), 5.17 (s, 2H), 4.08 (m, 2H), 3.39 (m, 2H), 3.09–2.84 (m, 2H), 2.69 (s, 3H), 2.03 (m, 1H), 1.98–1.77 (m, 2H), 1.70–1.48 (m, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.5, 168.8, 157.4, 129.6, 121.4, 114.7, 95.3, 74.0, 60.5, 54.7, 46.1, 34.6, 28.1. HRMS (ESI): calcd for C<sub>17</sub>H<sub>23</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 303.1703; found, 303.1703.</div></div><div id="sec4_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> <i>N</i>,<i>N</i>-Dimethyl-2-((5-(phenoxymethyl)isoxazol-3-yl)oxy)ethan-1-amine Hydrochloride (<b>49</b>)</h3><div class="NLM_p last">This compound was obtained from <b>38</b> employing method I. White solid; yield 68%; purity 98.4%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.84 (br s, 1H), 7.32 (t, <i>J</i> = 8.0 Hz, 2H), 7.03 (d, <i>J</i> = 12.0 Hz, 2H), 6.99 (t, <i>J</i> = 8.0 Hz, 1H), 6.44 (s, 1H), 5.19 (s, 2H), 4.58 (t, <i>J</i> = 4.0 Hz, 2H), 3.52 (t, <i>J</i> = 6.0 Hz, 2H), 2.81 (s, 6H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 170.6, 169.3, 157.4, 129.6, 114.7, 95.4, 64.4, 60.4, 54.9, 42.6. HRMS (ESI): calcd for C<sub>14</sub>H<sub>19</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 263.1390; found, 263.1393.</div></div><div id="sec4_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> <i>N</i>-Ethyl-<i>N</i>-methyl-2-((5-(phenoxymethyl)isoxazol-3-yl)oxy)ethan-1-amine Hydrochloride (<b>50</b>)</h3><div class="NLM_p last">This compound was obtained from <b>39</b> employing method I. White solid; yield 67%; purity 98.6%. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 7.32 (t, <i>J</i> = 8.0 Hz, 2H), 7.03 (t, <i>J</i> = 4.0 Hz, 1H), 6.99 (d, <i>J</i> = 8.0 Hz, 2H), 6.20 (s, 1H), 5.13 (s, 2H), 4.50 (t, <i>J</i> = 4.0 Hz, 2H), 3.70–3.56 (m, 1H), 3.53–3.41 (m, 1H), 3.36–3.24 (m, 1H), 3.23–3.10 (m, 1H), 2.85 (s, 3H), 1.25 (t, <i>J</i> = 8.0 Hz, 3H). <sup>13</sup>C NMR (101 MHz, D<sub>2</sub>O) δ 171.0, 169.7, 157.0, 129.9, 122.4, 115.2, 95.3, 63.7, 61.2, 53.7, 51.8, 39.4, 8.4. HRMS (ESI): calcd for C<sub>15</sub>H<sub>21</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 277.1547; found, 277.1561.</div></div><div id="sec4_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> <i>N</i>-Methyl-<i>N</i>-(2-((5-(phenoxymethyl)isoxazol-3-yl)oxy)ethyl)cyclobutanamine Hydrochloride (<b>51</b>)</h3><div class="NLM_p last">This compound was obtained from <b>38</b> and cyclobutanone employing method J. White solid; yield 54%; purity 97.3%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.99 (s, 1H), 7.36–7.28 (m, 2H), 7.03(d, <i>J</i> = 8.0 Hz, 2H), 6.99 (t, <i>J</i> = 8.0 Hz, 1H), 6.45 (s, 1H), 5.19 (s, 2H), 4.56 (m, 2H), 3.81–3.68 (m, 1H), 2.67 (s, 3H), 2.38–2.24 (m, 2H), 2.17 (m, 2H), 1.68 (m, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.9, 169.6, 157.0, 129.9, 122.3, 115.0, 95.4, 63.6, 61.1, 59.9, 52.0, 36.8, 25.9, 12.6. HRMS (ESI): calcd for C<sub>17</sub>H<sub>23</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 303.1703; found, 303.1711.</div></div><div id="sec4_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> <i>N</i>-Methyl-<i>N</i>-(2-((5-(phenoxymethyl)isoxazol-3-yl)oxy)ethyl)cyclopentanamine Hydrochloride (<b>52</b>)</h3><div class="NLM_p last">This compound was obtained from <b>38</b> and cyclopentanone employing method J. White solid; yield 58%; purity 97.3%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.11 (s, 1H), 7.32 (t, <i>J</i> = 8.0 Hz, 2H), 7.05–6.98 (m, 3H), 6.46 (s, 1H), 5.20 (s, 2H), 4.70–4.50 (m, 2H), 3.65–3.56 (m, 2H), 3.47 (m, 1H), 2.78 (d, <i>J</i> = 4.0 Hz, 3H), 2.03–1.97 (m, 2H), 1.82–1.71 (m, 4H), 1.55–1.53 (m, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.6, 169.3, 157.4, 129.6, 121.4, 114.7, 95.4, 66.4, 64.3, 60.6, 52.6, 38.3, 27.7, 27.2, 23.5. HRMS (ESI): calcd for C<sub>18</sub>H<sub>25</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 317.1860; found, 317.1856.</div></div><div id="sec4_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> <i>N</i>-(Cyclopropylmethyl)-<i>N</i>-methyl-2-((5-(phenoxymethyl)isoxazol-3-yl)oxy)ethan-1-amine Hydrochloride (<b>53</b>)</h3><div class="NLM_p last">This compound was obtained from <b>38</b> and cyclopropanecarboxaldehyde employing method J. White solid; yield 60%; purity 97.8% <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.40–7.18 (m, 2H), 7.00 (t, <i>J</i> = 8.0 Hz, 1H), 6.94 (d, <i>J</i> = 4.0 Hz, 2H), 5.99 (s, 1H), 5.03 (s, 2H), 4.35 (t, <i>J</i> = 6.0 Hz, 2H), 2.86 (t, <i>J</i> = 4.0 Hz, 2H), 2.39 (s, 3H), 2.34 (d, <i>J</i> = 4.0 Hz, 2H), 0.88 (m, 1H), 0.59–0.47 (m, 2H), 0.11 (m, 2H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 172.0, 168.9, 157.9, 129.8, 122.0, 115.0, 95.4, 67.8, 63.1, 61.8, 55.9, 42.9, 8.8, 4.1. HRMS (ESI): calcd for C<sub>17</sub>H<sub>22</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 303.1703; found, 303.1701.</div></div><div id="sec4_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> <i>N</i>-Methyl-<i>N</i>-(2-((5-(phenoxymethyl)isoxazol-3-yl)oxy)ethyl)cyclohexanamine Hydrochloride (<b>54</b>)</h3><div class="NLM_p last">This compound was obtained from <b>38</b> and cyclohexanone employing method J. White solid; yield 77%; purity 99.2%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.33–7.27 (m, 2H), 7.00 (t, <i>J</i> = 8.0 Hz, 1H), 6.94 (d, <i>J</i> = 8.0 Hz, 2H), 5.97 (s, 1H), 5.03 (s, 2H), 4.30 (t, <i>J</i> = 4.0 Hz, 2H), 2.84 (t, <i>J</i> = 6.0 Hz, 2H), 2.44–2.37 (m, 1H), 2.35 (s, 3H), 1.84–1.75 (m, 4H), 1.62 (d, <i>J</i> = 12.0 Hz, 1H), 1.28–1.02 (m, 5H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 171.9, 168.6, 157.7, 129.6, 121.8, 114.8, 95.2, 68.4, 63.1, 61.6, 51.8, 38.7, 28.6, 26.3, 26.0. HRMS (ESI): calcd for C<sub>19</sub>H<sub>26</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 331.2016; found, 331.2028.</div></div><div id="sec4_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> <i>N</i>-(Cyclopropylmethyl)-2-((5-((3-fluorophenoxy)methyl)isoxazol-3-yl)oxy)-<i>N</i>-methylethan-1-amine Hydrochloride (<b>55</b>)</h3><div class="NLM_p last">Colorless oil; yield 50%; purity 98.0%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.23 (m, 1H), 6.72 (dd, <i>J</i> = 8.0, 4.0 Hz, 2H), 6.66 (m, 1H), 5.98 (s, 1H), 5.01 (s, 2H), 4.35 (t, <i>J</i> = 6.0 Hz, 2H), 2.85 (t, <i>J</i> = 6.0 Hz, 2H), 2.38 (s, 3H), 2.33 (d, <i>J</i> = 6.0 Hz, 2H), 0.89 (m, 1H), 0.51 (m, 2H), 0.10 (m, 2H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 171.8, 168.0, 163.5 (d, <i>J</i><sub>C–F</sub> = 247.5 Hz), 159.0 (d, <i>J</i><sub>C–F</sub> = 11.1 Hz), 130.4 (d, <i>J</i><sub>C–F</sub> = 10.1 Hz), 110.4 (d, <i>J</i><sub>C–F</sub> = 3.0 Hz), 108.7 (d, <i>J</i><sub>C–F</sub> = 21.2 Hz), 102.8 (d, <i>J</i><sub>C–F</sub> = 25.3 Hz), 95.4, 67.7, 62.9, 61.8, 55.7, 42.7, 8.6, 3.9. HRMS (ESI): calcd for C<sub>17</sub>H<sub>22</sub>FN<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 321.1609; found, 321.1614.</div></div><div id="sec4_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> 2-((5-((3-Chlorophenoxy)methyl)isoxazol-3-yl)oxy)-<i>N</i>-(cyclopropylmethyl)-<i>N</i>-methylethan-1-amine Hydrochloride (<b>56</b>)</h3><div class="NLM_p last">Colorless oil; yield 50%; purity 98.9%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.20 (t, <i>J</i> = 8.0 Hz, 1H), 6.97 (d, <i>J</i> = 8.0 Hz, 2H), 6.82 (m, 1H), 5.97 (s, 1H), 5.00 (s, 2H), 4.34 (t, <i>J</i> = 6.0 Hz, 2H), 2.84 (t, <i>J</i> = 6.0 Hz, 2H), 2.38 (s, 3H), 2.33 (d, <i>J</i> = 8.0 Hz, 2H), 0.93–0.80 (m, 1H), 0.50 (m, 2H), 0.10 (m, 2H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 171.8, 167.9, 158.4, 135.0, 130.4, 122.1, 115.4, 113.1, 95.4, 67.7, 62.9, 61.7, 55.7, 42.7, 8.6, 3.9. HRMS (ESI): calcd for C<sub>17</sub>H<sub>22</sub>ClN<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 337.1327; found, 337.1313.</div></div><div id="sec4_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> <i>N</i>-(2-((5-((3-Fluorophenoxy)methyl)isoxazol-3-yl)oxy)ethyl)-<i>N</i>-methylcyclohexanamine Hydrochloride (<b>57</b>)</h3><div class="NLM_p last">Colorless oil; yield 50%; purity 95.7%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.26–7.20 (m, 1H), 6.71 (dd, <i>J</i> = 8.0, 4.0 Hz, 2H), 6.66 (m, 1H), 5.97 (s, 1H), 5.01 (s, 2H), 4.30 (t, <i>J</i> = 6.0 Hz, 2H), 2.84 (t, <i>J</i> = 6.0 Hz, 2H), 2.43–2.37 (m, 1H), 2.34 (s, 3H), 1.81–1.78 (m, 5H), 1.62 (m, 1H), 1.25–1.18 (m, 4H), 1.13–1.00 (m, 1H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 171.8, 168.0, 163.6 (d, <i>J</i><sub>C–F</sub> = 247.5 Hz), 159.0 (d, <i>J</i><sub>C–F</sub> = 11.1 Hz), 130.4 (d, <i>J</i><sub>C–F</sub> = 10.1 Hz), 110.4, 108.7 (d, <i>J</i><sub>C–F</sub> = 21.2 Hz), 102.8 (d, <i>J</i><sub>C–F</sub> = 25.3 Hz), 95.3, 68.5, 63.1, 61.8, 51.8, 38.7, 28.6, 26.3, 26.0. HRMS (ESI): calcd for C<sub>19</sub>H<sub>26</sub>FN<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 349.1922; found, 349.1934.</div></div><div id="sec4_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> <i>N</i>-(2-((5-((3-Chlorophenoxy)methyl)isoxazol-3-yl)oxy)ethyl)-<i>N</i>-methylcyclohexanamine Hydrochloride (<b>58</b>)</h3><div class="NLM_p last">Colorless oil; yield 49%; purity 95.1%. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 7.24 (t, <i>J</i> = 8.0 Hz, 1H), 7.02–7.01 (m, 2H), 6.90 (d, <i>J</i> = 8.0 Hz, 1H), 6.21 (s, 1H), 5.11 (s, 2H), 4.50 (m, 2H), 3.49 (m, 2H), 3.25 (t, <i>J</i> = 12.0 Hz, 1H), 2.80 (s, 3H), 1.92 (m, 2H), 1.81 (m, 2H), 1.58 (m, 1H), 1.42 (m, 2H), 1.24 (m, 2H), 1.08 (m, 1H). <sup>13</sup>C NMR (101 MHz, D<sub>2</sub>O) δ 170.9, 169.1, 157.9, 134.4, 130.8, 122.1, 115.5, 113.4, 95.5, 65.3, 64.2, 61.3, 51.3, 36.8, 26.1, 24.5, 24.4. HRMS (ESI): calcd for C<sub>19</sub>H<sub>26</sub>ClN<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 365.1626; found, 365.1627.</div></div><div id="sec4_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> 4-(2-((5-(Phenoxymethyl)isoxazol-3-yl)oxy)ethyl)morpholine Hydrochloride (<b>59</b>)</h3><div class="NLM_p last">To a stirred solution of <b>36</b> (100 mg, 0.45 mmol), 1-chloro-2-(2-chloroethoxy)ethane (280 mg, 2 mmol), and NaI (130 mg, 0.86 mmol) in anhydrous DMF (5 mL) was added K<sub>2</sub>CO<sub>3</sub> (500 mg, 4 mmol) at 80 °C under N<sub>2</sub>. After stirring overnight at 80 °C, the reaction mixture was cooled to rt and 20 mL of water was added. The resulting mixture was extracted with EtOAc (3 × 30 mL), and the combined organic layers were washed with water (3 × 20 mL) and brine (15 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under vacuum. The residue was purified by flash chromatography. To the solution of purified compound in CH<sub>2</sub>Cl<sub>2</sub> (3 mL) was added HCl/EtOAc (4 mol/L, 1 mL) under N<sub>2</sub> with ice cooling. The mixture was stirred overnight at rt. After the solvent was evaporated, the residue was triturated with diethyl ether (10 mL). The resultant solid was filtered off to give the HCl salt. White solid; yield 31%; purity 98.2%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.29 (m, 2H), 7.00 (t, <i>J</i> = 8.0 Hz, 1H), 6.94 (d, <i>J</i> = 8.0 Hz, 2H), 5.98 (s, 1H), 5.03 (s, 2H), 4.37 (t, <i>J</i> = 4.0 Hz, 2H), 3.72 (t, <i>J</i> = 4.0 Hz, 4H), 2.77 (t, <i>J</i> = 4.0 Hz, 2H), 2.53 (t, <i>J</i> = 4.0 Hz, 4H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 171.7, 168.8, 157.7, 129.6, 121.9, 114.8, 95.0, 67.1, 66.8, 61.6, 57.3, 53.9. HRMS (ESI): calcd for C<sub>16</sub>H<sub>20</sub>N<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 305.1496; found, 305.1518.</div></div><div id="sec4_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> <i>tert</i>-Butyl 3-Bromo-4,5-dihydroisoxazole-5-carboxylate (<b>62</b>)</h3><div class="NLM_p last">To a stirred solution of <b>60</b> (2.1 g, 10 mmol) in DMF (10 mL) was added 5 mL of <i>tert</i>-butyl acrylate (<b>61</b>) at 0 °C and subsequently 8 mL of saturated KHCO<sub>3</sub> solution at −10 °C. After stirring for 4 h at rt, HCl (1 M, 20 mL) was added to the reaction mixture. The resulting mixture was extracted with MTBE (3 × 20 mL), and the combined organic layers were washed with water (20 mL) and brine (15 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under vacuum. The residue was purified by flash chromatography to give the title compound as a colorless oil in 46% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 4.97 (dd, <i>J</i> = 8.0, 8.0 Hz, 1H), 3.46 (d, <i>J</i> = 4.0 Hz, 1H), 3.44 (m, 1H), 1.50 (s, 9H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 167.8, 136.5, 83.3, 79.0, 44.7, 28.0.</div></div><div id="sec4_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> <i>tert</i>-Butyl 3-(4-(<i>tert</i>-Butoxycarbonyl)piperazin-1-yl)isoxazole-5-carboxylate (<b>63</b>)</h3><div class="NLM_p last">To a stirred solution of <b>62</b> (1.0 g, 4 mmol) and <i>tert</i>-butyl piperazine-1-carboxylate (900 mg, 4.8 mmol) in 16 mL of <i>tert</i>-butyl alcohol was added a 10 mL aqueous solution of Na<sub>2</sub>CO<sub>3</sub> (1.0 g, 9.4 mmol). After stirring overnight at 80 °C, the resulting mixture was extracted with MTBE (3 × 20 mL), and the combined organic layers were washed with water (20 mL) and brine (15 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under vacuum. The residue was purified by flash chromatography to give <i>tert</i>-butyl 3-(4-(<i>tert</i>-butoxycarbonyl)piperazin-1-yl)-4,5-dihydroisoxazole-5-carboxylate 500 mg, which was dissolved in 5 mL of toluene. Imidazole (280 mg, 4.2 mmol) and I<sub>2</sub> (500 mg, 2.1 mmol) were then added in sequence. After stirring at 120 °C for 4 h, the reaction mixture was cooled to rt, diluted with EtOAc, and treated with Na<sub>2</sub>S<sub>2</sub>O<sub>6</sub> (10% aq). The aqueous layer was extracted with EtOAc (2 × 15 mL). The combined organic layers were washed with brine (15 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under vacuum. The residue was purified by flash chromatography to give the title compound as a white solid in 60% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.49 (s, 1H), 3.53 (m, 4H), 3.27 (m, 4H), 1.58 (s, 9H), 1.48 (s, 9H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 166.7, 161.3, 156.0, 154.6, 99.6, 83.8, 80.2, 47.1, 28.4, 28.0.</div></div><div id="sec4_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> <i>tert</i>-Butyl 4-(5-(Iodomethyl)isoxazol-3-yl)piperazine-1-carboxylate (<b>64</b>)</h3><div class="NLM_p last">This compound was obtained from <b>63</b> employing methods A and H. White solid; yield 43%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 5.94 (s, 1H), 4.27 (s, 2H), 3.52 (m, 4H), 3.24 (m, 4H), 1.48 (s, 9H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 168.6, 167.0, 154.6, 93.7, 80.2, 47.0, 28.4, −12.4.</div></div><div id="sec4_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> 5-(Phenoxymethyl)-3-(piperazin-1-yl)isoxazole Hydrochloride (<b>65</b>)</h3><div class="NLM_p last">This compound was obtained from <b>64</b> employing methods F and C. White solid; yield 45%; purity 97.0%. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 7.28 (t, <i>J</i> = 8.0 Hz, 2H), 7.09 (d, <i>J</i> = 8.0 Hz, 1H), 7.05 (d, <i>J</i> = 8.0 Hz, 2H), 6.23 (s, 1H), 5.09 (s, 2H), 3.55–3.30 (m, 4H), 3.35–3.07 (m, 4H), 1.46 (s, 1H). <sup>13</sup>C NMR (101 MHz, D<sub>2</sub>O) δ 168.7, 166.5, 129.9, 122.4, 115.2, 100.0, 95.4, 61.2, 43.8, 42.3. HRMS (ESI): calcd for C<sub>14</sub>H<sub>17</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 260.1394; found, 260.1416.</div></div><div id="sec4_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> 5-((3-Chlorophenoxy)methyl)-3-(piperazin-1-yl)isoxazole Hydrochloride (<b>66</b>)</h3><div class="NLM_p last">White solid; yield 60%; purity 98.9%. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 7.36 (t, <i>J</i> = 8.0 Hz, 1H), 7.13 (m, 2H), 7.01 (d, <i>J</i> = 8.0 Hz, 1H), 6.37 (s, 1H), 5.20 (s, 2H), 3.58 (m, 4H), 3.39 (m, 4H). <sup>13</sup>C NMR (101 MHz, D<sub>2</sub>O) δ 168.3, 166.0, 157.7, 134.5, 130.8, 122.3, 115.5, 113.7, 95.5, 61.4, 43.8, 42.4. HRMS (ESI): calcd for C<sub>14</sub>H<sub>17</sub>ClN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 294.1004; found, 294.1032.</div></div><div id="sec4_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> 3-(4-Methylpiperazin-1-yl)-5-(phenoxymethyl)isoxazole Hydrochloride (<b>67</b>)</h3><div class="NLM_p last">This compound was obtained from <b>65</b> employing method I. White solid; yield 65%; purity 96.3%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.30 (m, 2H), 7.00 (t, <i>J</i> = 8.0 Hz, 1H), 6.94 (d, <i>J</i> = 8.0 Hz, 2H), 5.98 (s, 1H), 5.03 (s, 2H), 3.38–3.19 (m, 4H), 2.56–2.45 (m, 4H), 2.33 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 168.1, 167.2, 158.0, 129.8, 121.9, 114.9, 94.4, 61.9, 54.4, 47.3, 46.5. HRMS (ESI): calcd for C<sub>15</sub>H<sub>19</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 274.1550; found, 274.1574.</div></div><div id="sec4_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> 4-(5-(Phenoxymethyl)isoxazol-3-yl)morpholine Hydrochloride (<b>68</b>)</h3><div class="NLM_p last">White solid; yield 67%; purity 96.4%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.34–7.28 (m, 2H), 7.00 (t, <i>J</i> = 6.0 Hz, 1H), 6.95 (d, <i>J</i> = 8.0 Hz, 2H), 5.98 (s, 1H), 5.05 (s, 2H), 3.82–3.76 (m, 4H), 3.29–3.22 (m, 4H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 168.2, 167.2, 157.8, 129.7, 121.8, 114.8, 93.9, 66.2, 61.7, 47.5. HRMS (ESI): calcd for C<sub>14</sub>H<sub>16</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 261.1234; found, 261.1239.</div></div><div id="sec4_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> 5-(Phenoxymethyl)-3-(piperidin-1-yl)isoxazole Hydrochloride (<b>69</b>)</h3><div class="NLM_p last">White solid; yield 68%; purity 97.1%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.30 (m, 2H), 7.00 (t, <i>J</i> = 6.0 Hz, 1H), 6.95 (d, <i>J</i> = 8.0 Hz, 2H), 5.97 (s, 1H), 5.03 (s, 2H), 3.24 (m, 4H), 1.67–1.60 (m, 6H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 167.7, 167.5, 158.1, 129.6, 121.9, 115.0, 94.5, 62.0, 48.5, 25.2, 24.3. HRMS (ESI): calcd for C<sub>15</sub>H<sub>18</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 259.1441; found, 259.1434.</div></div><div id="sec4_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> In Vitro Binding Studies</h3><div class="NLM_p last">Radioligand competition studies were carried out by the National Institute of Mental Health’s Psychoactive Drug Screening Program, contract no. HHSN-271–2008–00025-C (NIMH PDSP). For experimental details please refer to the PDSP Web site <a href="http://pdsp.med.unc.edu/" class="extLink">http://pdsp.med.unc.edu/</a>.</div></div><div id="sec4_65" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> General Procedures for Behavioral Studies</h3><div id="sec4_65_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> Animals</h4><div class="NLM_p last">Chinese Kun Ming (KM) mice weighing 22–27 g were used in behavioral and PK studies. All animal experiments conformed to the regulations drafted by the Association for Assessment and Accreditation of Laboratory Animal Care in Shanghai and were approved by the East China Normal University Center for Animal Research and Institutional Animal Care and Use Committees. The animals were obtained from Shanghai SLAC Laboratory Animal Co, Ltd. (Shanghai, China). All animal experiments were performed in a blinded manner, i.e., administration of drugs and behavioral assessments were performed by different investigators.</div></div><div id="sec4_65_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> Drugs</h4><div class="NLM_p last">Compounds <b>53</b> and <b>4</b> were synthesized according to procedures described in the text and literature.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Pregabalin was purchased from Energy Chemical, China. All compounds were dissolved in injectable water and administrated intraperitoneally (ip) in a volume of 10 mL/kg.</div></div><div id="sec4_65_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> Formalin Test</h4><div class="NLM_p last">KM mice were randomly grouped and allowed to habituate for at least 30 min in a transparent observation chamber before the experiment. The animals were given a subcutaneous injection of formalin (1%, 20 μL) into the plantar of the left hind paw. Formalin-induced nociception was assessed by scoring pain behaviors and licking time during a 45 min observation. Phases were defined as follows: phase I (0–10 min), and phase II (11–45 min). Compounds <b>53</b> or <b>4</b> was administrated intraperitoneally 15 min before the injection of formalin.</div></div><div id="sec4_65_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> Rotarod Test</h4><div class="NLM_p last">The motor performance of mice was assessed by an automated rotarod (JLBehv-RRTG, China). Mice were trained, and those which could not stay moving on the rod for 300 s in 10 rpm were omitted from the study before drug treatment. In the test, mice were required to walk against the motion of an elevated rotating drum at 10 rpm and the latencies to fall-down were recorded. With the selected animals, rotarod latencies were measured 30, 60, 90, and 120 min after ip administration of drugs.</div></div></div><div id="sec4_66" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> In Vitro PAMPA</h3><div class="NLM_p">The ability of compounds to cross the cell membrane was predicted and evaluated using PAMPA. Tested compounds were dissolved in DMSO at 5 mg/mL as stock solutions. A 10 μL sample of stock solution was diluted in PBS to make a secondary stock solution (final concentration 25 mg/mL). These solutions were filtered, and a 300 μL sample of secondary stock solution was added to the donor well. The porcine polar brain lipid was dissolved in dodecane at 20 mg/mL. The filter membrane was coated with 4 μL of porcine polar brain lipid solution, and the acceptor well was filled with 150 μL of PBS. The acceptor filter plate was carefully put on the donor plate to form a “sandwich” which was composed of the donor with tested compounds on the bottom, artificial lipid membrane in the middle, and the acceptor on the top. The sandwich was incubated undisturbed at room temperature for 18 h. The donor plate was removed after incubation. The concentrations of tested compounds in the acceptor and reference solutions were determined by a UV plate reader. Reference solutions were prepared by diluting the sample secondary stock solution to the same concentration as that with no membrane barrier. Every sample was analyzed at three wavelengths in three wells, and in three independent runs.</div><div id="sec4_66_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> Pharmacokinetics Study in Mice</h4><div class="NLM_p last">Compound <b>53</b> (40 mg/kg) was orally administered to KM mice before collection of plasma and brain samples at the following time points: 0.167, 0.5, 1, 2, 4, 6, and 8 h (<i>n</i> = 3/group). Aliquots of 10.0 μL of real samples, calibration curve samples, and QC samples were supplemented with 200 μL of precipitant. After vortexed for 3.00 min and centrifuged at 12000 rpm for 3.00 min, the supernatant 75.0 μL was transferred into 96-well plate with equal volume water after vortex. The mixture solution (10 μL) were injected for LC-MS/MS analysis.</div></div><div id="sec4_66_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> Statistical Analysis</h4><div class="NLM_p last">Data are expressed as the mean ± SEM. Multiple group comparisons for formalin test were performed using unpaired, two-tailed <i>t</i> test. Multiple group comparisons for rotarod test were performed by two-way ANOVA followed by Bonferroni post-test. Differences were considered statistically significant at * <i>p</i> < 0.05, ** <i>p</i> < 0.01, *** <i>p</i> < 0.001.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i90"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00571">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34562" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34562" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b00571" class="ext-link">10.1021/acs.jmedchem.6b00571</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline"><sup>1</sup>H and <sup>13</sup>C NMR spectra of all final compounds, PAMPA permeability of selected compounds, and functional profile of compound <b>53</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00571/suppl_file/jm6b00571_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00571/suppl_file/jm6b00571_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00571/suppl_file/jm6b00571_si_001.pdf">jm6b00571_si_001.pdf (4.5 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00571/suppl_file/jm6b00571_si_002.csv">jm6b00571_si_002.csv (3.28 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b00571" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06641" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06641" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jie Tang</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Engineering Research Center of Molecular Therapeutics and New Drug
Development, School of Chemistry and Molecular Engineering, East China Normal University, 3663 North Zhongshan Road, Shanghai 200062, China</span>; 
    <span class="hlFld-Affiliation affiliation">Shanghai
Key Laboratory of Green Chemistry and Chemical Process, School of
Chemistry and Molecular Engineering, East
China Normal University, 3663 North Zhongshan Road, Shanghai 200062, China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f49e80959a93b4979c9199da91979a81da919081da979a"><span class="__cf_email__" data-cfemail="c6acb2a7a8a186a5aea3abe8a3a5a8b3e8a3a2b3e8a5a8">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Li-Fang Yu</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Engineering Research Center of Molecular Therapeutics and New Drug
Development, School of Chemistry and Molecular Engineering, East China Normal University, 3663 North Zhongshan Road, Shanghai 200062, China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#c7aba1beb287b4a6b3e9a2a4a9b2e9a2a3b2e9a4a9"><span class="__cf_email__" data-cfemail="533f352a26132032277d36303d267d3637267d303d">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hao Sun</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Engineering Research Center of Molecular Therapeutics and New Drug
Development, School of Chemistry and Molecular Engineering, East China Normal University, 3663 North Zhongshan Road, Shanghai 200062, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Min Shi</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Engineering Research Center of Molecular Therapeutics and New Drug
Development, School of Chemistry and Molecular Engineering, East China Normal University, 3663 North Zhongshan Road, Shanghai 200062, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wei Zhang</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Engineering Research Center of Molecular Therapeutics and New Drug
Development, School of Chemistry and Molecular Engineering, East China Normal University, 3663 North Zhongshan Road, Shanghai 200062, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yue-Ming Zheng</span> - <span class="hlFld-Affiliation affiliation">CAS
Key Laboratory of Receptor Research, Shanghai Institute of Materia
Medica, Chinese Academy of Sciences, 501 Hai Ke Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ya-Zhou Xu</span> - <span class="hlFld-Affiliation affiliation">Jiangsu
Key Laboratory of Drug Screening, State Key Laboratory of Natural
Medicines, China Pharmaceutical University, Nanjing 210009, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jun-Jie Shi</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Engineering Research Center of Molecular Therapeutics and New Drug
Development, School of Chemistry and Molecular Engineering, East China Normal University, 3663 North Zhongshan Road, Shanghai 200062, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ting Liu</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Engineering Research Center of Molecular Therapeutics and New Drug
Development, School of Chemistry and Molecular Engineering, East China Normal University, 3663 North Zhongshan Road, Shanghai 200062, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hendra Gunosewoyo</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Faculty of Health Sciences, Curtin University, Bentley, Perth, Western Australia 6102, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tao Pang</span> - <span class="hlFld-Affiliation affiliation">Jiangsu
Key Laboratory of Drug Screening, State Key Laboratory of Natural
Medicines, China Pharmaceutical University, Nanjing 210009, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhao-Bing Gao</span> - <span class="hlFld-Affiliation affiliation">CAS
Key Laboratory of Receptor Research, Shanghai Institute of Materia
Medica, Chinese Academy of Sciences, 501 Hai Ke Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fan Yang</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Engineering Research Center of Molecular Therapeutics and New Drug
Development, School of Chemistry and Molecular Engineering, East China Normal University, 3663 North Zhongshan Road, Shanghai 200062, China</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d77e6178-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i91">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52865" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52865" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the National Natural Science Foundation of China (81402780), the Natural Science Foundation of Shanghai (14ZR1411000), and Innovation Program of East China Normal University (78210263). We thank the PDSP for performing binding affinity assays. We thank Jiangsu Nhwa Pharmaceutical Co., Ltd. for performing functional assays.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i92" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i92"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i93" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i93"> Abbreviations Used</h2><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">ADHD</td><td class="NLM_def"><p class="first last">attention deficit hyperactivity disorder</p></td></tr><tr><td class="NLM_term">MAM</td><td class="NLM_def"><p class="first last">mitochondrial-associated endoplasmic reticulum membrane</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">endoplasmic reticulum</p></td></tr><tr><td class="NLM_term">IP<sub>3</sub></td><td class="NLM_def"><p class="first last">inositol 1,4,5-trisphosphate</p></td></tr><tr><td class="NLM_term">BiP</td><td class="NLM_def"><p class="first last">binding-immunoglobulin protein</p></td></tr><tr><td class="NLM_term">PGRMC1</td><td class="NLM_def"><p class="first last">progesterone receptor membrane component 1</p></td></tr><tr><td class="NLM_term">DMT</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethyltryptamine</p></td></tr><tr><td class="NLM_term">NIMH-PDSP</td><td class="NLM_def"><p class="first last">National Institute of Mental Health—Psychoactive Drug Screening Program</p></td></tr><tr><td class="NLM_term">ADME-Tox</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, excretion, and toxicity</p></td></tr><tr><td class="NLM_term">nAChR(s)</td><td class="NLM_def"><p class="first last">nicotinic acetylcholine receptor(s)</p></td></tr><tr><td class="NLM_term">DAT</td><td class="NLM_def"><p class="first last">dopamine transporter</p></td></tr><tr><td class="NLM_term">NET</td><td class="NLM_def"><p class="first last">norepinephrine transporter</p></td></tr><tr><td class="NLM_term">SERT</td><td class="NLM_def"><p class="first last">serotonin transporter</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">CC</td><td class="NLM_def"><p class="first last">column chromatography</p></td></tr><tr><td class="NLM_term">rt</td><td class="NLM_def"><p class="first last">room temperature</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i94">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41541" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41541" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 37 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Martin, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eades, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huppler, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, P. E.</span><span> </span><span class="NLM_article-title">The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">197</span><span class="NLM_x">, </span> <span class="NLM_fpage">517</span><span class="NLM_x">–</span> <span class="NLM_lpage">532</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=945347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADyaE28XltlOhurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=197&publication_year=1976&pages=517-532&author=W.+R.+Martinauthor=C.+G.+Eadesauthor=J.+A.+Thompsonauthor=R.+E.+Hupplerauthor=P.+E.+Gilbert&title=The+effects+of+morphine-+and+nalorphine-+like+drugs+in+the+nondependent+and+morphine-dependent+chronic+spinal+dog"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog</span></div><div class="casAuthors">Martin, W. R.; Eades, C. G.; Thompson, J. A.; Huppler, R. E.; Gilbert, P. E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">197</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">517-32</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">Three different syndromes produced by congeners of morphine sulfate (I sulfate) [64-31-3] were identified in the nondependent chronic spinal dog.  These syndromes were attributed to interaction of agonists with three distinguishable receptors (μ, κ and σ).  I was the prototype agonist for the μ receptor, ketocyclazocine lactate [59985-33-0] for the κ receptor and SKF-10,047 lactate [59985-34-1] for the σ receptor.  The I syndrome (μ) in the dog was characterized by miosis, bradycardia, hypothermia, a general depression of the nociceptive responses and indifferences to environmental stimuli.  Ketocyclazocine (κ) constricted pupils, depressed the flexor reflex and produced sedation but did not markedly alter pulse rate or the skin twitch reflex.  SKF-10,047 (σ) caused mydriasis, tachypnea, tachycardia and mania.  The effects of these three drugs was antagonized by the pure antagonist naltrexone-HCl, indicating that they are agonists.  Further, chronic administration of I, ketocyclazocine and SKF-10,047 induced tolerance to their agonistic effects.  I suppressed abstinence in I-dependent dogs while ketocyclazocine did not.  Ketocyclazocine at best pptd. only a liminal abstinence syndrome in the I-dependent dog, indicating that it had little affinity for the I receptor.  Ketocyclazocine thus appears to be a selective agonist at the κ receptor.  Buprenorphine-HCl [53152-21-9] was a partial agonist of the μ type which both suppressed and pptd. abstinence in the I-dependent dog while I and d-propoxyphene-HCl [1639-60-7] were stronger agonists.  Apomorphine-HCl [314-19-2] and SKF-10,047 produced similar pharmacol. effects suggesting that σ activity may involve a dopaminergic mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6rgyf41iRTbVg90H21EOLACvtfcHk0lgMikEYYx7Beg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XltlOhurw%253D&md5=ca7c637f336ac9ecc2c3bb040dbcdbee</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DW.%2BR.%26aulast%3DEades%26aufirst%3DC.%2BG.%26aulast%3DThompson%26aufirst%3DJ.%2BA.%26aulast%3DHuppler%26aufirst%3DR.%2BE.%26aulast%3DGilbert%26aufirst%3DP.%2BE.%26atitle%3DThe%2520effects%2520of%2520morphine-%2520and%2520nalorphine-%2520like%2520drugs%2520in%2520the%2520nondependent%2520and%2520morphine-dependent%2520chronic%2520spinal%2520dog%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1976%26volume%3D197%26spage%3D517%26epage%3D532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Hayashi, T.</span><span> </span><span class="NLM_article-title">Sigma-1 receptor: The novel intracellular target of neuropsychotherapeutic drugs</span> <span class="citation_source-journal">J. Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">5</span><span class="refDoi"> DOI: 10.1016/j.jphs.2014.07.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.1016%2Fj.jphs.2014.07.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=25704011" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BC28Xislaks70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2015&pages=2-5&author=T.+Hayashi&title=Sigma-1+receptor%3A+The+novel+intracellular+target+of+neuropsychotherapeutic+drugs&doi=10.1016%2Fj.jphs.2014.07.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma-1 receptor: The novel intracellular target of neuropsychotherapeutic drugs</span></div><div class="casAuthors">Hayashi, Teruo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Sciences (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2-5</span>CODEN:
                <span class="NLM_cas:coden">JPSTGJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-8613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Sigma-1 receptor ligands have been long expected to serve as drugs for treatment of human diseases such as neurodegenerative disorders, depression, idiopathic pain, drug abuse, and cancer.  Recent research exploring the mol. function of the sigma-1 receptor started unveiling underlying mechanisms of the therapeutic activity of those ligands.  Via the mol. chaperone activity, the sigma-1 receptor regulates protein folding/degrdn., ER/oxidative stress, and cell survival.  The chaperone activity is activated or inhibited by synthetic sigma-1 receptor ligands in an agonist-antagonist manner.  Sigma-1 receptors are localized at the endoplasmic reticulum (ER) membranes that are phys. assocd. with the mitochondria (MAM: mitochondria-assocd. ER membrane).  In specific types of neurons (e.g., those at the spinal cord), sigma-1 receptors are also clustered at ER membranes that juxtapose postsynaptic plasma membranes.  Recent studies indicate that sigma-1 receptors, partly in sake of its unique subcellular localization, regulate the mitochondria function that involves bioenergetics and free radical generation.  The sigma-1 receptor may thus provide an intracellular drug target that enables controlling ER stress and free radical generation under pathol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeVEWApyOzPbVg90H21EOLACvtfcHk0ljzTcDcwr7CmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xislaks70%253D&md5=b98bbc555be9cfab37acb32e8d62269e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.jphs.2014.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jphs.2014.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DT.%26atitle%3DSigma-1%2520receptor%253A%2520The%2520novel%2520intracellular%2520target%2520of%2520neuropsychotherapeutic%2520drugs%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2015%26volume%3D127%26spage%3D2%26epage%3D5%26doi%3D10.1016%2Fj.jphs.2014.07.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Mach, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, W. G.</span><span> </span><span class="NLM_article-title">The sigma2 receptor: a novel protein for the imaging and treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">7137</span><span class="NLM_x">–</span> <span class="NLM_lpage">7160</span><span class="refDoi"> DOI: 10.1021/jm301545c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301545c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7137-7160&author=R.+H.+Machauthor=C.+Zengauthor=W.+G.+Hawkins&title=The+sigma2+receptor%3A+a+novel+protein+for+the+imaging+and+treatment+of+cancer&doi=10.1021%2Fjm301545c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Fjm301545c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301545c%26sid%3Dliteratum%253Aachs%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DZeng%26aufirst%3DC.%26aulast%3DHawkins%26aufirst%3DW.%2BG.%26atitle%3DThe%2520sigma2%2520receptor%253A%2520a%2520novel%2520protein%2520for%2520the%2520imaging%2520and%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7137%26epage%3D7160%26doi%3D10.1021%2Fjm301545c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Hanner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moebius, F. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flandorfer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knaus, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Striessnig, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kempner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glossmann, H.</span><span> </span><span class="NLM_article-title">Purification, molecular cloning, and expression of the mammalian sigma(1)-binding site</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">8072</span><span class="NLM_x">–</span> <span class="NLM_lpage">8077</span><span class="refDoi"> DOI: 10.1073/pnas.93.15.8072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.1073%2Fpnas.93.15.8072" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=8072-8077&author=M.+Hannerauthor=F.+F.+Moebiusauthor=A.+Flandorferauthor=H.+G.+Knausauthor=J.+Striessnigauthor=E.+Kempnerauthor=H.+Glossmann&title=Purification%2C+molecular+cloning%2C+and+expression+of+the+mammalian+sigma%281%29-binding+site&doi=10.1073%2Fpnas.93.15.8072"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1073%2Fpnas.93.15.8072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.93.15.8072%26sid%3Dliteratum%253Aachs%26aulast%3DHanner%26aufirst%3DM.%26aulast%3DMoebius%26aufirst%3DF.%2BF.%26aulast%3DFlandorfer%26aufirst%3DA.%26aulast%3DKnaus%26aufirst%3DH.%2BG.%26aulast%3DStriessnig%26aufirst%3DJ.%26aulast%3DKempner%26aufirst%3DE.%26aulast%3DGlossmann%26aufirst%3DH.%26atitle%3DPurification%252C%2520molecular%2520cloning%252C%2520and%2520expression%2520of%2520the%2520mammalian%2520sigma%25281%2529-binding%2520site%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1996%26volume%3D93%26spage%3D8072%26epage%3D8077%26doi%3D10.1073%2Fpnas.93.15.8072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Hayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzuto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajnoczky, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, T.-P.</span><span> </span><span class="NLM_article-title">MAM: more than just a housekeeper</span> <span class="citation_source-journal">Trends Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span><span class="refDoi"> DOI: 10.1016/j.tcb.2008.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.1016%2Fj.tcb.2008.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=19144519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1amtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=81-88&author=T.+Hayashiauthor=R.+Rizzutoauthor=G.+Hajnoczkyauthor=T.-P.+Su&title=MAM%3A+more+than+just+a+housekeeper&doi=10.1016%2Fj.tcb.2008.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">MAM: more than just a housekeeper</span></div><div class="casAuthors">Hayashi, Teruo; Rizzuto, Rosario; Hajnoczky, Gyorgy; Su, Tsung-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">81-88</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The phys. assocn. between the endoplasmic reticulum (ER) and mitochondria, which is known as the mitochondria-assocd. ER membrane (MAM), has important roles in various cellular housekeeping' functions including the non-vesicular transports of phospholipids.  It has recently become clear that the MAM also enables highly efficient transmission of Ca2+ from the ER to mitochondria to stimulate oxidative metab. and, conversely, might enable the metabolically energized mitochondria to regulate the ER Ca2+ homeostasis.  Recent studies have shed light on mol. chaperones such as calnexin, calreticulin, ERp44, ERp57, grp75 and the sigma-1 receptor at the MAM, which regulate the assocn. between the two organelles.  The MAM thus integrates signal transduction with metabolic pathways to regulate the communication and functional interactions between the ER and mitochondrion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4MAdoa1CVZbVg90H21EOLACvtfcHk0ljzTcDcwr7CmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1amtLw%253D&md5=646e3eebc50c0bd4425fe916e01f601e</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.tcb.2008.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tcb.2008.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DRizzuto%26aufirst%3DR.%26aulast%3DHajnoczky%26aufirst%3DG.%26aulast%3DSu%26aufirst%3DT.-P.%26atitle%3DMAM%253A%2520more%2520than%2520just%2520a%2520housekeeper%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2009%26volume%3D19%26spage%3D81%26epage%3D88%26doi%3D10.1016%2Fj.tcb.2008.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Su, T.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurice, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buch, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruoho, A. E.</span><span> </span><span class="NLM_article-title">The sigma-1 receptor chaperone as an inter-organelle signaling modulator</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">557</span><span class="NLM_x">–</span> <span class="NLM_lpage">566</span><span class="refDoi"> DOI: 10.1016/j.tips.2010.08.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.1016%2Fj.tips.2010.08.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=20869780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVGisbbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=557-566&author=T.-P.+Suauthor=T.+Hayashiauthor=T.+Mauriceauthor=S.+Buchauthor=A.+E.+Ruoho&title=The+sigma-1+receptor+chaperone+as+an+inter-organelle+signaling+modulator&doi=10.1016%2Fj.tips.2010.08.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The sigma-1 receptor chaperone as an inter-organelle signaling modulator</span></div><div class="casAuthors">Su, Tsung-Ping; Hayashi, Teruo; Maurice, Tangui; Buch, Shilpa; Ruoho, Arnold E.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">557-566</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Inter-organelle signaling plays important roles in many physiol. functions.  Endoplasmic reticulum (ER)-mitochondrion signaling affects intramitochondrial calcium (Ca2+) homeostasis and cellular bioenergetics.  ER-nucleus signaling attenuates ER stress.  ER-plasma membrane signaling regulates cytosolic Ca2+ homeostasis and ER-mitochondrion-plasma membrane signaling regulates hippocampal dendritic spine formation.  Here, we propose that the sigma-1 receptor (Sig-1R), an ER chaperone protein, acts as an inter-organelle signaling modulator.  Sig-1Rs normally reside at the ER-mitochondrion contact called the MAM (mitochondrion-assocd. ER membrane), where Sig-1Rs regulate ER-mitochondrion signaling and ER-nucleus crosstalk.  When cells are stimulated by ligands or undergo prolonged stress, Sig-1Rs translocate from the MAM to the ER reticular network and plasmalemma/plasma membrane to regulate a variety of functional proteins, including ion channels, receptors and kinases.  Thus, the Sig-1R serves as an inter-organelle signaling modulator locally at the MAM and remotely at the plasmalemma/plasma membrane.  Many pharmacol./physiol. effects of Sig-1Rs might relate to this unique action of Sig-1Rs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqgD87pznGvLVg90H21EOLACvtfcHk0ljzTcDcwr7CmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVGisbbE&md5=a768850c77087ebf6732c0d57577f111</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2010.08.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2010.08.007%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DT.-P.%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DMaurice%26aufirst%3DT.%26aulast%3DBuch%26aufirst%3DS.%26aulast%3DRuoho%26aufirst%3DA.%2BE.%26atitle%3DThe%2520sigma-1%2520receptor%2520chaperone%2520as%2520an%2520inter-organelle%2520signaling%2520modulator%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2010%26volume%3D31%26spage%3D557%26epage%3D566%26doi%3D10.1016%2Fj.tips.2010.08.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Hayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, T. P.</span><span> </span><span class="NLM_article-title">Regulating ankyrin dynamics: Roles of sigma-1 receptors</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span><span class="refDoi"> DOI: 10.1073/pnas.98.2.491</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.1073%2Fpnas.98.2.491" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=11149946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnslKhsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=491-496&author=T.+Hayashiauthor=T.+P.+Su&title=Regulating+ankyrin+dynamics%3A+Roles+of+sigma-1+receptors&doi=10.1073%2Fpnas.98.2.491"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Regulating ankyrin dynamics: roles of sigma-1 receptors</span></div><div class="casAuthors">Hayashi, Teruo; Su, Tsung-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">491-496</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Ankyrin is a cytoskeletal adaptor protein that controls important cellular functions, including Ca2+ efflux at inositol 1,4,5-trisphosphate receptors (IP3R) on the endoplasmic reticulum.  The present study found that sigma-1 receptors (Sig-1R), unique endoplasmic reticulum proteins that bind certain steroids, neuroleptics, and psychotropic drugs, form a trimeric complex with ankyrin B and IP3R type 3 (IP3R-3) in NG-108 cells.  The trimeric complex could be coimmunopptd. by antibodies against any of the three proteins.  Sig-1R agonists such as pregenolone sulfate and cocaine caused the dissocn. of an ankyrin B isoform (ANK 220) from IP3R-3.  This effect caused by Sig-1R agonists was blocked by a Sig-1R antagonist.  The degree of dissocn. of ANK 220 from IP3R-3 caused by Sig-1R ligands correlates excellently with the ligands' efficacies in potentiating the bradykinin-induced increase in cytosolic free Ca2+ concn.  Immunocytohistochem. showed that Sig-1R, ankyrin B, and IP3R-3 are colocalized in NG-108 cells in perinuclear areas and in regions of cell-to-cell communication.  These results suggest that Sig-1R and assocd. ligands may play important roles in cells by controlling the function of cytoskeletal proteins and that the Sig-1R/ANK220/IP3R-3 complex regulating Ca2+ signaling may represent a site of action for neurosteroids and cocaine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ424uZx5ag7Vg90H21EOLACvtfcHk0ljJ6MH6auA4sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnslKhsA%253D%253D&md5=2fc5684bc59fa8d0c69494de29847681</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1073%2Fpnas.98.2.491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.98.2.491%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DSu%26aufirst%3DT.%2BP.%26atitle%3DRegulating%2520ankyrin%2520dynamics%253A%2520Roles%2520of%2520sigma-1%2520receptors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2001%26volume%3D98%26spage%3D491%26epage%3D496%26doi%3D10.1073%2Fpnas.98.2.491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Hayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, T.-P.</span><span> </span><span class="NLM_article-title">Sigma-1 receptor chaperones at the ER-Mitochondrion interface regulate Ca2+ signaling and cell survival</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">596</span><span class="NLM_x">–</span> <span class="NLM_lpage">610</span><span class="refDoi"> DOI: 10.1016/j.cell.2007.08.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.1016%2Fj.cell.2007.08.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=17981125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlWitrzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2007&pages=596-610&author=T.+Hayashiauthor=T.-P.+Su&title=Sigma-1+receptor+chaperones+at+the+ER-Mitochondrion+interface+regulate+Ca2%2B+signaling+and+cell+survival&doi=10.1016%2Fj.cell.2007.08.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca2+ signaling and cell survival</span></div><div class="casAuthors">Hayashi, Teruo; Su, Tsung-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">596-610</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Communication between the endoplasmic reticulum (ER) and mitochondrion is important for bioenergetics and cellular survival.  The ER supplies Ca2+ directly to mitochondria via inositol 1,4,5-trisphosphate receptors (IP3Rs) at close contacts between the two organelles referred to as mitochondrion-assocd. ER membrane (MAM).  We found here that the ER protein sigma-1 receptor (Sig-1R), which is implicated in neuroprotection, carcinogenesis, and neuroplasticity, is a Ca2+-sensitive and ligand-operated receptor chaperone at MAM.  Normally, Sig-1Rs form a complex at MAM with another chaperone, BiP.  Upon ER Ca2+ depletion or via ligand stimulation, Sig-1Rs dissoc. from BiP, leading to a prolonged Ca2+ signaling into mitochondria via IP3Rs.  Sig-1Rs can translocate under chronic ER stress.  Increasing Sig-1Rs in cells counteracts ER stress response, whereas decreasing them enhances apoptosis.  These results reveal that the orchestrated ER chaperone machinery at MAM, by sensing ER Ca2+ concns., regulates ER-mitochondrial interorganellar Ca2+ signaling and cell survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFqHhdVumdO7Vg90H21EOLACvtfcHk0ljJ6MH6auA4sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlWitrzK&md5=7bb4e806d7ad895f9ed1a8c4f7eb7f6c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.08.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.08.036%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DSu%26aufirst%3DT.-P.%26atitle%3DSigma-1%2520receptor%2520chaperones%2520at%2520the%2520ER-Mitochondrion%2520interface%2520regulate%2520Ca2%252B%2520signaling%2520and%2520cell%2520survival%26jtitle%3DCell%26date%3D2007%26volume%3D131%26spage%3D596%26epage%3D610%26doi%3D10.1016%2Fj.cell.2007.08.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Fontanilla, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johannessen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajipour, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cozzi, N. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruoho, A. E.</span><span> </span><span class="NLM_article-title">The hallucinogen N,N-dimethyltryptamine (DMT) Is an endogenous sigma-1 receptor regulator</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">323</span><span class="NLM_x">, </span> <span class="NLM_fpage">934</span><span class="NLM_x">–</span> <span class="NLM_lpage">937</span><span class="refDoi"> DOI: 10.1126/science.1166127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.1126%2Fscience.1166127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=19213917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhslSgsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=323&publication_year=2009&pages=934-937&author=D.+Fontanillaauthor=M.+Johannessenauthor=A.+R.+Hajipourauthor=N.+V.+Cozziauthor=M.+B.+Jacksonauthor=A.+E.+Ruoho&title=The+hallucinogen+N%2CN-dimethyltryptamine+%28DMT%29+Is+an+endogenous+sigma-1+receptor+regulator&doi=10.1126%2Fscience.1166127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The Hallucinogen N,N-Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator</span></div><div class="casAuthors">Fontanilla, Dominique; Johannessen, Molly; Hajipour, Abdol R.; Cozzi, Nicholas V.; Jackson, Meyer B.; Ruoho, Arnold E.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">323</span>
        (<span class="NLM_cas:issue">5916</span>),
    <span class="NLM_cas:pages">934-937</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The sigma-1 receptor is widely distributed in the central nervous system and periphery.  Originally mischaracterized as an opioid receptor, the sigma-1 receptor binds a vast no. of synthetic compds. but does not bind opioid peptides; it is currently considered an orphan receptor.  The sigma-1 receptor pharmacophore includes an alkylamine core, also found in the endogenous compd. N,N-dimethyltryptamine (DMT).  DMT acts as a hallucinogen, but its receptor target has been unclear.  DMT bound to sigma-1 receptors and inhibited voltage-gated sodium ion (Na+) channels in both native cardiac myocytes and heterologous cells that express sigma-1 receptors.  DMT induced hypermobility in wild-type mice but not in sigma-1 receptor knockout mice.  These biochem., physiol., and behavioral expts. indicate that DMT is an endogenous agonist for the sigma-1 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAp8p0wmc1wLVg90H21EOLACvtfcHk0ljJ6MH6auA4sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhslSgsbw%253D&md5=480f24607d42dbe5c5fcd9cdc8ee5e5c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1126%2Fscience.1166127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1166127%26sid%3Dliteratum%253Aachs%26aulast%3DFontanilla%26aufirst%3DD.%26aulast%3DJohannessen%26aufirst%3DM.%26aulast%3DHajipour%26aufirst%3DA.%2BR.%26aulast%3DCozzi%26aufirst%3DN.%2BV.%26aulast%3DJackson%26aufirst%3DM.%2BB.%26aulast%3DRuoho%26aufirst%3DA.%2BE.%26atitle%3DThe%2520hallucinogen%2520N%252CN-dimethyltryptamine%2520%2528DMT%2529%2520Is%2520an%2520endogenous%2520sigma-1%2520receptor%2520regulator%26jtitle%3DScience%26date%3D2009%26volume%3D323%26spage%3D934%26epage%3D937%26doi%3D10.1126%2Fscience.1166127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Robson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noorbakhsh, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seminerio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, R. R.</span><span> </span><span class="NLM_article-title">Sigma-1 receptors: potential targets for the treatment of substance abuse</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">902</span><span class="NLM_x">–</span> <span class="NLM_lpage">919</span><span class="refDoi"> DOI: 10.2174/138161212799436601</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.2174%2F138161212799436601" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=22288407" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvVSqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=902-919&author=M.+J.+Robsonauthor=B.+Noorbakhshauthor=M.+J.+Seminerioauthor=R.+R.+Matsumoto&title=Sigma-1+receptors%3A+potential+targets+for+the+treatment+of+substance+abuse&doi=10.2174%2F138161212799436601"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma-1 receptors: potential targets for the treatment of substance abuse</span></div><div class="casAuthors">Robson, Matthew J.; Noorbakhsh, Bahar; Seminerio, Michael J.; Matsumoto, Rae R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">902-919</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Drug abuse is currently a large economic and societal burden in countries around the globe.  Many drugs of abuse currently lack adequate therapies aimed at treating both the addiction and neg. complications often assocd. with their use.  Sigma-1 receptors were discovered over 30 years ago and have recently become targets for the development of pharmacotherapies aimed at treating substance abuse and addiction.  In vivo preclin. studies have revealed that sigma receptor ligands are able to ameliorate select behavioral effects of many drugs of abuse including cocaine, methamphetamine, ethanol and nicotine.  In addn., recent studies have begun to elucidate the mechanisms by which sigma-1 receptors modulate the effects of these drugs on neurotransmission, gene regulation and neuroplasticity.  Overall, these recent findings suggest that compds. targeting sigma-1 receptors may represent a potential new class of therapeutics aimed at treating drug abuse.  Future studies involving clin. populations will be crit. for validating the therapeutic potential of sigma-1 receptor ligands for the treatment of substance abuse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqj4JIyYKlhXLVg90H21EOLACvtfcHk0ljgoaOwCLtePQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvVSqt7g%253D&md5=04593b431f718394f720ead714cc9d95</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F138161212799436601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161212799436601%26sid%3Dliteratum%253Aachs%26aulast%3DRobson%26aufirst%3DM.%2BJ.%26aulast%3DNoorbakhsh%26aufirst%3DB.%26aulast%3DSeminerio%26aufirst%3DM.%2BJ.%26aulast%3DMatsumoto%26aufirst%3DR.%2BR.%26atitle%3DSigma-1%2520receptors%253A%2520potential%2520targets%2520for%2520the%2520treatment%2520of%2520substance%2520abuse%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2012%26volume%3D18%26spage%3D902%26epage%3D919%26doi%3D10.2174%2F138161212799436601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Yao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgello, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buch, S.</span><span> </span><span class="NLM_article-title">Cocaine hijacks sigma1 receptor to initiate induction of activated leukocyte cell adhesion molecule: implication for increased monocyte adhesion and migration in the CNS</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">5942</span><span class="NLM_x">–</span> <span class="NLM_lpage">5955</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.5618-10.2011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.1523%2FJNEUROSCI.5618-10.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=21508219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsFSqs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=5942-5955&author=H.+Yaoauthor=K.+Kimauthor=M.+Duanauthor=T.+Hayashiauthor=M.+Guoauthor=S.+Morgelloauthor=A.+Pratauthor=J.+Wangauthor=T.+P.+Suauthor=S.+Buch&title=Cocaine+hijacks+sigma1+receptor+to+initiate+induction+of+activated+leukocyte+cell+adhesion+molecule%3A+implication+for+increased+monocyte+adhesion+and+migration+in+the+CNS&doi=10.1523%2FJNEUROSCI.5618-10.2011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Cocaine hijacks σ1 receptor to initiate induction of activated leukocyte cell adhesion molecule: implication for increased monocyte adhesion and migration in the CNS</span></div><div class="casAuthors">Yao, Honghong; Kim, Keejun; Duan, Ming; Hayashi, Teruo; Guo, Minglei; Morgello, Susan; Prat, Alexander; Wang, John; Su, Tsung-Ping; Buch, Shilpa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5942-5955</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Human immunodeficiency virus (HIV)-assocd. increase in monocyte adhesion and trafficking is exacerbated by cocaine abuse.  The underlying mechanisms involve cocaine-mediated upregulation of adhesion mols. with subsequent disruption of the blood-brain barrier (BBB).  Recently, a novel activated leukocyte cell adhesion mol. (ALCAM) has been implicated in leukocyte transmigration across the endothelium.  We now show that upregulation of ALCAM in the brain endothelium seen in HIV+/cocacine drug abusers paralleled increased CD68 immunostaining compared with HIV+/no cocaine or uninfected controls, suggesting the important role of ALCAM in promoting leukocyte infiltration across the BBB.  Furthermore, ALCAM expression was increased in cocaine-treated mice with concomitant increase in monocyte adhesion and transmigration in vivo, which was ameliorated by pretreating with the neutralizing antibody to ALCAM, lending addnl. support to the role of ALCAM.  This new concept was further confirmed by in vitro expts.  Cocaine-mediated induction of ALCAM in human brain microvascular endothelial cells through the translocation of σ receptor to the plasma membrane, followed by phosphorylation of PDGF-β (platelet-derived growth factor-β) receptor.  Downstream activation of mitogen-activated protein kinases, Akt, and NF-κB (nuclear factor-κB) pathways resulted in induced expression of ALCAM.  Functional implication of upregulated ALCAM was confirmed using cell adhesion and transmigration assays.  Neutralizing antibody to ALCAM ameliorated this effect.  Together, these findings implicate cocaine-mediated induction of ALCAM as a mediator of increased monocyte adhesion/transmigration into the CNS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD8BTVSKcjTbVg90H21EOLACvtfcHk0ljgoaOwCLtePQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsFSqs7s%253D&md5=541db055042aaa42c28119937e73ac26</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.5618-10.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.5618-10.2011%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DDuan%26aufirst%3DM.%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DGuo%26aufirst%3DM.%26aulast%3DMorgello%26aufirst%3DS.%26aulast%3DPrat%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DSu%26aufirst%3DT.%2BP.%26aulast%3DBuch%26aufirst%3DS.%26atitle%3DCocaine%2520hijacks%2520sigma1%2520receptor%2520to%2520initiate%2520induction%2520of%2520activated%2520leukocyte%2520cell%2520adhesion%2520molecule%253A%2520implication%2520for%2520increased%2520monocyte%2520adhesion%2520and%2520migration%2520in%2520the%2520CNS%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D5942%26epage%3D5955%26doi%3D10.1523%2FJNEUROSCI.5618-10.2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Almansa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vela, J. M.</span><span> </span><span class="NLM_article-title">Selective sigma-1 receptor antagonists for the treatment of pain</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1179</span><span class="NLM_x">–</span> <span class="NLM_lpage">1199</span><span class="refDoi"> DOI: 10.4155/fmc.14.54</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.4155%2Ffmc.14.54" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=25078137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVyjurjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1179-1199&author=C.+Almansaauthor=J.+M.+Vela&title=Selective+sigma-1+receptor+antagonists+for+the+treatment+of+pain&doi=10.4155%2Ffmc.14.54"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Selective sigma-1 receptor antagonists for the treatment of pain</span></div><div class="casAuthors">Almansa, Carmen; Vela, Jose Miguel</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1179-1199</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The sigma-1 receptor (σ1R) is located in areas of the CNS key for pain control and belongs to a unique target class with chaperoning functions over different mol. targets involved in transmission and amplification of nociceptive messages.  Preclin. evidence supports a role for σ1R antagonists in the treatment of pain states where hypersensitivity develops as hyperalgesia and allodynia, two common symptoms encountered in neuropathic and other chronic pain conditions.  Addnl., σ1R antagonists increase opioid analgesia without increasing opioid-related unwanted effects, which point to their potential use as opioid adjuvant therapy.  This review summarizes the structure and function of the σ1R as well as the medicinal chem. and pharmacol. studies directed to the identification of σ1R antagonists for the treatment of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQ0qGYS21i37Vg90H21EOLACvtfcHk0ljgoaOwCLtePQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVyjurjK&md5=3ced452012e44f478a377f0fa52995d4</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.4155%2Ffmc.14.54&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.14.54%26sid%3Dliteratum%253Aachs%26aulast%3DAlmansa%26aufirst%3DC.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26atitle%3DSelective%2520sigma-1%2520receptor%2520antagonists%2520for%2520the%2520treatment%2520of%2520pain%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2014%26volume%3D6%26spage%3D1179%26epage%3D1199%26doi%3D10.4155%2Ffmc.14.54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Nguyen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucke-Wold, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mookerjee, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavendish, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scandinaro, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, R. R.</span><span> </span><span class="NLM_article-title">Role of sigma-1 receptors in neurodegenerative diseases</span> <span class="citation_source-journal">J. Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span><span class="refDoi"> DOI: 10.1016/j.jphs.2014.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.1016%2Fj.jphs.2014.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=25704014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BC28XislaksLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2015&pages=17-29&author=L.+Nguyenauthor=B.+P.+Lucke-Woldauthor=S.+A.+Mookerjeeauthor=J.+Z.+Cavendishauthor=M.+J.+Robsonauthor=A.+L.+Scandinaroauthor=R.+R.+Matsumoto&title=Role+of+sigma-1+receptors+in+neurodegenerative+diseases&doi=10.1016%2Fj.jphs.2014.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Role of sigma-1 receptors in neurodegenerative diseases</span></div><div class="casAuthors">Nguyen, Linda; Lucke-Wold, Brandon P.; Mookerjee, Shona A.; Cavendish, John Z.; Robson, Matthew J.; Scandinaro, Anna L.; Matsumoto, Rae R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Sciences (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-29</span>CODEN:
                <span class="NLM_cas:coden">JPSTGJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-8613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Neurodegenerative diseases with distinct genetic etiologies and pathol. phenotypes appear to share common mechanisms of neuronal cellular dysfunction, including excitotoxicity, calcium dysregulation, oxidative damage, ER stress and mitochondrial dysfunction.  Glial cells, including microglia and astrocytes, play an increasingly recognized role in both the promotion and prevention of neurodegeneration.  Sigma receptors, particularly the sigma-1 receptor subtype, which are expressed in both neurons and glia of multiple regions within the central nervous system, are a unique class of intracellular proteins that can modulate many biol. mechanisms assocd. with neurodegeneration.  These receptors therefore represent compelling putative targets for pharmacol. treating neurodegenerative disorders.  In this review, we provide an overview of the biol. mechanisms frequently assocd. with neurodegeneration, and discuss how sigma-1 receptors may alter these mechanisms to preserve or restore neuronal function.  In addn., we speculate on their therapeutic potential in the treatment of various neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdBzbVUAlU9rVg90H21EOLACvtfcHk0lgSUVBawUx9AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XislaksLY%253D&md5=1aa1ab1a9eb49ef2d69eef975a568a2d</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.jphs.2014.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jphs.2014.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DL.%26aulast%3DLucke-Wold%26aufirst%3DB.%2BP.%26aulast%3DMookerjee%26aufirst%3DS.%2BA.%26aulast%3DCavendish%26aufirst%3DJ.%2BZ.%26aulast%3DRobson%26aufirst%3DM.%2BJ.%26aulast%3DScandinaro%26aufirst%3DA.%2BL.%26aulast%3DMatsumoto%26aufirst%3DR.%2BR.%26atitle%3DRole%2520of%2520sigma-1%2520receptors%2520in%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2015%26volume%3D127%26spage%3D17%26epage%3D29%26doi%3D10.1016%2Fj.jphs.2014.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Urfer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moebius, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skoloudik, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santamarina, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mita, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muir, K. W.</span><span> </span><span class="NLM_article-title">Cutamesine Stroke Recovery Study, G. Phase II trial of the Sigma-1 receptor agonist cutamesine (SA4503) for recovery enhancement after acute ischemic stroke</span> <span class="citation_source-journal">Stroke</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">3304</span><span class="NLM_x">–</span> <span class="NLM_lpage">3310</span><span class="refDoi"> DOI: 10.1161/STROKEAHA.114.005835</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.1161%2FSTROKEAHA.114.005835" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2014&pages=3304-3310&author=R.+Urferauthor=H.+J.+Moebiusauthor=D.+Skoloudikauthor=E.+Santamarinaauthor=W.+Satoauthor=S.+Mitaauthor=K.+W.+Muir&title=Cutamesine+Stroke+Recovery+Study%2C+G.+Phase+II+trial+of+the+Sigma-1+receptor+agonist+cutamesine+%28SA4503%29+for+recovery+enhancement+after+acute+ischemic+stroke&doi=10.1161%2FSTROKEAHA.114.005835"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1161%2FSTROKEAHA.114.005835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FSTROKEAHA.114.005835%26sid%3Dliteratum%253Aachs%26aulast%3DUrfer%26aufirst%3DR.%26aulast%3DMoebius%26aufirst%3DH.%2BJ.%26aulast%3DSkoloudik%26aufirst%3DD.%26aulast%3DSantamarina%26aufirst%3DE.%26aulast%3DSato%26aufirst%3DW.%26aulast%3DMita%26aufirst%3DS.%26aulast%3DMuir%26aufirst%3DK.%2BW.%26atitle%3DCutamesine%2520Stroke%2520Recovery%2520Study%252C%2520G.%2520Phase%2520II%2520trial%2520of%2520the%2520Sigma-1%2520receptor%2520agonist%2520cutamesine%2520%2528SA4503%2529%2520for%2520recovery%2520enhancement%2520after%2520acute%2520ischemic%2520stroke%26jtitle%3DStroke%26date%3D2014%26volume%3D45%26spage%3D3304%26epage%3D3310%26doi%3D10.1161%2FSTROKEAHA.114.005835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Jin, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X. Y.</span><span> </span><span class="NLM_article-title">Roles of sigma-1 receptors in Alzheimer’s disease</span> <span class="citation_source-journal">Int. J. Clin. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">4808</span><span class="NLM_x">–</span> <span class="NLM_lpage">4820</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=26131055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A280%3ADC%252BC2MbptFynsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2015&pages=4808-4820&author=J.+L.+Jinauthor=M.+Fangauthor=Y.+X.+Zhaoauthor=X.+Y.+Liu&title=Roles+of+sigma-1+receptors+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of sigma-1 receptors in Alzheimer's disease</span></div><div class="casAuthors">Jin Jia-Li; Fang Min; Zhao Yan-Xin; Liu Xue-Yuan</div><div class="citationInfo"><span class="NLM_cas:title">International journal of clinical and experimental medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">4808-20</span>
        ISSN:<span class="NLM_cas:issn">1940-5901</span>.
    </div><div class="casAbstract">Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the leading cause of senile dementia all over the world.  Still no existing drugs can effectively reverse the cognitive impairment.  However, Sigma-1 (σ-1) receptors have been long implicated in multiple neurological and psychiatric conditions over these years.  In this review, we discuss the current understanding of σ-1 receptor functions.  Through regulation of lipid rafts, secretases, kinases, neuroceptors and ion channels, σ-1 receptors can influence cellular signal transduction, TCA cycle, oxidative stress, neuron plasticity and neurotransmitter release etc.  Based on this, we suggest the key cellular mechanisms linking σ-1 receptor to Alzheimer's disease.  Besides, we detail the evidences showing that σ-1 receptors agonists, being the promising compounds for treatment of cognitive dysfunction, exhibit robust neuroprotection and anti-amnesia effect against Aβ neurotoxicity in the progress of Alzheimer's disease.  The evidence comes from animal models, preclinical studies in humans and full clinical trials.  In addition, the questions to be solved regarding this receptor are also presented.  When concerned with NMDAR, σ-1 receptor activation may result in two totally different influences on AD.  Utilization of σ-1 agents early in AD remains an overlooked therapeutic opportunity.  This article may pave the way for further studies about sigma-1 receptor on Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQtgNNdI_x_xG52AMpI4GK2fW6udTcc2ebmiTja9w7Nubntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MbptFynsQ%253D%253D&md5=9a885f6b442e658b1037e96c4fabdfa1</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DJ.%2BL.%26aulast%3DFang%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DY.%2BX.%26aulast%3DLiu%26aufirst%3DX.%2BY.%26atitle%3DRoles%2520of%2520sigma-1%2520receptors%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DInt.%2520J.%2520Clin.%2520Exp.%2520Med.%26date%3D2015%26volume%3D8%26spage%3D4808%26epage%3D4820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Haiman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratt, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, A.</span><span> </span><span class="NLM_article-title">Effects of dextromethorphan/quinidine on auditory event-related potentials in multiple sclerosis patients with pseudobulbar affect</span> <span class="citation_source-journal">J. Clin. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">444</span><span class="NLM_x">–</span> <span class="NLM_lpage">452</span><span class="refDoi"> DOI: 10.1097/JCP.0b013e3181b5ae5c</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.1097%2FJCP.0b013e3181b5ae5c" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=19745644" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFWhtbjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=444-452&author=G.+Haimanauthor=H.+Prattauthor=A.+Miller&title=Effects+of+dextromethorphan%2Fquinidine+on+auditory+event-related+potentials+in+multiple+sclerosis+patients+with+pseudobulbar+affect&doi=10.1097%2FJCP.0b013e3181b5ae5c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of Dextromethorphan/Quinidine on Auditory Event-Related Potentials in Multiple Sclerosis Patients With Pseudobulbar Affect</span></div><div class="casAuthors">Haiman, Guy; Pratt, Hillel; Miller, Ariel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychopharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">444-452</span>CODEN:
                <span class="NLM_cas:coden">JCPYDR</span>;
        ISSN:<span class="NLM_cas:issn">0271-0749</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The purpose of this study was to characterize the brain activity and assocd. cortical structures involved in pseudobulbar affect (PBA), a condition characterized by uncontrollable episodes of laughing and/or crying in patients with multiple sclerosis before and after treatment with dextromethorphan/quinidine (DM/Q).  Behavioral responses and event-related potentials (ERPs) in response to subjectively significant and neutral verbal stimuli were recorded from 2 groups: 6 multiple sclerosis patients with PBA before (PBA-preTx) and after (PBA-DM/Q) treatment with DM/Q and 6 healthy control (HC) subjects.  Statistical nonparametric mapping comparisons of ERP source c.d. distributions between groups were conducted for subjectively significant and neutral stimuli sep. before and after treatment with DM/Q.  Treatment with DM/Q had a normalizing effect on the behavioral responses of PBA patients.  Event-related potential waveform comparisons of PBA-preTx and PBA-DM/Q with HC, for both neutral and subjectively significant stimuli, revealed effects on early ERP components.  Comparisons between PBA-preTx and HC, in response to subjectively significant stimuli, revealed both early and late effects.  Source anal. comparisons between PBA-preTx and PBA-DM/Q indicated distinct activations in areas involved in emotional processing and high-level and associative visual processing in response to neutral stimuli and in areas involved in emotional, somatosensory, primary, and premotor processing in response to subjectively significant stimuli.  In most cases, stimuli evoked higher c.d. in PBA-DM/Q compared with the other groups.  In conclusion, differences in brain activity were obsd. before and after medication.  Also, DM/Q administration resulted in normalization of behavioral and electrophysiol. measures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm3vDkTNZP3rVg90H21EOLACvtfcHk0lgSUVBawUx9AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFWhtbjM&md5=662d1fab46aa12d39fd01fb276dc75a0</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1097%2FJCP.0b013e3181b5ae5c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FJCP.0b013e3181b5ae5c%26sid%3Dliteratum%253Aachs%26aulast%3DHaiman%26aufirst%3DG.%26aulast%3DPratt%26aufirst%3DH.%26aulast%3DMiller%26aufirst%3DA.%26atitle%3DEffects%2520of%2520dextromethorphan%252Fquinidine%2520on%2520auditory%2520event-related%2520potentials%2520in%2520multiple%2520sclerosis%2520patients%2520with%2520pseudobulbar%2520affect%26jtitle%3DJ.%2520Clin.%2520Psychopharmacol.%26date%3D2009%26volume%3D29%26spage%3D444%26epage%3D452%26doi%3D10.1097%2FJCP.0b013e3181b5ae5c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Kulkarni, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhir, A.</span><span> </span><span class="NLM_article-title">sigma-1 receptors in major depression and anxiety</span> <span class="citation_source-journal">Expert Rev. Neurother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1021</span><span class="NLM_x">–</span> <span class="NLM_lpage">1034</span><span class="refDoi"> DOI: 10.1586/ern.09.40</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.1586%2Fern.09.40" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=19589051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BD1MXos1egtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=1021-1034&author=S.+K.+Kulkarniauthor=A.+Dhir&title=sigma-1+receptors+in+major+depression+and+anxiety&doi=10.1586%2Fern.09.40"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">σ-1 receptors in major depression and anxiety</span></div><div class="casAuthors">Kulkarni, Shrinivas K.; Dhir, Ashish</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Neurotherapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1021-1034</span>CODEN:
                <span class="NLM_cas:coden">ERNXAR</span>;
        ISSN:<span class="NLM_cas:issn">1473-7175</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Major depression and anxiety are two of the major psychiatric disorders that have some overlapping pathophysiologies, the most significant being the dysfunction in the monoaminergic, GABAergic and glutamatergic systems.  A large no. of drugs that alter these neurotransmitter levels/systems are effective in the treatment of major depression and anxiety.  However, full remission of the clin. symptoms has not been achieved, perhaps owing to the complex pathophysiol. of the diseases.  Thus, the search for newer targets and target-specific drugs continues.  Recently, the role of σ-receptors, particularly the σ-1 receptor subtype, has been identified as a target for the pathophysiol. of neuropsychiatric disorders, and σ-1 receptor modulators are considered to be the drugs of the future for the treatment of major depression and anxiety.  The present review attempts to discuss the role of σ-1 receptors in the pathophysiol. of major depression and anxiety and also tries to position the use of its receptor modulators in the treatment of these two major disorders.  The role of σ-1 receptors in the mechanism of antidepressant action of venlafaxine, bupropion, neurosteroids and one of the herbal antidepressants, berberine, is reviewed.  Although, σ-1 receptor modulators may be future therapeutic options, either as individual agents or adjuvants in the treatment of mental disorders, the topic needs further preclin. and clin. exploration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSBtnV2P59xLVg90H21EOLACvtfcHk0lhPHQbqfW_vBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXos1egtL0%253D&md5=a26dd8928fbbb21fa2f137c4b6b4bc29</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1586%2Fern.09.40&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fern.09.40%26sid%3Dliteratum%253Aachs%26aulast%3DKulkarni%26aufirst%3DS.%2BK.%26aulast%3DDhir%26aufirst%3DA.%26atitle%3Dsigma-1%2520receptors%2520in%2520major%2520depression%2520and%2520anxiety%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2009%26volume%3D9%26spage%3D1021%26epage%3D1034%26doi%3D10.1586%2Fern.09.40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Cendan, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pujalte, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portillo-Salido, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montoliu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baeyens, J. M.</span><span> </span><span class="NLM_article-title">Formalin-induced pain is reduced in sigma(1) receptor knockout mice</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">511</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">74</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2005.01.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.1016%2Fj.ejphar.2005.01.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=15777781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitlCjsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=511&publication_year=2005&pages=73-74&author=C.+M.+Cendanauthor=J.+M.+Pujalteauthor=E.+Portillo-Salidoauthor=L.+Montoliuauthor=J.+M.+Baeyens&title=Formalin-induced+pain+is+reduced+in+sigma%281%29+receptor+knockout+mice&doi=10.1016%2Fj.ejphar.2005.01.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Formalin-induced pain is reduced in σ1 receptor knockout mice</span></div><div class="casAuthors">Cendan, Cruz Miguel; Pujalte, Jose Miguel; Portillo-Salido, Enrique; Montoliu, Lluis; Baeyens, Jose M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">511</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-74</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The role of σ1 receptors in non-acute pain has not been explored.  In this study we show that both phases of formalin-induced pain were reduced by approx. 55% in σ1 receptor knockout mice in comparison to wild-type animals.  These results suggest that the tonic pain induced by formalin is altered in mice lacking σ1 receptors, and highlight the potential usefulness of further studies of the role of σ1 receptors in models of non-acute pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLfs5SOcqYY7Vg90H21EOLACvtfcHk0lhPHQbqfW_vBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitlCjsLs%253D&md5=71d93bc7957c3f85824ab4a63d174a6b</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2005.01.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2005.01.036%26sid%3Dliteratum%253Aachs%26aulast%3DCendan%26aufirst%3DC.%2BM.%26aulast%3DPujalte%26aufirst%3DJ.%2BM.%26aulast%3DPortillo-Salido%26aufirst%3DE.%26aulast%3DMontoliu%26aufirst%3DL.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26atitle%3DFormalin-induced%2520pain%2520is%2520reduced%2520in%2520sigma%25281%2529%2520receptor%2520knockout%2520mice%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2005%26volume%3D511%26spage%3D73%26epage%3D74%26doi%3D10.1016%2Fj.ejphar.2005.01.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Entrena, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cobos, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieto, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cendan, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gris, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Pozo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamanillo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baeyens, J. M.</span><span> </span><span class="NLM_article-title">Sigma-1 receptors are essential for capsaicin-induced mechanical hypersensitivity: studies with selective sigma-1 ligands and sigma-1 knockout mice</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">252</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span><span class="refDoi"> DOI: 10.1016/j.pain.2009.03.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.1016%2Fj.pain.2009.03.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=19375855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BD1MXls1Ortr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2009&pages=252-261&author=J.+M.+Entrenaauthor=E.+J.+Cobosauthor=F.+R.+Nietoauthor=C.+M.+Cendanauthor=G.+Grisauthor=E.+Del+Pozoauthor=D.+Zamanilloauthor=J.+M.+Baeyens&title=Sigma-1+receptors+are+essential+for+capsaicin-induced+mechanical+hypersensitivity%3A+studies+with+selective+sigma-1+ligands+and+sigma-1+knockout+mice&doi=10.1016%2Fj.pain.2009.03.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma-1 receptors are essential for capsaicin-induced mechanical hypersensitivity: Studies with selective sigma-1 ligands and sigma-1 knockout mice</span></div><div class="casAuthors">Entrena, Jose Manuel; Cobos, Enrique Jose; Nieto, Francisco Rafael; Cendan, Cruz Miguel; Gris, Georgia; Del Pozo, Esperanza; Zamanillo, Daniel; Baeyens, Jose Manuel</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">252-261</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">We evaluated the role of σ1 receptors on capsaicin-induced mech. hypersensitivity and on nociceptive pain induced by punctate mech. stimuli, using wild-type and σ1 receptor knockout (σ1-KO) mice and selective σ1 receptor-acting drugs.  Mutation in σ1-KO mice was confirmed by PCR anal. of genomic DNA and, at the protein level, by [3H](+)-pentazocine binding assays.  Both wild-type and σ1-KO mice not treated with capsaicin showed similar responses to different intensities of mech. stimuli (0.05-8 g force), ranging from innocuous to noxious, applied to the hind paw.  This indicates that σ1 gene inactivation does not modify the perception of punctate mech. stimuli.  The intraplantar (i.pl.) administration of capsaicin induced dose-dependent mech. allodynia in wild-type mice (markedly reducing both the threshold force necessary to induce paw withdrawal and the latency to paw withdrawal induced by a given force).  In contrast, capsaicin was completely unable to induce mech. hypersensitivity in σ1-KO mice.  The high-affinity and selective σ1 antagonists BD-1063, BD-1047 and NE-100, administered s.c. dose-dependently inhibited mech. allodynia induced by capsaicin (1 μg,i.pl.), yielding ED50 (mg/kg) values of 15.80 ± 0.93, 29.31 ± 1.65 and 40.74 ± 7.20, resp.  The effects of the σ1 antagonists were reversed by the σ1 agonist PRE-084 (32 mg/kg, s.c.).  None of the drugs tested modified the responses induced by a painful mech. punctate stimulus (4 g force) in nonsensitized animals.  These results suggest that σ1 receptors are essential for capsaicin-induced mech. hypersensitivity, but are not involved in mech. nociceptive pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxwYUgwwMlprVg90H21EOLACvtfcHk0lhPHQbqfW_vBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXls1Ortr0%253D&md5=e51c7b76ea146ba992c7d1768e1da9a3</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2009.03.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2009.03.011%26sid%3Dliteratum%253Aachs%26aulast%3DEntrena%26aufirst%3DJ.%2BM.%26aulast%3DCobos%26aufirst%3DE.%2BJ.%26aulast%3DNieto%26aufirst%3DF.%2BR.%26aulast%3DCendan%26aufirst%3DC.%2BM.%26aulast%3DGris%26aufirst%3DG.%26aulast%3DDel%2BPozo%26aufirst%3DE.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26atitle%3DSigma-1%2520receptors%2520are%2520essential%2520for%2520capsaicin-induced%2520mechanical%2520hypersensitivity%253A%2520studies%2520with%2520selective%2520sigma-1%2520ligands%2520and%2520sigma-1%2520knockout%2520mice%26jtitle%3DPain%26date%3D2009%26volume%3D143%26spage%3D252%26epage%3D261%26doi%3D10.1016%2Fj.pain.2009.03.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Chien, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasternak, G. W.</span><span> </span><span class="NLM_article-title">Selective antagonism of opioid analgesia by a sigma system</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x">, </span> <span class="NLM_fpage">1583</span><span class="NLM_x">–</span> <span class="NLM_lpage">1590</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=7996472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADyaK2MXislelu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1994&pages=1583-1590&author=C.+C.+Chienauthor=G.+W.+Pasternak&title=Selective+antagonism+of+opioid+analgesia+by+a+sigma+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Selective antagonism of opioid analgesia by a sigma system</span></div><div class="casAuthors">Chien, Chih-Cheng; Pasternak, Gavril W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1583-90</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">(+)-Pentazocine antagonizes morphine analgesia as potently as its (-) isomer, ruling out an opioid receptor mechanism of action and suggesting a role for sigma1 receptors.  Systemic (+)-pentazocine also reverses supraspinal or spinal morphine analgesia.  1,3-Di(2-tolyl)guanidine, a sigma ligand with no appreciable opioid receptor affinity, antagonizes morphine analgesia.  The actions of both (+)-pentazocine and 1,3-di(2-tolyl)guanidine are reversed by haloperidol, which has high affinity for both sigma and D2 receptors, but not by the D2-selective antagonist (-)-sulpiride, which lacks activity at sigma sites.  The antiopioid sigma system is tonically active.  Haloperidol, but not (-)-sulpiride, decreases morphine ED50 almost 2-fold.  The antiopioid system modulates only mu analgesia.  Unlike analgesia, (+)-pentazocine does not influence morphine's inhibition of gastrointestinal transit or lethality.  (+)-Pentazocine also antagonizes kappa1, kappa3 and delta analgesia through sigma mechanisms in a haloperidol-sensitive manner.  (-)-Sulpiride is inactive.  Alone, haloperidol enhances kappa1, kappa3 and delta analgesia more dramatically than morphine, which indicates that the sigma system is active against all opioid analgesic systems.  Sigma systems are responsible for some strain differences in kappa receptor sensitivity.  Unlike CD-1 mice, BALB-C mice are relatively insensitive toward the kappa1 agent U50,488H and the kappa3 analgesic naloxone benzoylhydrazone.  Blockade of the sigma system with haloperidol eliminates these strain differences.  In conclusion, sigma1 systems functionally antagonize opioid analgesia without affecting morphine's effects on gastrointestinal transit or lethality.  The antiopioid sigma system is tonically active and is more active against kappa analgesia than mu.  The level of this tonic activity plays a significant role in strain differences in analgesic sensitivity toward opioid analgesia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPi-tKcGCFM7Vg90H21EOLACvtfcHk0lgD6rwTXYv9CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXislelu7k%253D&md5=d1314dcf06a32a48599975aa5208c4b8</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DC.%2BC.%26aulast%3DPasternak%26aufirst%3DG.%2BW.%26atitle%3DSelective%2520antagonism%2520of%2520opioid%2520analgesia%2520by%2520a%2520sigma%2520system%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1994%26volume%3D271%26spage%3D1583%26epage%3D1590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Cendan, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pujalte, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portillo-Salido, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baeyens, J. M.</span><span> </span><span class="NLM_article-title">Antinociceptive effects of haloperidol and its metabolites in the formalin test in mice</span> <span class="citation_source-journal">Psychopharmacology (Heidelberg, Ger.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">182</span><span class="NLM_x">, </span> <span class="NLM_fpage">485</span><span class="NLM_x">–</span> <span class="NLM_lpage">493</span><span class="refDoi"> DOI: 10.1007/s00213-005-0127-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.1007%2Fs00213-005-0127-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=16075285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFahtbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=2005&pages=485-493&author=C.+M.+Cendanauthor=J.+M.+Pujalteauthor=E.+Portillo-Salidoauthor=J.+M.+Baeyens&title=Antinociceptive+effects+of+haloperidol+and+its+metabolites+in+the+formalin+test+in+mice&doi=10.1007%2Fs00213-005-0127-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Antinociceptive effects of haloperidol and its metabolites in the formalin test in mice</span></div><div class="casAuthors">Cendan, Cruz M.; Pujalte, Jose M.; Portillo-Salido, Enrique; Baeyens, Jose M.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">182</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">485-493</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Rationale: Formalin-induced pain is reduced in sigma-1 (σ1) receptor knockout mice; therefore, the authors hypothesized that haloperidol and its metabolites I and II, which have affinity for σ1 receptors, may modulate formalin-induced pain.  Results: Intraplantar administration of formalin (2.5%) to CD-1 mice produced a biphasic period of pain.  Haloperidol (0.03-1 mg/kg, s.c.) and reduced haloperidol (metabolite II, 0.25-8 mg/kg, s.c.) dose-dependently inhibited both phases of formalin-induced pain.  Haloperidol metabolite I (4-128 mg/kg, s.c.) also produced dose-dependent antinociception in the second phase of the formalin test, but was less potent and effective against first-phase pain.  Haloperidol metabolite III (16 and 128 mg/kg) and (-)sulpiride (200 mg/kg), which have no affinity for σ1 receptors, did not produce significant antinociception in either phase of the formalin test.  The order of potency of the drugs to produce their antinociceptive effect [haloperidol > metabolite II > metabolite I » metabolite III= (-)sulpiride=inactive] correlated with their affinity for σ1 receptors, but not with their affinity for σ2 or dopamine D2 receptors.  Naloxone (1 mg/kg, s.c.) did not antagonize the antinociception induced by haloperidol and its metabolites.  None of the antinociceptive drugs in the formalin test produced any antinociception in the tail flick test.  Conclusion: These results suggest that the antinociceptive effect of haloperidol and its metabolites in the formalin test is not due to unspecific/generalized inhibition of nociception or modulation of opioid receptors, and that it may be related, at least partially, to the ability of these drugs to interact with σ1 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFuqvqHXFzk7Vg90H21EOLACvtfcHk0lgD6rwTXYv9CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFahtbzP&md5=3d55ac20e082e77f70769659224994f1</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2Fs00213-005-0127-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-005-0127-z%26sid%3Dliteratum%253Aachs%26aulast%3DCendan%26aufirst%3DC.%2BM.%26aulast%3DPujalte%26aufirst%3DJ.%2BM.%26aulast%3DPortillo-Salido%26aufirst%3DE.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26atitle%3DAntinociceptive%2520effects%2520of%2520haloperidol%2520and%2520its%2520metabolites%2520in%2520the%2520formalin%2520test%2520in%2520mice%26jtitle%3DPsychopharmacology%2520%2528Heidelberg%252C%2520Ger.%2529%26date%3D2005%26volume%3D182%26spage%3D485%26epage%3D493%26doi%3D10.1007%2Fs00213-005-0127-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Vela, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almansa, C.</span><span> </span><span class="NLM_article-title">Investigational sigma-1 receptor antagonists for the treatment of pain</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">883</span><span class="NLM_x">–</span> <span class="NLM_lpage">896</span><span class="refDoi"> DOI: 10.1517/13543784.2015.1048334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.1517%2F13543784.2015.1048334" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2015&pages=883-896&author=J.+M.+Velaauthor=M.+Merlosauthor=C.+Almansa&title=Investigational+sigma-1+receptor+antagonists+for+the+treatment+of+pain&doi=10.1517%2F13543784.2015.1048334"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1517%2F13543784.2015.1048334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2015.1048334%26sid%3Dliteratum%253Aachs%26aulast%3DVela%26aufirst%3DJ.%2BM.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DAlmansa%26aufirst%3DC.%26atitle%3DInvestigational%2520sigma-1%2520receptor%2520antagonists%2520for%2520the%2520treatment%2520of%2520pain%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2015%26volume%3D24%26spage%3D883%26epage%3D896%26doi%3D10.1517%2F13543784.2015.1048334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Vidal-Torres, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de la Puente, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocasalbas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tourino, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bura, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez-Pastor, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Codony, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamanillo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buschmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baeyens, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maldonado, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vela, J. M.</span><span> </span><span class="NLM_article-title">Sigma-1 receptor antagonism as opioid adjuvant strategy: enhancement of opioid antinociception without increasing adverse effects</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">711</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2013.04.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.1016%2Fj.ejphar.2013.04.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=23632394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptVyksLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=711&publication_year=2013&pages=63-72&author=A.+Vidal-Torresauthor=B.+de+la+Puenteauthor=M.+Rocasalbasauthor=C.+Tourinoauthor=S.+A.+Buraauthor=B.+Fernandez-Pastorauthor=L.+Romeroauthor=X.+Codonyauthor=D.+Zamanilloauthor=H.+Buschmannauthor=M.+Merlosauthor=J.+M.+Baeyensauthor=R.+Maldonadoauthor=J.+M.+Vela&title=Sigma-1+receptor+antagonism+as+opioid+adjuvant+strategy%3A+enhancement+of+opioid+antinociception+without+increasing+adverse+effects&doi=10.1016%2Fj.ejphar.2013.04.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma-1 receptor antagonism as opioid adjuvant strategy: Enhancement of opioid antinociception without increasing adverse effects</span></div><div class="casAuthors">Vidal-Torres, Alba; de la Puente, Beatriz; Rocasalbas, Maria; Tourino, Clara; Andreea Bura, Simona; Fernandez-Pastor, Begona; Romero, Luz; Codony, Xavier; Zamanillo, Daniel; Buschmann, Helmut; Merlos, Manuel; Manuel Baeyens, Jose; Maldonado, Rafael; Vela, Jose Miguel</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">711</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">63-72</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">While opioids are potent analgesics widely used in the management of pain, a no. of well-known adverse effects limit their use.  The sigma-1 receptor is a ligand-regulated mol. chaperone involved in pain processing, including modulation of opioid antinociception.  However, data supporting the potential use of sigma-1 receptor ligands as suitable opioid adjuvants are based on studies that use non selective ligands.  Also, safety issues derived from combination therapy are poorly addressed.  In this study we used the new selective sigma-1 receptor antagonist S1RA (E-52862) to characterize the effect of selective sigma-1 receptor blockade on opioid-induced efficacy- and safety-related outcomes in mice.  S1RA (40 mg/kg) had no effect in the tail-flick test but did enhance the antinociceptive potency of several opioids by a factor between 2 and 3.3.  The potentiating effect of S1RA on morphine antinociception did not occur in sigma-1 receptor knockout mice, which supports the selective involvement of the sigma-1 receptor.  Interestingly, S1RA co-administration restored morphine antinociception in tolerant mice and reverted the reward effects of morphine in the conditioned place preference paradigm.  In addn., enhancement of antinociception was not accompanied by potentiation of other opioid-induced effects, such as the development of morphine analgesic tolerance, phys. dependence, inhibition of gastrointestinal transit, or mydriasis.  The use of sigma-1 receptor antagonists as opioid adjuvants could represent a promising pharmacol. strategy to enhance opioid potency and, most importantly, to increase the safety margin of opioids.  S1RA is currently in phase II clin. trials for the treatment of several pain conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVTGE08MufobVg90H21EOLACvtfcHk0lhcOZ8Jl0GC9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptVyksLc%253D&md5=c2cd0eb6fe5a9232bff11fe1539f74d4</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2013.04.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2013.04.018%26sid%3Dliteratum%253Aachs%26aulast%3DVidal-Torres%26aufirst%3DA.%26aulast%3Dde%2Bla%2BPuente%26aufirst%3DB.%26aulast%3DRocasalbas%26aufirst%3DM.%26aulast%3DTourino%26aufirst%3DC.%26aulast%3DBura%26aufirst%3DS.%2BA.%26aulast%3DFernandez-Pastor%26aufirst%3DB.%26aulast%3DRomero%26aufirst%3DL.%26aulast%3DCodony%26aufirst%3DX.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DBuschmann%26aufirst%3DH.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26aulast%3DMaldonado%26aufirst%3DR.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26atitle%3DSigma-1%2520receptor%2520antagonism%2520as%2520opioid%2520adjuvant%2520strategy%253A%2520enhancement%2520of%2520opioid%2520antinociception%2520without%2520increasing%2520adverse%2520effects%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D711%26spage%3D63%26epage%3D72%26doi%3D10.1016%2Fj.ejphar.2013.04.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Diaz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christmann, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrens, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Port, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascual, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgueno, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monroy, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balada, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vela, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almansa, C.</span><span> </span><span class="NLM_article-title">Synthesis and structure-activity relationship study of a new series of selective sigma(1) receptor ligands for the treatment of pain: 4-aminotriazoles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2441</span><span class="NLM_x">–</span> <span class="NLM_lpage">2451</span><span class="refDoi"> DOI: 10.1021/jm501920g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501920g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitlWms78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2441-2451&author=J.+L.+Diazauthor=U.+Christmannauthor=A.+Fernandezauthor=A.+Torrensauthor=A.+Portauthor=R.+Pascualauthor=I.+Alvarezauthor=J.+Burguenoauthor=X.+Monroyauthor=A.+Monteroauthor=A.+Baladaauthor=J.+M.+Velaauthor=C.+Almansa&title=Synthesis+and+structure-activity+relationship+study+of+a+new+series+of+selective+sigma%281%29+receptor+ligands+for+the+treatment+of+pain%3A+4-aminotriazoles&doi=10.1021%2Fjm501920g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Structure-Activity Relationship Study of a New Series of Selective σ1 Receptor Ligands for the Treatment of Pain: 4-Aminotriazoles</span></div><div class="casAuthors">Diaz, Jose Luis; Christmann, Ute; Fernandez, Ariadna; Torrens, Antoni; Port, Adriana; Pascual, Rosalia; Alvarez, Ines; Burgueno, Javier; Monroy, Xavier; Montero, Ana; Balada, Ariadna; Vela, Jose Miguel; Almansa, Carmen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2441-2451</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis and pharmacol. activity of a new series of 4-aminotriazoles I [R1 = 4-Cl-C6H4, 3,4-Cl2-C6H3, benzyl, cyclohexyl, etc; R2 = H, COMe, SO2Me, etc; R3 = piperidin-1-yl, morpholin-1-yl, 4-cyclohexylpiperizin-1-yl, etc; n = 1, 2] as potent σ1 receptor (σ1R) ligands are reported.  The compds. were prepd. using a 4-5-step process, involving as a key step a click chem. reaction between ynamides and azides.  The most active compds. exhibited nanomolar potency for the σ1R, and the selectivity over the σ2R was improved on decreasing the central amine basicity.  It was concluded that in order to achieve good σ1R potency a min. lipophilicity was required, while limiting to a defined range of cLogP avoided human ether-a-go-go-related gene channel inhibition.  This made the most interesting derivs. to be concd. in a narrow margin of lipophilicity.  Among them, compd. I [R1 = 2,3-Cl2-benzyl, R2 = H, R3 = morpholin-1-yl, n = 1] exhibited the most potent in vivo antinociceptive properties, which are indicative of its antagonist character.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxmyKI9YzVhbVg90H21EOLACvtfcHk0lhcOZ8Jl0GC9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitlWms78%253D&md5=7dc178db143bbce4f8c7f33e62a062b6</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm501920g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501920g%26sid%3Dliteratum%253Aachs%26aulast%3DDiaz%26aufirst%3DJ.%2BL.%26aulast%3DChristmann%26aufirst%3DU.%26aulast%3DFernandez%26aufirst%3DA.%26aulast%3DTorrens%26aufirst%3DA.%26aulast%3DPort%26aufirst%3DA.%26aulast%3DPascual%26aufirst%3DR.%26aulast%3DAlvarez%26aufirst%3DI.%26aulast%3DBurgueno%26aufirst%3DJ.%26aulast%3DMonroy%26aufirst%3DX.%26aulast%3DMontero%26aufirst%3DA.%26aulast%3DBalada%26aufirst%3DA.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26aulast%3DAlmansa%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationship%2520study%2520of%2520a%2520new%2520series%2520of%2520selective%2520sigma%25281%2529%2520receptor%2520ligands%2520for%2520the%2520treatment%2520of%2520pain%253A%25204-aminotriazoles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2441%26epage%3D2451%26doi%3D10.1021%2Fjm501920g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Diaz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christmann, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luengo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bordas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enrech, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascual, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgueno, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benet-Buchholz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceron-Bertran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramirez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinoso, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez de Henestrosa, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vela, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almansa, C.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of a new series of hexahydro-2H-pyrano[3,2-c]quinolines as novel selective sigma1 receptor ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3656</span><span class="NLM_x">–</span> <span class="NLM_lpage">3665</span><span class="refDoi"> DOI: 10.1021/jm400181k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400181k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3656-3665&author=J.+L.+Diazauthor=U.+Christmannauthor=A.+Fernandezauthor=M.+Luengoauthor=M.+Bordasauthor=R.+Enrechauthor=M.+Carroauthor=R.+Pascualauthor=J.+Burguenoauthor=M.+Merlosauthor=J.+Benet-Buchholzauthor=J.+Ceron-Bertranauthor=J.+Ramirezauthor=R.+F.+Reinosoauthor=A.+R.+Fernandez+de+Henestrosaauthor=J.+M.+Velaauthor=C.+Almansa&title=Synthesis+and+biological+evaluation+of+a+new+series+of+hexahydro-2H-pyrano%5B3%2C2-c%5Dquinolines+as+novel+selective+sigma1+receptor+ligands&doi=10.1021%2Fjm400181k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm400181k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400181k%26sid%3Dliteratum%253Aachs%26aulast%3DDiaz%26aufirst%3DJ.%2BL.%26aulast%3DChristmann%26aufirst%3DU.%26aulast%3DFernandez%26aufirst%3DA.%26aulast%3DLuengo%26aufirst%3DM.%26aulast%3DBordas%26aufirst%3DM.%26aulast%3DEnrech%26aufirst%3DR.%26aulast%3DCarro%26aufirst%3DM.%26aulast%3DPascual%26aufirst%3DR.%26aulast%3DBurgueno%26aufirst%3DJ.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DBenet-Buchholz%26aufirst%3DJ.%26aulast%3DCeron-Bertran%26aufirst%3DJ.%26aulast%3DRamirez%26aufirst%3DJ.%26aulast%3DReinoso%26aufirst%3DR.%2BF.%26aulast%3DFernandez%2Bde%2BHenestrosa%26aufirst%3DA.%2BR.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26aulast%3DAlmansa%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520a%2520new%2520series%2520of%2520hexahydro-2H-pyrano%255B3%252C2-c%255Dquinolines%2520as%2520novel%2520selective%2520sigma1%2520receptor%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3656%26epage%3D3665%26doi%3D10.1021%2Fjm400181k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Lan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of novel sigma-1 receptor antagonists based on pyrimidine scaffold as agents for treating neuropathic pain</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">10404</span><span class="NLM_x">–</span> <span class="NLM_lpage">10423</span><span class="refDoi"> DOI: 10.1021/jm501207r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501207r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFOhsbbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10404-10423&author=Y.+Lanauthor=Y.+Chenauthor=X.+Caoauthor=J.+Zhangauthor=J.+Wangauthor=X.+Xuauthor=Y.+Qiuauthor=T.+Zhangauthor=X.+Liuauthor=B.+F.+Liuauthor=G.+Zhang&title=Synthesis+and+biological+evaluation+of+novel+sigma-1+receptor+antagonists+based+on+pyrimidine+scaffold+as+agents+for+treating+neuropathic+pain&doi=10.1021%2Fjm501207r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of Novel Sigma-1 Receptor Antagonists Based on Pyrimidine Scaffold As Agents for Treating Neuropathic Pain</span></div><div class="casAuthors">Lan, Yu; Chen, Yin; Cao, Xudong; Zhang, Juecheng; Wang, Jie; Xu, Xiangqing; Qiu, Yinli; Zhang, Tan; Liu, Xin; Liu, Bi-Feng; Zhang, Guisen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10404-10423</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery and synthesis of a new series of pyrimidines as potent sigma-1 receptor (σ1R) antagonists, assocd. with pharmacol. antineuropathic pain activity, are the focus of this article.  The new compds. were evaluated in vitro in σ-1 and σ-2 receptor binding assays.  The nature of the pyrimidine scaffold was crucial for activity, and a basic amine was shown to be necessary according to the known pharmacophoric model.  The most promising deriv. was 5-chloro-2-(4-chlorophenyl)-4-methyl-6-(3-(piperidin-1-yl)propoxy)pyrimidine (I), which exhibited a high binding affinity to σ1R receptor (Ki σ1 = 1.06 nM) and good σ-1/2 selectivity (1344-fold).  In in vivo tests, I exerted dose-dependent antinociceptive effects in mice formalin model and rats CCI models of neuropathic pain.  In addn., no motor impairments were found in rotarod tests; acceptable pharmacokinetic properties were also noted.  These data suggest I may constitute a novel class of drugs for the treatment of neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-dkiomNDrPLVg90H21EOLACvtfcHk0lhcP5N1P-gnUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFOhsbbE&md5=bd003488b014b40e739cc42c825424ce</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm501207r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501207r%26sid%3Dliteratum%253Aachs%26aulast%3DLan%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DB.%2BF.%26aulast%3DZhang%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520sigma-1%2520receptor%2520antagonists%2520based%2520on%2520pyrimidine%2520scaffold%2520as%2520agents%2520for%2520treating%2520neuropathic%2520pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10404%26epage%3D10423%26doi%3D10.1021%2Fjm501207r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Yu, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunosewoyo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span> </span><span class="NLM_article-title">From alpha4beta2 nicotinic ligands to the discovery of sigma1 receptor ligands: pharmacophore analysis and rational design</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1054</span><span class="NLM_x">–</span> <span class="NLM_lpage">1058</span><span class="refDoi"> DOI: 10.1021/ml3002715</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml3002715" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFamtr3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=1054-1058&author=L.+F.+Yuauthor=H.+K.+Zhangauthor=H.+Gunosewoyoauthor=A.+P.+Kozikowski&title=From+alpha4beta2+nicotinic+ligands+to+the+discovery+of+sigma1+receptor+ligands%3A+pharmacophore+analysis+and+rational+design&doi=10.1021%2Fml3002715"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">From α4β2 Nicotinic Ligands to the Discovery of σ1 Receptor Ligands: Pharmacophore Analysis and Rational Design</span></div><div class="casAuthors">Yu, Li-Fang; Zhang, Han-Kun; Gunosewoyo, Hendra; Kozikowski, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1054-1058</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Comparative analyses of the pharmacophoric elements required for σ1 and nicotinic ligands led to the identification of a potent and selective σ1 ligand (15, I).  Compd. 15 displayed high selectivity for the σ1 receptor (Ki, σ1 = 4.1 nM; Ki, σ2 = 1312 nM) with moderate binding affinity for the DAT (Ki = 373 nM) and NET (Ki = 203 nM) in the PDSP broad screening panel of common CNS neurotransmitter transporters and receptors.  The key finding in this present work is that a subtle structural modification could be used as a tool to switch a ligand's selectivity between nAChRs and sigma receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp00SphSwYKLrVg90H21EOLACvtfcHk0lhcP5N1P-gnUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFamtr3K&md5=908dc6a13498beb6e751249b33d35e71</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fml3002715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml3002715%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DL.%2BF.%26aulast%3DZhang%26aufirst%3DH.%2BK.%26aulast%3DGunosewoyo%26aufirst%3DH.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DFrom%2520alpha4beta2%2520nicotinic%2520ligands%2520to%2520the%2520discovery%2520of%2520sigma1%2520receptor%2520ligands%253A%2520pharmacophore%2520analysis%2520and%2520rational%2520design%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D1054%26epage%3D1058%26doi%3D10.1021%2Fml3002715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Yu, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuckmantel, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eaton, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldarone, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedolak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanania, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span> </span><span class="NLM_article-title">Identification of novel alpha4beta2-nicotinic acetylcholine receptor (nAChR) agonists based on an isoxazole ether scaffold that demonstrate antidepressant-like activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">812</span><span class="NLM_x">–</span> <span class="NLM_lpage">823</span><span class="refDoi"> DOI: 10.1021/jm201301h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201301h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=812-823&author=L.+F.+Yuauthor=W.+Tuckmantelauthor=J.+B.+Eatonauthor=B.+Caldaroneauthor=A.+Fedolakauthor=T.+Hananiaauthor=D.+Brunnerauthor=R.+J.+Lukasauthor=A.+P.+Kozikowski&title=Identification+of+novel+alpha4beta2-nicotinic+acetylcholine+receptor+%28nAChR%29+agonists+based+on+an+isoxazole+ether+scaffold+that+demonstrate+antidepressant-like+activity&doi=10.1021%2Fjm201301h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm201301h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201301h%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DL.%2BF.%26aulast%3DTuckmantel%26aufirst%3DW.%26aulast%3DEaton%26aufirst%3DJ.%2BB.%26aulast%3DCaldarone%26aufirst%3DB.%26aulast%3DFedolak%26aufirst%3DA.%26aulast%3DHanania%26aufirst%3DT.%26aulast%3DBrunner%26aufirst%3DD.%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DIdentification%2520of%2520novel%2520alpha4beta2-nicotinic%2520acetylcholine%2520receptor%2520%2528nAChR%2529%2520agonists%2520based%2520on%2520an%2520isoxazole%2520ether%2520scaffold%2520that%2520demonstrate%2520antidepressant-like%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D812%26epage%3D823%26doi%3D10.1021%2Fjm201301h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="note"><p class="first last"><i>K</i><sub>i</sub> determinations were generously provided by the National Institute of Mental Health’s Psychoactive Drug Screening Program, contract no. HHSN-271-2008-00025-C (NIMH PDSP). The NIMH PDSP is directed by Bryan L. Roth M.D., Ph.D., at the University of North Carolina at Chapel Hill and Project Officer Jamie Driscol at NIMH, Bethesda, MD, USA.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Narayanan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesangeau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupaert, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCurdy, C. R.</span><span> </span><span class="NLM_article-title">Early development of sigma-receptor ligands</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span><span class="refDoi"> DOI: 10.4155/fmc.10.279</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.4155%2Ffmc.10.279" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=21428827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1WgtbzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=79-94&author=S.+Narayananauthor=R.+Bhatauthor=C.+Mesangeauauthor=J.+H.+Poupaertauthor=C.+R.+McCurdy&title=Early+development+of+sigma-receptor+ligands&doi=10.4155%2Ffmc.10.279"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Early development of sigma-receptor ligands</span></div><div class="casAuthors">Narayanan, Sanju; Bhat, Rohit; Mesangeau, Christophe; Poupaert, Jacques H.; McCurdy, Christopher R.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">79-94</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Sigma receptors (σ-1 and σ-2) are non-opioid proteins implicated in the pathophysiol. of various neurol. disorders and cancer.  The σ-1 subtype is a chaperon protein widely distributed in the CNS and peripheral tissues.  These receptors are involved in the modulation of K+- and Ca2+-dependent signaling cascades at the endoplasmic reticulum and modulation of neurotransmitter release. σ-1 receptors are emerging targets for the treatment of neurophychiatric diseases (schizophrenia and depression) and cocaine addiction. σ-2 receptors are lipid raft proteins.  They are highly expressed on many tumor cells and hence considered potential targets for anticancer drugs. σ receptors bind to a diverse class of pharmacol. compds. like cocaine, methamphetamine, benzomorphans like (±)-pentazocine, (±)-SKF-10,047 and endogenous neurosteroids and sphingolipids.  In this review we focus on the early development of σ receptor-specific ligands and radiolabeling agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraY6MpL93nLbVg90H21EOLACvtfcHk0lhcP5N1P-gnUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1WgtbzE&md5=d9bfcd36c9ebbaaa1223b7eec923e061</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.4155%2Ffmc.10.279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.10.279%26sid%3Dliteratum%253Aachs%26aulast%3DNarayanan%26aufirst%3DS.%26aulast%3DBhat%26aufirst%3DR.%26aulast%3DMesangeau%26aufirst%3DC.%26aulast%3DPoupaert%26aufirst%3DJ.%2BH.%26aulast%3DMcCurdy%26aufirst%3DC.%2BR.%26atitle%3DEarly%2520development%2520of%2520sigma-receptor%2520ligands%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2011%26volume%3D3%26spage%3D79%26epage%3D94%26doi%3D10.4155%2Ffmc.10.279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Clark, D. E.</span><span> </span><span class="NLM_article-title">Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">815</span><span class="NLM_x">–</span> <span class="NLM_lpage">21</span><span class="refDoi"> DOI: 10.1021/js980402t</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.1021%2Fjs980402t" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10430548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADyaK1MXjvFGitbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1999&pages=815-21&author=D.+E.+Clark&title=Rapid+calculation+of+polar+molecular+surface+area+and+its+application+to+the+prediction+of+transport+phenomena.+2.+Prediction+of+blood-brain+barrier+penetration&doi=10.1021%2Fjs980402t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid Calculation of Polar Molecular Surface Area and Its Application to the Prediction of Transport Phenomena. 2. Prediction of Blood-Brain Barrier Penetration</span></div><div class="casAuthors">Clark, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">815-821</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This paper describes the derivation of a simple QSAR model for the prediction of log BB from a set of 55 diverse org. compds.  The model contains two variables: polar surface area (PSA) and calcd. logP, both of which can be rapidly computed.  It therefore permits the prediction of log BB for large compd. sets, such as virtual combinatorial libraries.  The performance of this QSAR on two test sets taken from the literature is illustrated and compared with results from other reported computational approaches to log BB prediction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHa3ieLzy0RbVg90H21EOLACvtfcHk0lidobBTd8B0XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjvFGitbk%253D&md5=949f8bf41525d8d04694e1288f24b626</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjs980402t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjs980402t%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DD.%2BE.%26atitle%3DRapid%2520calculation%2520of%2520polar%2520molecular%2520surface%2520area%2520and%2520its%2520application%2520to%2520the%2520prediction%2520of%2520transport%2520phenomena.%25202.%2520Prediction%2520of%2520blood-brain%2520barrier%2520penetration%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1999%26volume%3D88%26spage%3D815%26epage%3D21%26doi%3D10.1021%2Fjs980402t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ablordeppey, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ismaiel, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">el-Ashmawy, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howie, K. B.</span><span> </span><span class="NLM_article-title">Structural features important for sigma 1 receptor binding</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1214</span><span class="NLM_x">–</span> <span class="NLM_lpage">1219</span><span class="refDoi"> DOI: 10.1021/jm00034a020</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00034a020" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADyaK2cXksV2lsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=1214-1219&author=R.+A.+Glennonauthor=S.+Y.+Ablordeppeyauthor=A.+M.+Ismaielauthor=M.+B.+el-Ashmawyauthor=J.+B.+Fischerauthor=K.+B.+Howie&title=Structural+features+important+for+sigma+1+receptor+binding&doi=10.1021%2Fjm00034a020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Features Important for σ1 Receptor Binding</span></div><div class="casAuthors">Glennon, Richard A.; Ablordeppey, Seth Y.; Ismaiel, Abd M.; El-Ashmawy, Mahmoud B.; Fischer, James B.; Howie, Kathleen Burke</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1214-19</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Two problems that have hampered σ receptor research are a lack of high-affinity agents and the recent identification of multiple populations of σ receptors (i.e., σ1 and σ2 sites).  Recently, several high-affinity σ ligands have been identified, and the term superpotent σ ligands has been coined to describe agents with Ki values of <1 nM.  It was previously shown that appropriately N-substituted phenylalkylamines bind at σ receptors with high affinity.  The structure-affinity relationships of these phenylalkylamine derivs. for σ1 binding are examd. and some of the first superpotent σ1 ligands described.  A binding model was developed to account for the structural features of the phenylalkylamines that appear to be important for the interaction of these agents with σ1 sites.  Some of the amines were prepd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6nnZHspQ0MLVg90H21EOLACvtfcHk0lidobBTd8B0XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXksV2lsrY%253D&md5=3c9b4ff203d7c304da3779a874837bf5</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm00034a020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00034a020%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DAblordeppey%26aufirst%3DS.%2BY.%26aulast%3DIsmaiel%26aufirst%3DA.%2BM.%26aulast%3Del-Ashmawy%26aufirst%3DM.%2BB.%26aulast%3DFischer%26aufirst%3DJ.%2BB.%26aulast%3DHowie%26aufirst%3DK.%2BB.%26atitle%3DStructural%2520features%2520important%2520for%2520sigma%25201%2520receptor%2520binding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D1214%26epage%3D1219%26doi%3D10.1021%2Fjm00034a020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Diaz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuberes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berrocal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contijoch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christmann, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Port, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holenz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buschmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laggner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serafini, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgueno, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamanillo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vela, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almansa, C.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of the 1-arylpyrazole class of sigma(1) receptor antagonists: identification of 4-{2-[5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yloxy]ethyl}morpholine (S1RA, E-52862)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">8211</span><span class="NLM_x">–</span> <span class="NLM_lpage">8224</span><span class="refDoi"> DOI: 10.1021/jm3007323</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3007323" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVWht7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8211-8224&author=J.+L.+Diazauthor=R.+Cuberesauthor=J.+Berrocalauthor=M.+Contijochauthor=U.+Christmannauthor=A.+Fernandezauthor=A.+Portauthor=J.+Holenzauthor=H.+Buschmannauthor=C.+Laggnerauthor=M.+T.+Serafiniauthor=J.+Burguenoauthor=D.+Zamanilloauthor=M.+Merlosauthor=J.+M.+Velaauthor=C.+Almansa&title=Synthesis+and+biological+evaluation+of+the+1-arylpyrazole+class+of+sigma%281%29+receptor+antagonists%3A+identification+of+4-%7B2-%5B5-methyl-1-%28naphthalen-2-yl%29-1H-pyrazol-3-yloxy%5Dethyl%7Dmorpholine+%28S1RA%2C+E-52862%29&doi=10.1021%2Fjm3007323"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of the 1-Arylpyrazole Class of σ1 Receptor Antagonists: Identification of 4-{2-[5-Methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yloxy]ethyl}morpholine (S1RA, E-52862)</span></div><div class="casAuthors">Diaz, Jose Luis; Cuberes, Rosa; Berrocal, Joana; Contijoch, Montserrat; Christmann, Ute; Fernandez, Ariadna; Port, Adriana; Holenz, Jorg; Buschmann, Helmut; Laggner, Christian; Serafini, Maria Teresa; Burgueno, Javier; Zamanillo, Daniel; Merlos, Manuel; Vela, Jose Miguel; Almansa, Carmen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8211-8224</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis and pharmacol. activity of a new series of 1-arylpyrazoles as potent σ1 receptor (σ1R) antagonists are reported.  The new compds. were evaluated in vitro in human σ1R and guinea pig σ2 receptor (σ2R) binding assays.  The nature of the pyrazole substituents was crucial for activity, and a basic amine was shown to be necessary, in accordance with known receptor pharmacophores.  A wide variety of amines and spacer lengths between the amino and pyrazole groups was tolerated, but only the ethylenoxy spacer and small cyclic amines provided compds. with sufficient selectivity for σ1R vs σ2R.  The most selective compds. were further profiled, and 4-{2-[5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yloxy]ethyl}morpholine (S1RA, E-52862, I), which showed high activity in the mouse capsaicin model of neurogenic pain, emerged as the most interesting candidate.  In addn., compd. I exerted dose-dependent antinociceptive effects in several neuropathic pain models.  This, together with its good physicochem., safety, and ADME properties, led compd. I to be selected as clin. candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreQxd7-vnvc7Vg90H21EOLACvtfcHk0lidobBTd8B0XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVWht7bI&md5=0d6a5c8008d27635117c3901ec1db3c4</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm3007323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3007323%26sid%3Dliteratum%253Aachs%26aulast%3DDiaz%26aufirst%3DJ.%2BL.%26aulast%3DCuberes%26aufirst%3DR.%26aulast%3DBerrocal%26aufirst%3DJ.%26aulast%3DContijoch%26aufirst%3DM.%26aulast%3DChristmann%26aufirst%3DU.%26aulast%3DFernandez%26aufirst%3DA.%26aulast%3DPort%26aufirst%3DA.%26aulast%3DHolenz%26aufirst%3DJ.%26aulast%3DBuschmann%26aufirst%3DH.%26aulast%3DLaggner%26aufirst%3DC.%26aulast%3DSerafini%26aufirst%3DM.%2BT.%26aulast%3DBurgueno%26aufirst%3DJ.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26aulast%3DAlmansa%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520the%25201-arylpyrazole%2520class%2520of%2520sigma%25281%2529%2520receptor%2520antagonists%253A%2520identification%2520of%25204-%257B2-%255B5-methyl-1-%2528naphthalen-2-yl%2529-1H-pyrazol-3-yloxy%255Dethyl%257Dmorpholine%2520%2528S1RA%252C%2520E-52862%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8211%26epage%3D8224%26doi%3D10.1021%2Fjm3007323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Cobos, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baeyens, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Pozo, E.</span><span> </span><span class="NLM_article-title">Phenytoin differentially modulates the affinity of agonist and antagonist ligands for sigma 1 receptors of guinea pig brain</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">192</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span><span class="refDoi"> DOI: 10.1002/syn.20103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.1002%2Fsyn.20103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=15635593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Cgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2005&pages=192-195&author=E.+J.+Cobosauthor=J.+M.+Baeyensauthor=E.+Del+Pozo&title=Phenytoin+differentially+modulates+the+affinity+of+agonist+and+antagonist+ligands+for+sigma+1+receptors+of+guinea+pig+brain&doi=10.1002%2Fsyn.20103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Phenytoin differentially modulates the affinity of agonist and antagonist ligands for σ1 receptors of guinea pig brain</span></div><div class="casAuthors">Cobos, Enrique J.; Baeyens, Jose M.; Del Pozo, Esperanza</div><div class="citationInfo"><span class="NLM_cas:title">Synapse (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">192-195</span>CODEN:
                <span class="NLM_cas:coden">SYNAET</span>;
        ISSN:<span class="NLM_cas:issn">0887-4476</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The authors evaluated the effects of phenytoin (DPH) on the affinity for sigma-1 (σ1) receptors of agonist or antagonist σ1 ligands in guinea pig brain.  Heterologous competition expts. showed that DPH (250 μM and 1 mM) concn.-dependently increased the affinity of the σ1 agonists dextromethorphan, (+)-SKF-10,047, (+)-3-PPP, and PRE-084.  However, neither DPH 250 μM nor 1 mM increased (in fact, they slightly decreased) the affinity of the σ1 receptor antagonists haloperidol, BD 1063, NE-100, progesterone, and BD 1047.  These findings suggest that allosteric modulation by DPH of the affinity of σ1 receptor ligands depends on the agonist or antagonist characteristics of the ligand.  Therefore, detg. in vitro the differential modulation by DPH of σ1 ligand affinity appears to constitute a procedure that can predict the pharmacol. profile of different σ1 ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoossDgzqW_ibVg90H21EOLACvtfcHk0ljLEzhTtT1IBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Cgtb4%253D&md5=2243891ce029ec03b1910ce6bd4e49c8</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fsyn.20103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fsyn.20103%26sid%3Dliteratum%253Aachs%26aulast%3DCobos%26aufirst%3DE.%2BJ.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26aulast%3DDel%2BPozo%26aufirst%3DE.%26atitle%3DPhenytoin%2520differentially%2520modulates%2520the%2520affinity%2520of%2520agonist%2520and%2520antagonist%2520ligands%2520for%2520sigma%25201%2520receptors%2520of%2520guinea%2520pig%2520brain%26jtitle%3DSynapse%26date%3D2005%26volume%3D55%26spage%3D192%26epage%3D195%26doi%3D10.1002%2Fsyn.20103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Tjolsen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berge, O. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunskaar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosland, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hole, K.</span><span> </span><span class="NLM_article-title">The formalin test: an evaluation of the method</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span><span class="refDoi"> DOI: 10.1016/0304-3959(92)90003-T</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.1016%2F0304-3959%2892%2990003-T" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1454405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A280%3ADyaK3s%252FoslSnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1992&pages=5-17&author=A.+Tjolsenauthor=O.+G.+Bergeauthor=S.+Hunskaarauthor=J.+H.+Roslandauthor=K.+Hole&title=The+formalin+test%3A+an+evaluation+of+the+method&doi=10.1016%2F0304-3959%2892%2990003-T"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">The formalin test: an evaluation of the method</span></div><div class="casAuthors">Tjolsen Arne; Berge Odd-Geir; Hunskaar Steinar; Rosland Jan Henrik; Hole Kjell</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-17</span>
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    </div><div class="casAbstract">The formalin test for nociception, which is predominantly used with rats and mice, involves moderate, continuous pain generated by injured tissue.  In this way it differs from most traditional tests of nociception which rely upon brief stimuli of threshold intensity.  In this article we describe the main features of the formalin test, including the characteristics of the stimulus and how changes in nociceptive behaviour may be measured and interpreted.  The response to formalin shows an early and a late phase.  The early phase seems to be caused predominantly by C-fibre activation due to the peripheral stimulus, while the late phase appears to be dependent on the combination of an inflammatory reaction in the peripheral tissue and functional changes in the dorsal horn of the spinal cord.  These functional changes seem to be initiated by the C-fibre barrage during the early phase.  In mice, the behavioural response in the late phase depends on the ambient temperature.  We argue that the peripheral tissue temperature as well as other factors influencing the peripheral inflammation may affect the response, possibly confounding the results obtained with the test.  Furthermore, we discuss the methods of recording the response and the value of observing more than one aspect of behaviour.  Scoring of several behavioural variables provides a means of assessing motor or sensorimotor function as possible causes for changes in behaviour.  In conclusion, the formalin test is a valuable addition to the battery of methods available to study nociception.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSEPstJUQcfvkEksK8CslK8fW6udTcc2ebkYE6rn7TzBrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3s%252FoslSnsA%253D%253D&md5=d56dc5eb88d109dd30d319dcf580c781</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2F0304-3959%2892%2990003-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3959%252892%252990003-T%26sid%3Dliteratum%253Aachs%26aulast%3DTjolsen%26aufirst%3DA.%26aulast%3DBerge%26aufirst%3DO.%2BG.%26aulast%3DHunskaar%26aufirst%3DS.%26aulast%3DRosland%26aufirst%3DJ.%2BH.%26aulast%3DHole%26aufirst%3DK.%26atitle%3DThe%2520formalin%2520test%253A%2520an%2520evaluation%2520of%2520the%2520method%26jtitle%3DPain%26date%3D1992%26volume%3D51%26spage%3D5%26epage%3D17%26doi%3D10.1016%2F0304-3959%2892%2990003-T" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Mogil, J. S.</span><span> </span><span class="NLM_article-title">Animal models of pain: progress and challenges</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span><span class="refDoi"> DOI: 10.1038/nrn2606</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.1038%2Fnrn2606" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=19259101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisFCntLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=283-294&author=J.+S.+Mogil&title=Animal+models+of+pain%3A+progress+and+challenges&doi=10.1038%2Fnrn2606"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Animal models of pain: progress and challenges</span></div><div class="casAuthors">Mogil, Jeffrey S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">283-294</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Many are frustrated with the lack of translational progress in the pain field, in which huge gains in basic science knowledge obtained using animal models have not led to the development of many new clin. effective compds.  A careful re-examn. of animal models of pain is therefore warranted.  Pain researchers now have at their disposal a much wider range of mutant animals to study, assays that more closely resemble clin. pain states, and dependent measures beyond simple reflexive withdrawal.  However, the complexity of the phenomenon of pain has made it difficult to assess the true value of these advances.  In addn., pain studies are importantly affected by a wide range of modulatory factors, including sex, genotype and social communication, all of which must be taken into account when using an animal model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFMgN3i1-8BbVg90H21EOLACvtfcHk0ljLEzhTtT1IBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisFCntLY%253D&md5=364f8c94a9fa144fe4ea13c6f1f6641f</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnrn2606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn2606%26sid%3Dliteratum%253Aachs%26aulast%3DMogil%26aufirst%3DJ.%2BS.%26atitle%3DAnimal%2520models%2520of%2520pain%253A%2520progress%2520and%2520challenges%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2009%26volume%3D10%26spage%3D283%26epage%3D294%26doi%3D10.1038%2Fnrn2606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerns, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConnell, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, G. T.</span><span> </span><span class="NLM_article-title">High throughput artificial membrane permeability assay for blood-brain barrier</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span><span class="refDoi"> DOI: 10.1016/S0223-5234(03)00012-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.1016%2FS0223-5234%2803%2900012-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=12667689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=223-232&author=L.+Diauthor=E.+H.+Kernsauthor=K.+Fanauthor=O.+J.+McConnellauthor=G.+T.+Carter&title=High+throughput+artificial+membrane+permeability+assay+for+blood-brain+barrier&doi=10.1016%2FS0223-5234%2803%2900012-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">High throughput artificial membrane permeability assay for blood-brain barrier</span></div><div class="casAuthors">Di, Li; Kerns, Edward H.; Fan, Kristi; McConnell, Oliver J.; Carter, Guy T.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">223-232</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">The recent advances in high throughput screening for biol. activities and combinatorial chem. have greatly expanded the no. of drug candidates.  Rapid screening for BBB penetration potential early in drug discovery programs provides important information for compd. selection and guidance of synthesis for desirable CNS properties.  In this paper, we discuss a modification of the parallel artificial membrane permeation assay (PAMPA) for the prediction of blood-brain barrier penetration (PAMPA-BBB).  The assay was developed with 30 structurally diverse com. drugs and validated with 14 Wyeth Research compds.  The PAMPA-BBB assay has the advantages of: predicting passive blood-brain barrier penetration with high success, high throughput, low cost, and reproducibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZCg9Ka4mziLVg90H21EOLACvtfcHk0lj4r5pCdIgBDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D&md5=d228d5808ba8df23deed92c5e2bf3863</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2FS0223-5234%2803%2900012-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0223-5234%252803%252900012-6%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DMcConnell%26aufirst%3DO.%2BJ.%26aulast%3DCarter%26aufirst%3DG.%2BT.%26atitle%3DHigh%2520throughput%2520artificial%2520membrane%2520permeability%2520assay%2520for%2520blood-brain%2520barrier%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2003%26volume%3D38%26spage%3D223%26epage%3D232%26doi%3D10.1016%2FS0223-5234%2803%2900012-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':[],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 16 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Young-Hwan Jung, Veronica Salmaso, Zhiwei Wen, John M. Bennett, Ngan B. Phung, David I. Lieberman, Varun Gopinatth, John C. R. Randle, Zhoumou Chen, Daniela Salvemini, Tadeusz P. Karcz, Donald N. Cook, <span class="NLM_string-name hlFld-ContribAuthor">Kenneth A. Jacobson</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–Activity Relationship of Heterocyclic P2Y14 Receptor Antagonists: Removal of the Zwitterionic Character with Piperidine Bioisosteres. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (8)
                                     , 5099-5122. <a href="https://doi.org/10.1021/acs.jmedchem.1c00164" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00164</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00164%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%2525E2%252580%252593Activity%252BRelationship%252Bof%252BHeterocyclic%252BP2Y14%252BReceptor%252BAntagonists%25253A%252BRemoval%252Bof%252Bthe%252BZwitterionic%252BCharacter%252Bwith%252BPiperidine%252BBioisosteres%26aulast%3DJung%26aufirst%3DYoung-Hwan%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D28012021%26date%3D31032021%26volume%3D64%26issue%3D8%26spage%3D5099%26epage%3D5122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Youyi Peng, Qiang Zhang, <span class="NLM_string-name hlFld-ContribAuthor">William J. Welsh</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Sigma 1 Receptor Antagonists as Potential Therapeutics for Pain Management. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (1)
                                     , 890-904. <a href="https://doi.org/10.1021/acs.jmedchem.0c01964" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01964</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01964&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01964%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BSigma%252B1%252BReceptor%252BAntagonists%252Bas%252BPotential%252BTherapeutics%252Bfor%252BPain%252BManagement%26aulast%3DPeng%26aufirst%3DYouyi%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D12112020%26date%3D29122020%26volume%3D64%26issue%3D1%26spage%3D890%26epage%3D904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Na Ye, Wangzhi Qin, Sheng Tian, Qingfeng Xu, Eric A. Wold, Jia Zhou, <span class="NLM_string-name hlFld-ContribAuthor">Xue-Chu Zhen</span>. </span><span class="cited-content_cbyCitation_article-title">Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (24)
                                     , 15187-15217. <a href="https://doi.org/10.1021/acs.jmedchem.0c01192" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01192</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01192%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall%252BMolecules%252BSelectively%252BTargeting%252BSigma-1%252BReceptor%252Bfor%252Bthe%252BTreatment%252Bof%252BNeurological%252BDiseases%26aulast%3DYe%26aufirst%3DNa%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D09072020%26date%3D28102020%26volume%3D63%26issue%3D24%26spage%3D15187%26epage%3D15217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Youyi Peng, Hiep Dong, <span class="NLM_string-name hlFld-ContribAuthor">William J. Welsh</span>. </span><span class="cited-content_cbyCitation_article-title">Comprehensive 3D-QSAR Model Predicts Binding Affinity of Structurally Diverse Sigma 1 Receptor Ligands. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2019,</strong> <em>59 </em>
                                    (1)
                                     , 486-497. <a href="https://doi.org/10.1021/acs.jcim.8b00521" title="DOI URL">https://doi.org/10.1021/acs.jcim.8b00521</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.8b00521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.8b00521%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DComprehensive%252B3D-QSAR%252BModel%252BPredicts%252BBinding%252BAffinity%252Bof%252BStructurally%252BDiverse%252BSigma%252B1%252BReceptor%252BLigands%26aulast%3DPeng%26aufirst%3DYouyi%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D01082018%26date%3D14122018%26date%3D29112018%26volume%3D59%26issue%3D1%26spage%3D486%26epage%3D497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James J.  Sahn</span>, <span class="hlFld-ContribAuthor ">Timothy R.  Hodges</span>, <span class="hlFld-ContribAuthor ">Jessica Z.  Chan</span>, and <span class="hlFld-ContribAuthor ">Stephen F.  Martin</span>  . </span><span class="cited-content_cbyCitation_article-title">Norbenzomorphan Scaffold: Chemical Tool for Modulating Sigma Receptor-Subtype Selectivity. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (4)
                                     , 455-460. <a href="https://doi.org/10.1021/acsmedchemlett.7b00066" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00066</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00066%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNorbenzomorphan%252BScaffold%25253A%252BChemical%252BTool%252Bfor%252BModulating%252BSigma%252BReceptor-Subtype%252BSelectivity%26aulast%3DSahn%26aufirst%3DJames%2BJ.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D15022017%26date%3D21032017%26date%3D28032017%26date%3D13042017%26date%3D21032017%26volume%3D8%26issue%3D4%26spage%3D455%26epage%3D460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Winnie  Deuther-Conrad</span>, <span class="hlFld-ContribAuthor ">Daniel  Diez-Iriepa</span>, <span class="hlFld-ContribAuthor ">Isabel  Iriepa</span>, <span class="hlFld-ContribAuthor ">Francisco  López-Muñoz</span>, <span class="hlFld-ContribAuthor ">María Angeles  Martínez-Grau</span>, <span class="hlFld-ContribAuthor ">Michael  Gütschow</span>, <span class="hlFld-ContribAuthor ">José  Marco-Contelles</span>. </span><span class="cited-content_cbyCitation_article-title">Studies on the affinity of 6-[(
              n
              -(cyclo)aminoalkyl)oxy]-4
              H
              -chromen-4-ones for sigma 1/2 receptors. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2021,</strong> <em>12 </em>
                                    (6)
                                     , 1000-1004. <a href="https://doi.org/10.1039/D1MD00105A" title="DOI URL">https://doi.org/10.1039/D1MD00105A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1MD00105A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1MD00105A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DStudies%252Bon%252Bthe%252Baffinity%252Bof%252B6-%25255B%252528%252Bn%252B-%252528cyclo%252529aminoalkyl%252529oxy%25255D-4%252BH%252B-chromen-4-ones%252Bfor%252Bsigma%252B1%25252F2%252Breceptors%26aulast%3DDeuther-Conrad%26aufirst%3DWinnie%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D6%26spage%3D1000%26epage%3D1004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun-Jie  Shi</span>, <span class="hlFld-ContribAuthor ">Qi-Hui  Jiang</span>, <span class="hlFld-ContribAuthor ">Tian-Ning  Zhang</span>, <span class="hlFld-ContribAuthor ">Hao  Sun</span>, <span class="hlFld-ContribAuthor ">Wen-Wen  Shi</span>, <span class="hlFld-ContribAuthor ">Hendra  Gunosewoyo</span>, <span class="hlFld-ContribAuthor ">Fan  Yang</span>, <span class="hlFld-ContribAuthor ">Jie  Tang</span>, <span class="hlFld-ContribAuthor ">Tao  Pang</span>, <span class="hlFld-ContribAuthor ">Li-Fang  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Sigma-1 Receptor Agonist TS-157 Improves Motor Functional Recovery by Promoting Neurite Outgrowth and pERK in Rats with Focal Cerebral Ischemia. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (5)
                                     , 1212. <a href="https://doi.org/10.3390/molecules26051212" title="DOI URL">https://doi.org/10.3390/molecules26051212</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26051212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26051212%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSigma-1%252BReceptor%252BAgonist%252BTS-157%252BImproves%252BMotor%252BFunctional%252BRecovery%252Bby%252BPromoting%252BNeurite%252BOutgrowth%252Band%252BpERK%252Bin%252BRats%252Bwith%252BFocal%252BCerebral%252BIschemia%26aulast%3DShi%26aufirst%3DJun-Jie%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D5%26spage%3D1212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mireia  Casanovas</span>, <span class="hlFld-ContribAuthor ">Mireia  Jiménez‐Rosés</span>, <span class="hlFld-ContribAuthor ">Arnau  Cordomí</span>, <span class="hlFld-ContribAuthor ">Alejandro  Lillo</span>, <span class="hlFld-ContribAuthor ">Ignacio  Vega‐Quiroga</span>, <span class="hlFld-ContribAuthor ">Joan  Izquierdo</span>, <span class="hlFld-ContribAuthor ">Mireia  Medrano</span>, <span class="hlFld-ContribAuthor ">Katia  Gysling</span>, <span class="hlFld-ContribAuthor ">Leonardo  Pardo</span>, <span class="hlFld-ContribAuthor ">Gemma  Navarro</span>, <span class="hlFld-ContribAuthor ">Rafael  Franco</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a macromolecular complex mediating the hunger suppressive actions of cocaine: Structural and functional properties. </span><span class="cited-content_cbyCitation_journal-name">Addiction Biology</span><span> <strong>2021,</strong> <em>32 </em><a href="https://doi.org/10.1111/adb.13017" title="DOI URL">https://doi.org/10.1111/adb.13017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/adb.13017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fadb.13017%26sid%3Dliteratum%253Aachs%26jtitle%3DAddiction%2520Biology%26atitle%3DDiscovery%252Bof%252Ba%252Bmacromolecular%252Bcomplex%252Bmediating%252Bthe%252Bhunger%252Bsuppressive%252Bactions%252Bof%252Bcocaine%25253A%252BStructural%252Band%252Bfunctional%252Bproperties%26aulast%3DCasanovas%26aufirst%3DMireia%26date%3D2021%26date%3D2021%26volume%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun‐Jie  Shi</span>, <span class="hlFld-ContribAuthor ">Kun‐Hang  Jia</span>, <span class="hlFld-ContribAuthor ">Hao  Sun</span>, <span class="hlFld-ContribAuthor ">Hendra  Gunosewoyo</span>, <span class="hlFld-ContribAuthor ">Fan  Yang</span>, <span class="hlFld-ContribAuthor ">Jie  Tang</span>, <span class="hlFld-ContribAuthor ">Jian  Luo</span>, <span class="hlFld-ContribAuthor ">Li‐Fang  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Pharmacological Evaluation of σ2 Receptor Ligands Based on a 3‐Alkoxyisoxazole Scaffold: Potential Antitumor Effects against Osteosarcoma. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>16 </em>
                                    (3)
                                     , 524-536. <a href="https://doi.org/10.1002/cmdc.202000461" title="DOI URL">https://doi.org/10.1002/cmdc.202000461</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000461%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DSynthesis%252Band%252BPharmacological%252BEvaluation%252Bof%252B%2525CF%2525832%252BReceptor%252BLigands%252BBased%252Bon%252Ba%252B3%2525E2%252580%252590Alkoxyisoxazole%252BScaffold%25253A%252BPotential%252BAntitumor%252BEffects%252Bagainst%252BOsteosarcoma%26aulast%3DShi%26aufirst%3DJun%25E2%2580%2590Jie%26date%3D2021%26date%3D2020%26volume%3D16%26issue%3D3%26spage%3D524%26epage%3D536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gemma  Navarro</span>, <span class="hlFld-ContribAuthor ">Mireia  Medrano</span>, <span class="hlFld-ContribAuthor ">David  Aguinaga</span>, <span class="hlFld-ContribAuthor ">Ignacio  Vega-Quiroga</span>, <span class="hlFld-ContribAuthor ">Alejandro  Lillo</span>, <span class="hlFld-ContribAuthor ">Jasmina  Jiménez</span>, <span class="hlFld-ContribAuthor ">Mireia  Casanovas</span>, <span class="hlFld-ContribAuthor ">Enric I.  Canela</span>, <span class="hlFld-ContribAuthor ">Josefa  Mallol</span>, <span class="hlFld-ContribAuthor ">Katia  Gysling</span>, <span class="hlFld-ContribAuthor ">Rafael  Franco</span>. </span><span class="cited-content_cbyCitation_article-title">Differential effect of amphetamine over the corticotropin-releasing factor CRF2 receptor, the orexin OX1 receptor and the CRF2-OX1 heteroreceptor complex. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2019,</strong> <em>152 </em>, 102-111. <a href="https://doi.org/10.1016/j.neuropharm.2018.11.014" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2018.11.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2018.11.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2018.11.014%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DDifferential%252Beffect%252Bof%252Bamphetamine%252Bover%252Bthe%252Bcorticotropin-releasing%252Bfactor%252BCRF2%252Breceptor%25252C%252Bthe%252Borexin%252BOX1%252Breceptor%252Band%252Bthe%252BCRF2-OX1%252Bheteroreceptor%252Bcomplex%26aulast%3DNavarro%26aufirst%3DGemma%26date%3D2019%26volume%3D152%26spage%3D102%26epage%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Iredia D.  Iyamu</span>, <span class="hlFld-ContribAuthor ">Wei  Lv</span>, <span class="hlFld-ContribAuthor ">Neha  Malik</span>, <span class="hlFld-ContribAuthor ">Rama K.  Mishra</span>, <span class="hlFld-ContribAuthor ">Gary E.  Schiltz</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a novel class of potent and selective tetrahydroindazole-based sigma-1 receptor ligands. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (9)
                                     , 1824-1835. <a href="https://doi.org/10.1016/j.bmc.2019.03.030" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.03.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.03.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.03.030%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252Bnovel%252Bclass%252Bof%252Bpotent%252Band%252Bselective%252Btetrahydroindazole-based%252Bsigma-1%252Breceptor%252Bligands%26aulast%3DIyamu%26aufirst%3DIredia%2BD.%26date%3D2019%26volume%3D27%26issue%3D9%26spage%3D1824%26epage%3D1835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xudong  Cao</span>, <span class="hlFld-ContribAuthor ">Zhongyuan  Yao</span>, <span class="hlFld-ContribAuthor ">Fei  Dou</span>, <span class="hlFld-ContribAuthor ">Yifang  Zhang</span>, <span class="hlFld-ContribAuthor ">Yinli  Qiu</span>, <span class="hlFld-ContribAuthor ">Song  Zhao</span>, <span class="hlFld-ContribAuthor ">Xiangqing  Xu</span>, <span class="hlFld-ContribAuthor ">Xin  Liu</span>, <span class="hlFld-ContribAuthor ">Bi‐Feng  Liu</span>, <span class="hlFld-ContribAuthor ">Yin  Chen</span>, <span class="hlFld-ContribAuthor ">Guisen  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of Sigma‐1 (σ
              1
              ) Receptor Ligands Based on Phenyl‐1,2,4‐oxadiazole Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Chemistry & Biodiversity</span><span> <strong>2019,</strong> <em>16 </em>
                                    (3)
                                     , e1800599. <a href="https://doi.org/10.1002/cbdv.201800599" title="DOI URL">https://doi.org/10.1002/cbdv.201800599</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbdv.201800599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbdv.201800599%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%2526%2520Biodiversity%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BSigma%2525E2%252580%2525901%252B%252528%2525CF%252583%252B1%252B%252529%252BReceptor%252BLigands%252BBased%252Bon%252BPhenyl%2525E2%252580%2525901%25252C2%25252C4%2525E2%252580%252590oxadiazole%252BDerivatives%26aulast%3DCao%26aufirst%3DXudong%26date%3D2019%26date%3D2019%26volume%3D16%26issue%3D3%26spage%3De1800599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David  Aguinaga</span>, <span class="hlFld-ContribAuthor ">Mireia  Medrano</span>, <span class="hlFld-ContribAuthor ">Arnau  Cordomí</span>, <span class="hlFld-ContribAuthor ">Mireia  Jiménez-Rosés</span>, <span class="hlFld-ContribAuthor ">Edgar  Angelats</span>, <span class="hlFld-ContribAuthor ">Mireia  Casanovas</span>, <span class="hlFld-ContribAuthor ">Ignacio  Vega-Quiroga</span>, <span class="hlFld-ContribAuthor ">Enric I.  Canela</span>, <span class="hlFld-ContribAuthor ">Milos  Petrovic</span>, <span class="hlFld-ContribAuthor ">Katia  Gysling</span>, <span class="hlFld-ContribAuthor ">Leonardo  Pardo</span>, <span class="hlFld-ContribAuthor ">Rafael  Franco</span>, <span class="hlFld-ContribAuthor ">Gemma  Navarro</span>. </span><span class="cited-content_cbyCitation_article-title">Cocaine Blocks Effects of Hunger Hormone, Ghrelin, Via Interaction with Neuronal Sigma-1 Receptors. </span><span class="cited-content_cbyCitation_journal-name">Molecular Neurobiology</span><span> <strong>2019,</strong> <em>56 </em>
                                    (2)
                                     , 1196-1210. <a href="https://doi.org/10.1007/s12035-018-1140-7" title="DOI URL">https://doi.org/10.1007/s12035-018-1140-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12035-018-1140-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12035-018-1140-7%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Neurobiology%26atitle%3DCocaine%252BBlocks%252BEffects%252Bof%252BHunger%252BHormone%25252C%252BGhrelin%25252C%252BVia%252BInteraction%252Bwith%252BNeuronal%252BSigma-1%252BReceptors%26aulast%3DAguinaga%26aufirst%3DDavid%26date%3D2019%26date%3D2018%26volume%3D56%26issue%3D2%26spage%3D1196%26epage%3D1210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hao  Sun</span>, <span class="hlFld-ContribAuthor ">Yun-Jie  Wang</span>, <span class="hlFld-ContribAuthor ">Wen-Wen  Shi</span>, <span class="hlFld-ContribAuthor ">Fan  Yang</span>, <span class="hlFld-ContribAuthor ">Jie  Tang</span>, <span class="hlFld-ContribAuthor ">Tao  Pang</span>, <span class="hlFld-ContribAuthor ">Li-Fang  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of
              N
              -cyclobutylaminoethoxyisoxazole derivatives as novel sigma-1 receptor ligands with neurite outgrowth efficacy in cells. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2018,</strong> <em>8 </em>
                                    (13)
                                     , 7080-7088. <a href="https://doi.org/10.1039/C8RA00072G" title="DOI URL">https://doi.org/10.1039/C8RA00072G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8RA00072G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8RA00072G%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DDiscovery%252Bof%252BN%252B-cyclobutylaminoethoxyisoxazole%252Bderivatives%252Bas%252Bnovel%252Bsigma-1%252Breceptor%252Bligands%252Bwith%252Bneurite%252Boutgrowth%252Befficacy%252Bin%252Bcells%26aulast%3DSun%26aufirst%3DHao%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D13%26spage%3D7080%26epage%3D7088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emanuela  Arena</span>, <span class="hlFld-ContribAuthor ">Maria  Dichiara</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Floresta</span>, <span class="hlFld-ContribAuthor ">Carmela  Parenti</span>, <span class="hlFld-ContribAuthor ">Agostino  Marrazzo</span>, <span class="hlFld-ContribAuthor ">Valeria  Pittalà</span>, <span class="hlFld-ContribAuthor ">Emanuele  Amata</span>, <span class="hlFld-ContribAuthor ">Orazio  Prezzavento</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Sigma-1 receptor antagonists: from opioids to small molecules: what is new?. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2018,</strong> <em>10 </em>
                                    (2)
                                     , 231-256. <a href="https://doi.org/10.4155/fmc-2017-0164" title="DOI URL">https://doi.org/10.4155/fmc-2017-0164</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2017-0164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2017-0164%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BSigma-1%252Breceptor%252Bantagonists%25253A%252Bfrom%252Bopioids%252Bto%252Bsmall%252Bmolecules%25253A%252Bwhat%252Bis%252Bnew%25253F%26aulast%3DArena%26aufirst%3DEmanuela%26date%3D2018%26volume%3D10%26issue%3D2%26spage%3D231%26epage%3D256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Silvia  Franchini</span>, <span class="hlFld-ContribAuthor ">Claudia  Sorbi</span>, <span class="hlFld-ContribAuthor ">Umberto Maria  Battisti</span>, <span class="hlFld-ContribAuthor ">Annalisa  Tait</span>, <span class="hlFld-ContribAuthor ">Leda Ivanova  Bencheva</span>, <span class="hlFld-ContribAuthor ">Elena  Cichero</span>, <span class="hlFld-ContribAuthor ">Paola  Fossa</span>, <span class="hlFld-ContribAuthor ">Antonio  Cilia</span>, <span class="hlFld-ContribAuthor ">Orazio  Prezzavento</span>, <span class="hlFld-ContribAuthor ">Simone  Ronsisvalle</span>, <span class="hlFld-ContribAuthor ">Giuseppina  Aricò</span>, <span class="hlFld-ContribAuthor ">Luisa  Benassi</span>, <span class="hlFld-ContribAuthor ">Cristina  Vaschieri</span>, <span class="hlFld-ContribAuthor ">Paola  Azzoni</span>, <span class="hlFld-ContribAuthor ">Cristina  Magnoni</span>, <span class="hlFld-ContribAuthor ">Livio  Brasili</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Activity Relationships within a Series of σ
              1
              and σ
              2
              Receptor Ligands: Identification of a σ
              2
              Receptor Agonist (BS148) with Selective Toxicity against Metastatic Melanoma. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2017,</strong> <em>12 </em>
                                    (22)
                                     , 1893-1905. <a href="https://doi.org/10.1002/cmdc.201700427" title="DOI URL">https://doi.org/10.1002/cmdc.201700427</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201700427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201700427%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DStructure-Activity%252BRelationships%252Bwithin%252Ba%252BSeries%252Bof%252B%2525CF%252583%252B1%252Band%252B%2525CF%252583%252B2%252BReceptor%252BLigands%25253A%252BIdentification%252Bof%252Ba%252B%2525CF%252583%252B2%252BReceptor%252BAgonist%252B%252528BS148%252529%252Bwith%252BSelective%252BToxicity%252Bagainst%252BMetastatic%252BMelanoma%26aulast%3DFranchini%26aufirst%3DSilvia%26date%3D2017%26date%3D2017%26volume%3D12%26issue%3D22%26spage%3D1893%26epage%3D1905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/medium/jm-2016-00571g_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/large/jm-2016-00571g_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00571&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/medium/jm-2016-00571g_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/large/jm-2016-00571g_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Selected σ receptor ligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/large/jm-2016-00571g_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00571&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/medium/jm-2016-00571g_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/large/jm-2016-00571g_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. σ1 receptor pharmacophore model and proposed match of substructures with pharmacophore elements for compounds <b>8</b>, <b>9</b>, <b>53</b>, and <b>54</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/large/jm-2016-00571g_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00571&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/medium/jm-2016-00571g_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/large/jm-2016-00571g_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/large/jm-2016-00571g_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00571&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>N</i>-hydroxyurea, 1,5-diazabicyclo[5.4.0]undec-5-ene, MeOH, 0 °C, then HCl; (b) 1-(<i>tert</i>-butoxycarbonyl)-2(<i>S</i>)-pyrrolidinylmethanol, diisopropyl azodicarboxylate, PPh<sub>3</sub>, THF, 0 °C to rt; (c) NaOH, THF, rt; (d) DCC, DMAP, phenol, CH<sub>2</sub>Cl<sub>2</sub>, rt; (e) TFA/CH<sub>2</sub>Cl<sub>2</sub>, rt, or HCl/EtOAc, rt; (f) EDC, DMAP, aniline or indoline, rt; (g) LiBH<sub>4</sub>, THF, 0 °C to rt; (h) I<sub>2</sub>, PPh<sub>3</sub>, imidazole, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt; (i) phenol, or naphthalen-2-ol, or substituted phenol, K<sub>2</sub>CO<sub>3</sub>, DMF, rt; (j) PhSH, K<sub>2</sub>CO<sub>3</sub>, DMF, rt; (k) PhNCO, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/medium/jm-2016-00571g_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/large/jm-2016-00571g_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/large/jm-2016-00571g_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00571&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HCHO, CF<sub>3</sub>CH<sub>2</sub>OH, NaBH<sub>4</sub>, 40 °C; (b) aldehyde or ketone, Na(CN)BH<sub>3</sub>, CH<sub>3</sub>CO<sub>2</sub>H, CH<sub>3</sub>OH, rt; (c) (ClCH<sub>2</sub>CH<sub>2</sub>)<sub>2</sub>O, NaI, K<sub>2</sub>CO<sub>3</sub>, DMF.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/medium/jm-2016-00571g_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/large/jm-2016-00571g_0008.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/large/jm-2016-00571g_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00571&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) KHCO<sub>3</sub>, DMF, −10 °C to rt then 1 N HCl; (b) (i) <i>N-</i>Boc piperazine, <sup><i>t</i></sup>BuOH, Na<sub>2</sub>CO<sub>3</sub>, reflux, (ii) imidazole, I<sub>2</sub>, PhMe, 110 °C; (c) LiBH<sub>4</sub>, THF; (d) PPh<sub>3</sub>, imidazole, I<sub>2</sub>, rt; (e) phenol, K<sub>2</sub>CO<sub>3</sub>, DMF, rt; (f) HCl, EtOAc, rt.</p></p></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/medium/jm-2016-00571g_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/large/jm-2016-00571g_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Analgesic effects of compound <b>53</b> and <b>4</b> in phase I (0–10 min) and phase II (11–45) of the mouse formalin test at the dose of 80 mg/kg. All drugs were administered intraperitoneally; each column and vertical line represents mean ± SEM of the values obtained in at least six animals. Statistically significant differences: * <i>p</i> < 0.05, ** <i>p</i> < 0.01, *** <i>p</i> < 0.001 vs vehicle using unpaired, two-tailed <i>t</i> test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/large/jm-2016-00571g_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00571&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/medium/jm-2016-00571g_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/large/jm-2016-00571g_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Dose response effect of <b>53</b> and pregabalin on rotarod test. Data obtained from the 8–10 mice per group and expressed as mean ± SEM latency (s) to fall down from the rod. Statistically significant differences: * <i>p</i> < 0.05, ** <i>p</i> < 0.01, *** <i>p</i> < 0.001 vs vehicle (two-way ANOVA followed by Bonferroni test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00571/20160708/images/large/jm-2016-00571g_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00571&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i94">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15572" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15572" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 37 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Martin, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eades, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huppler, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, P. E.</span><span> </span><span class="NLM_article-title">The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">197</span><span class="NLM_x">, </span> <span class="NLM_fpage">517</span><span class="NLM_x">–</span> <span class="NLM_lpage">532</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=945347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADyaE28XltlOhurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=197&publication_year=1976&pages=517-532&author=W.+R.+Martinauthor=C.+G.+Eadesauthor=J.+A.+Thompsonauthor=R.+E.+Hupplerauthor=P.+E.+Gilbert&title=The+effects+of+morphine-+and+nalorphine-+like+drugs+in+the+nondependent+and+morphine-dependent+chronic+spinal+dog"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog</span></div><div class="casAuthors">Martin, W. R.; Eades, C. G.; Thompson, J. A.; Huppler, R. E.; Gilbert, P. E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">197</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">517-32</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">Three different syndromes produced by congeners of morphine sulfate (I sulfate) [64-31-3] were identified in the nondependent chronic spinal dog.  These syndromes were attributed to interaction of agonists with three distinguishable receptors (μ, κ and σ).  I was the prototype agonist for the μ receptor, ketocyclazocine lactate [59985-33-0] for the κ receptor and SKF-10,047 lactate [59985-34-1] for the σ receptor.  The I syndrome (μ) in the dog was characterized by miosis, bradycardia, hypothermia, a general depression of the nociceptive responses and indifferences to environmental stimuli.  Ketocyclazocine (κ) constricted pupils, depressed the flexor reflex and produced sedation but did not markedly alter pulse rate or the skin twitch reflex.  SKF-10,047 (σ) caused mydriasis, tachypnea, tachycardia and mania.  The effects of these three drugs was antagonized by the pure antagonist naltrexone-HCl, indicating that they are agonists.  Further, chronic administration of I, ketocyclazocine and SKF-10,047 induced tolerance to their agonistic effects.  I suppressed abstinence in I-dependent dogs while ketocyclazocine did not.  Ketocyclazocine at best pptd. only a liminal abstinence syndrome in the I-dependent dog, indicating that it had little affinity for the I receptor.  Ketocyclazocine thus appears to be a selective agonist at the κ receptor.  Buprenorphine-HCl [53152-21-9] was a partial agonist of the μ type which both suppressed and pptd. abstinence in the I-dependent dog while I and d-propoxyphene-HCl [1639-60-7] were stronger agonists.  Apomorphine-HCl [314-19-2] and SKF-10,047 produced similar pharmacol. effects suggesting that σ activity may involve a dopaminergic mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6rgyf41iRTbVg90H21EOLACvtfcHk0lj2yvx8_rQXUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XltlOhurw%253D&md5=ca7c637f336ac9ecc2c3bb040dbcdbee</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DW.%2BR.%26aulast%3DEades%26aufirst%3DC.%2BG.%26aulast%3DThompson%26aufirst%3DJ.%2BA.%26aulast%3DHuppler%26aufirst%3DR.%2BE.%26aulast%3DGilbert%26aufirst%3DP.%2BE.%26atitle%3DThe%2520effects%2520of%2520morphine-%2520and%2520nalorphine-%2520like%2520drugs%2520in%2520the%2520nondependent%2520and%2520morphine-dependent%2520chronic%2520spinal%2520dog%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1976%26volume%3D197%26spage%3D517%26epage%3D532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Hayashi, T.</span><span> </span><span class="NLM_article-title">Sigma-1 receptor: The novel intracellular target of neuropsychotherapeutic drugs</span> <span class="citation_source-journal">J. Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">5</span><span class="refDoi"> DOI: 10.1016/j.jphs.2014.07.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.1016%2Fj.jphs.2014.07.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=25704011" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BC28Xislaks70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2015&pages=2-5&author=T.+Hayashi&title=Sigma-1+receptor%3A+The+novel+intracellular+target+of+neuropsychotherapeutic+drugs&doi=10.1016%2Fj.jphs.2014.07.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma-1 receptor: The novel intracellular target of neuropsychotherapeutic drugs</span></div><div class="casAuthors">Hayashi, Teruo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Sciences (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2-5</span>CODEN:
                <span class="NLM_cas:coden">JPSTGJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-8613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Sigma-1 receptor ligands have been long expected to serve as drugs for treatment of human diseases such as neurodegenerative disorders, depression, idiopathic pain, drug abuse, and cancer.  Recent research exploring the mol. function of the sigma-1 receptor started unveiling underlying mechanisms of the therapeutic activity of those ligands.  Via the mol. chaperone activity, the sigma-1 receptor regulates protein folding/degrdn., ER/oxidative stress, and cell survival.  The chaperone activity is activated or inhibited by synthetic sigma-1 receptor ligands in an agonist-antagonist manner.  Sigma-1 receptors are localized at the endoplasmic reticulum (ER) membranes that are phys. assocd. with the mitochondria (MAM: mitochondria-assocd. ER membrane).  In specific types of neurons (e.g., those at the spinal cord), sigma-1 receptors are also clustered at ER membranes that juxtapose postsynaptic plasma membranes.  Recent studies indicate that sigma-1 receptors, partly in sake of its unique subcellular localization, regulate the mitochondria function that involves bioenergetics and free radical generation.  The sigma-1 receptor may thus provide an intracellular drug target that enables controlling ER stress and free radical generation under pathol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeVEWApyOzPbVg90H21EOLACvtfcHk0lgGnav6wtATgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xislaks70%253D&md5=b98bbc555be9cfab37acb32e8d62269e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.jphs.2014.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jphs.2014.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DT.%26atitle%3DSigma-1%2520receptor%253A%2520The%2520novel%2520intracellular%2520target%2520of%2520neuropsychotherapeutic%2520drugs%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2015%26volume%3D127%26spage%3D2%26epage%3D5%26doi%3D10.1016%2Fj.jphs.2014.07.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Mach, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, W. G.</span><span> </span><span class="NLM_article-title">The sigma2 receptor: a novel protein for the imaging and treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">7137</span><span class="NLM_x">–</span> <span class="NLM_lpage">7160</span><span class="refDoi"> DOI: 10.1021/jm301545c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301545c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7137-7160&author=R.+H.+Machauthor=C.+Zengauthor=W.+G.+Hawkins&title=The+sigma2+receptor%3A+a+novel+protein+for+the+imaging+and+treatment+of+cancer&doi=10.1021%2Fjm301545c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Fjm301545c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301545c%26sid%3Dliteratum%253Aachs%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DZeng%26aufirst%3DC.%26aulast%3DHawkins%26aufirst%3DW.%2BG.%26atitle%3DThe%2520sigma2%2520receptor%253A%2520a%2520novel%2520protein%2520for%2520the%2520imaging%2520and%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7137%26epage%3D7160%26doi%3D10.1021%2Fjm301545c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Hanner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moebius, F. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flandorfer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knaus, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Striessnig, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kempner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glossmann, H.</span><span> </span><span class="NLM_article-title">Purification, molecular cloning, and expression of the mammalian sigma(1)-binding site</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">8072</span><span class="NLM_x">–</span> <span class="NLM_lpage">8077</span><span class="refDoi"> DOI: 10.1073/pnas.93.15.8072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.1073%2Fpnas.93.15.8072" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=8072-8077&author=M.+Hannerauthor=F.+F.+Moebiusauthor=A.+Flandorferauthor=H.+G.+Knausauthor=J.+Striessnigauthor=E.+Kempnerauthor=H.+Glossmann&title=Purification%2C+molecular+cloning%2C+and+expression+of+the+mammalian+sigma%281%29-binding+site&doi=10.1073%2Fpnas.93.15.8072"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1073%2Fpnas.93.15.8072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.93.15.8072%26sid%3Dliteratum%253Aachs%26aulast%3DHanner%26aufirst%3DM.%26aulast%3DMoebius%26aufirst%3DF.%2BF.%26aulast%3DFlandorfer%26aufirst%3DA.%26aulast%3DKnaus%26aufirst%3DH.%2BG.%26aulast%3DStriessnig%26aufirst%3DJ.%26aulast%3DKempner%26aufirst%3DE.%26aulast%3DGlossmann%26aufirst%3DH.%26atitle%3DPurification%252C%2520molecular%2520cloning%252C%2520and%2520expression%2520of%2520the%2520mammalian%2520sigma%25281%2529-binding%2520site%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1996%26volume%3D93%26spage%3D8072%26epage%3D8077%26doi%3D10.1073%2Fpnas.93.15.8072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Hayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzuto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajnoczky, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, T.-P.</span><span> </span><span class="NLM_article-title">MAM: more than just a housekeeper</span> <span class="citation_source-journal">Trends Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span><span class="refDoi"> DOI: 10.1016/j.tcb.2008.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.1016%2Fj.tcb.2008.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=19144519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1amtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=81-88&author=T.+Hayashiauthor=R.+Rizzutoauthor=G.+Hajnoczkyauthor=T.-P.+Su&title=MAM%3A+more+than+just+a+housekeeper&doi=10.1016%2Fj.tcb.2008.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">MAM: more than just a housekeeper</span></div><div class="casAuthors">Hayashi, Teruo; Rizzuto, Rosario; Hajnoczky, Gyorgy; Su, Tsung-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">81-88</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The phys. assocn. between the endoplasmic reticulum (ER) and mitochondria, which is known as the mitochondria-assocd. ER membrane (MAM), has important roles in various cellular housekeeping' functions including the non-vesicular transports of phospholipids.  It has recently become clear that the MAM also enables highly efficient transmission of Ca2+ from the ER to mitochondria to stimulate oxidative metab. and, conversely, might enable the metabolically energized mitochondria to regulate the ER Ca2+ homeostasis.  Recent studies have shed light on mol. chaperones such as calnexin, calreticulin, ERp44, ERp57, grp75 and the sigma-1 receptor at the MAM, which regulate the assocn. between the two organelles.  The MAM thus integrates signal transduction with metabolic pathways to regulate the communication and functional interactions between the ER and mitochondrion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4MAdoa1CVZbVg90H21EOLACvtfcHk0lgGnav6wtATgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1amtLw%253D&md5=646e3eebc50c0bd4425fe916e01f601e</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.tcb.2008.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tcb.2008.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DRizzuto%26aufirst%3DR.%26aulast%3DHajnoczky%26aufirst%3DG.%26aulast%3DSu%26aufirst%3DT.-P.%26atitle%3DMAM%253A%2520more%2520than%2520just%2520a%2520housekeeper%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2009%26volume%3D19%26spage%3D81%26epage%3D88%26doi%3D10.1016%2Fj.tcb.2008.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Su, T.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurice, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buch, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruoho, A. E.</span><span> </span><span class="NLM_article-title">The sigma-1 receptor chaperone as an inter-organelle signaling modulator</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">557</span><span class="NLM_x">–</span> <span class="NLM_lpage">566</span><span class="refDoi"> DOI: 10.1016/j.tips.2010.08.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.1016%2Fj.tips.2010.08.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=20869780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVGisbbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=557-566&author=T.-P.+Suauthor=T.+Hayashiauthor=T.+Mauriceauthor=S.+Buchauthor=A.+E.+Ruoho&title=The+sigma-1+receptor+chaperone+as+an+inter-organelle+signaling+modulator&doi=10.1016%2Fj.tips.2010.08.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The sigma-1 receptor chaperone as an inter-organelle signaling modulator</span></div><div class="casAuthors">Su, Tsung-Ping; Hayashi, Teruo; Maurice, Tangui; Buch, Shilpa; Ruoho, Arnold E.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">557-566</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Inter-organelle signaling plays important roles in many physiol. functions.  Endoplasmic reticulum (ER)-mitochondrion signaling affects intramitochondrial calcium (Ca2+) homeostasis and cellular bioenergetics.  ER-nucleus signaling attenuates ER stress.  ER-plasma membrane signaling regulates cytosolic Ca2+ homeostasis and ER-mitochondrion-plasma membrane signaling regulates hippocampal dendritic spine formation.  Here, we propose that the sigma-1 receptor (Sig-1R), an ER chaperone protein, acts as an inter-organelle signaling modulator.  Sig-1Rs normally reside at the ER-mitochondrion contact called the MAM (mitochondrion-assocd. ER membrane), where Sig-1Rs regulate ER-mitochondrion signaling and ER-nucleus crosstalk.  When cells are stimulated by ligands or undergo prolonged stress, Sig-1Rs translocate from the MAM to the ER reticular network and plasmalemma/plasma membrane to regulate a variety of functional proteins, including ion channels, receptors and kinases.  Thus, the Sig-1R serves as an inter-organelle signaling modulator locally at the MAM and remotely at the plasmalemma/plasma membrane.  Many pharmacol./physiol. effects of Sig-1Rs might relate to this unique action of Sig-1Rs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqgD87pznGvLVg90H21EOLACvtfcHk0ljHh__OloaxKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVGisbbE&md5=a768850c77087ebf6732c0d57577f111</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2010.08.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2010.08.007%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DT.-P.%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DMaurice%26aufirst%3DT.%26aulast%3DBuch%26aufirst%3DS.%26aulast%3DRuoho%26aufirst%3DA.%2BE.%26atitle%3DThe%2520sigma-1%2520receptor%2520chaperone%2520as%2520an%2520inter-organelle%2520signaling%2520modulator%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2010%26volume%3D31%26spage%3D557%26epage%3D566%26doi%3D10.1016%2Fj.tips.2010.08.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Hayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, T. P.</span><span> </span><span class="NLM_article-title">Regulating ankyrin dynamics: Roles of sigma-1 receptors</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span><span class="refDoi"> DOI: 10.1073/pnas.98.2.491</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.1073%2Fpnas.98.2.491" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=11149946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnslKhsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=491-496&author=T.+Hayashiauthor=T.+P.+Su&title=Regulating+ankyrin+dynamics%3A+Roles+of+sigma-1+receptors&doi=10.1073%2Fpnas.98.2.491"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Regulating ankyrin dynamics: roles of sigma-1 receptors</span></div><div class="casAuthors">Hayashi, Teruo; Su, Tsung-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">491-496</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Ankyrin is a cytoskeletal adaptor protein that controls important cellular functions, including Ca2+ efflux at inositol 1,4,5-trisphosphate receptors (IP3R) on the endoplasmic reticulum.  The present study found that sigma-1 receptors (Sig-1R), unique endoplasmic reticulum proteins that bind certain steroids, neuroleptics, and psychotropic drugs, form a trimeric complex with ankyrin B and IP3R type 3 (IP3R-3) in NG-108 cells.  The trimeric complex could be coimmunopptd. by antibodies against any of the three proteins.  Sig-1R agonists such as pregenolone sulfate and cocaine caused the dissocn. of an ankyrin B isoform (ANK 220) from IP3R-3.  This effect caused by Sig-1R agonists was blocked by a Sig-1R antagonist.  The degree of dissocn. of ANK 220 from IP3R-3 caused by Sig-1R ligands correlates excellently with the ligands' efficacies in potentiating the bradykinin-induced increase in cytosolic free Ca2+ concn.  Immunocytohistochem. showed that Sig-1R, ankyrin B, and IP3R-3 are colocalized in NG-108 cells in perinuclear areas and in regions of cell-to-cell communication.  These results suggest that Sig-1R and assocd. ligands may play important roles in cells by controlling the function of cytoskeletal proteins and that the Sig-1R/ANK220/IP3R-3 complex regulating Ca2+ signaling may represent a site of action for neurosteroids and cocaine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ424uZx5ag7Vg90H21EOLACvtfcHk0ljHh__OloaxKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnslKhsA%253D%253D&md5=2fc5684bc59fa8d0c69494de29847681</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1073%2Fpnas.98.2.491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.98.2.491%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DSu%26aufirst%3DT.%2BP.%26atitle%3DRegulating%2520ankyrin%2520dynamics%253A%2520Roles%2520of%2520sigma-1%2520receptors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2001%26volume%3D98%26spage%3D491%26epage%3D496%26doi%3D10.1073%2Fpnas.98.2.491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Hayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, T.-P.</span><span> </span><span class="NLM_article-title">Sigma-1 receptor chaperones at the ER-Mitochondrion interface regulate Ca2+ signaling and cell survival</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">596</span><span class="NLM_x">–</span> <span class="NLM_lpage">610</span><span class="refDoi"> DOI: 10.1016/j.cell.2007.08.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.1016%2Fj.cell.2007.08.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=17981125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlWitrzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2007&pages=596-610&author=T.+Hayashiauthor=T.-P.+Su&title=Sigma-1+receptor+chaperones+at+the+ER-Mitochondrion+interface+regulate+Ca2%2B+signaling+and+cell+survival&doi=10.1016%2Fj.cell.2007.08.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca2+ signaling and cell survival</span></div><div class="casAuthors">Hayashi, Teruo; Su, Tsung-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">596-610</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Communication between the endoplasmic reticulum (ER) and mitochondrion is important for bioenergetics and cellular survival.  The ER supplies Ca2+ directly to mitochondria via inositol 1,4,5-trisphosphate receptors (IP3Rs) at close contacts between the two organelles referred to as mitochondrion-assocd. ER membrane (MAM).  We found here that the ER protein sigma-1 receptor (Sig-1R), which is implicated in neuroprotection, carcinogenesis, and neuroplasticity, is a Ca2+-sensitive and ligand-operated receptor chaperone at MAM.  Normally, Sig-1Rs form a complex at MAM with another chaperone, BiP.  Upon ER Ca2+ depletion or via ligand stimulation, Sig-1Rs dissoc. from BiP, leading to a prolonged Ca2+ signaling into mitochondria via IP3Rs.  Sig-1Rs can translocate under chronic ER stress.  Increasing Sig-1Rs in cells counteracts ER stress response, whereas decreasing them enhances apoptosis.  These results reveal that the orchestrated ER chaperone machinery at MAM, by sensing ER Ca2+ concns., regulates ER-mitochondrial interorganellar Ca2+ signaling and cell survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFqHhdVumdO7Vg90H21EOLACvtfcHk0ljHh__OloaxKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlWitrzK&md5=7bb4e806d7ad895f9ed1a8c4f7eb7f6c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.08.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.08.036%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DSu%26aufirst%3DT.-P.%26atitle%3DSigma-1%2520receptor%2520chaperones%2520at%2520the%2520ER-Mitochondrion%2520interface%2520regulate%2520Ca2%252B%2520signaling%2520and%2520cell%2520survival%26jtitle%3DCell%26date%3D2007%26volume%3D131%26spage%3D596%26epage%3D610%26doi%3D10.1016%2Fj.cell.2007.08.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Fontanilla, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johannessen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajipour, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cozzi, N. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruoho, A. E.</span><span> </span><span class="NLM_article-title">The hallucinogen N,N-dimethyltryptamine (DMT) Is an endogenous sigma-1 receptor regulator</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">323</span><span class="NLM_x">, </span> <span class="NLM_fpage">934</span><span class="NLM_x">–</span> <span class="NLM_lpage">937</span><span class="refDoi"> DOI: 10.1126/science.1166127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.1126%2Fscience.1166127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=19213917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhslSgsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=323&publication_year=2009&pages=934-937&author=D.+Fontanillaauthor=M.+Johannessenauthor=A.+R.+Hajipourauthor=N.+V.+Cozziauthor=M.+B.+Jacksonauthor=A.+E.+Ruoho&title=The+hallucinogen+N%2CN-dimethyltryptamine+%28DMT%29+Is+an+endogenous+sigma-1+receptor+regulator&doi=10.1126%2Fscience.1166127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The Hallucinogen N,N-Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator</span></div><div class="casAuthors">Fontanilla, Dominique; Johannessen, Molly; Hajipour, Abdol R.; Cozzi, Nicholas V.; Jackson, Meyer B.; Ruoho, Arnold E.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">323</span>
        (<span class="NLM_cas:issue">5916</span>),
    <span class="NLM_cas:pages">934-937</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The sigma-1 receptor is widely distributed in the central nervous system and periphery.  Originally mischaracterized as an opioid receptor, the sigma-1 receptor binds a vast no. of synthetic compds. but does not bind opioid peptides; it is currently considered an orphan receptor.  The sigma-1 receptor pharmacophore includes an alkylamine core, also found in the endogenous compd. N,N-dimethyltryptamine (DMT).  DMT acts as a hallucinogen, but its receptor target has been unclear.  DMT bound to sigma-1 receptors and inhibited voltage-gated sodium ion (Na+) channels in both native cardiac myocytes and heterologous cells that express sigma-1 receptors.  DMT induced hypermobility in wild-type mice but not in sigma-1 receptor knockout mice.  These biochem., physiol., and behavioral expts. indicate that DMT is an endogenous agonist for the sigma-1 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAp8p0wmc1wLVg90H21EOLACvtfcHk0ljHh__OloaxKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhslSgsbw%253D&md5=480f24607d42dbe5c5fcd9cdc8ee5e5c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1126%2Fscience.1166127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1166127%26sid%3Dliteratum%253Aachs%26aulast%3DFontanilla%26aufirst%3DD.%26aulast%3DJohannessen%26aufirst%3DM.%26aulast%3DHajipour%26aufirst%3DA.%2BR.%26aulast%3DCozzi%26aufirst%3DN.%2BV.%26aulast%3DJackson%26aufirst%3DM.%2BB.%26aulast%3DRuoho%26aufirst%3DA.%2BE.%26atitle%3DThe%2520hallucinogen%2520N%252CN-dimethyltryptamine%2520%2528DMT%2529%2520Is%2520an%2520endogenous%2520sigma-1%2520receptor%2520regulator%26jtitle%3DScience%26date%3D2009%26volume%3D323%26spage%3D934%26epage%3D937%26doi%3D10.1126%2Fscience.1166127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Robson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noorbakhsh, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seminerio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, R. R.</span><span> </span><span class="NLM_article-title">Sigma-1 receptors: potential targets for the treatment of substance abuse</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">902</span><span class="NLM_x">–</span> <span class="NLM_lpage">919</span><span class="refDoi"> DOI: 10.2174/138161212799436601</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.2174%2F138161212799436601" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=22288407" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvVSqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=902-919&author=M.+J.+Robsonauthor=B.+Noorbakhshauthor=M.+J.+Seminerioauthor=R.+R.+Matsumoto&title=Sigma-1+receptors%3A+potential+targets+for+the+treatment+of+substance+abuse&doi=10.2174%2F138161212799436601"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma-1 receptors: potential targets for the treatment of substance abuse</span></div><div class="casAuthors">Robson, Matthew J.; Noorbakhsh, Bahar; Seminerio, Michael J.; Matsumoto, Rae R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">902-919</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Drug abuse is currently a large economic and societal burden in countries around the globe.  Many drugs of abuse currently lack adequate therapies aimed at treating both the addiction and neg. complications often assocd. with their use.  Sigma-1 receptors were discovered over 30 years ago and have recently become targets for the development of pharmacotherapies aimed at treating substance abuse and addiction.  In vivo preclin. studies have revealed that sigma receptor ligands are able to ameliorate select behavioral effects of many drugs of abuse including cocaine, methamphetamine, ethanol and nicotine.  In addn., recent studies have begun to elucidate the mechanisms by which sigma-1 receptors modulate the effects of these drugs on neurotransmission, gene regulation and neuroplasticity.  Overall, these recent findings suggest that compds. targeting sigma-1 receptors may represent a potential new class of therapeutics aimed at treating drug abuse.  Future studies involving clin. populations will be crit. for validating the therapeutic potential of sigma-1 receptor ligands for the treatment of substance abuse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqj4JIyYKlhXLVg90H21EOLACvtfcHk0lioQ_yiurT9EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvVSqt7g%253D&md5=04593b431f718394f720ead714cc9d95</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F138161212799436601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161212799436601%26sid%3Dliteratum%253Aachs%26aulast%3DRobson%26aufirst%3DM.%2BJ.%26aulast%3DNoorbakhsh%26aufirst%3DB.%26aulast%3DSeminerio%26aufirst%3DM.%2BJ.%26aulast%3DMatsumoto%26aufirst%3DR.%2BR.%26atitle%3DSigma-1%2520receptors%253A%2520potential%2520targets%2520for%2520the%2520treatment%2520of%2520substance%2520abuse%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2012%26volume%3D18%26spage%3D902%26epage%3D919%26doi%3D10.2174%2F138161212799436601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Yao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgello, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buch, S.</span><span> </span><span class="NLM_article-title">Cocaine hijacks sigma1 receptor to initiate induction of activated leukocyte cell adhesion molecule: implication for increased monocyte adhesion and migration in the CNS</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">5942</span><span class="NLM_x">–</span> <span class="NLM_lpage">5955</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.5618-10.2011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.1523%2FJNEUROSCI.5618-10.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=21508219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsFSqs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=5942-5955&author=H.+Yaoauthor=K.+Kimauthor=M.+Duanauthor=T.+Hayashiauthor=M.+Guoauthor=S.+Morgelloauthor=A.+Pratauthor=J.+Wangauthor=T.+P.+Suauthor=S.+Buch&title=Cocaine+hijacks+sigma1+receptor+to+initiate+induction+of+activated+leukocyte+cell+adhesion+molecule%3A+implication+for+increased+monocyte+adhesion+and+migration+in+the+CNS&doi=10.1523%2FJNEUROSCI.5618-10.2011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Cocaine hijacks σ1 receptor to initiate induction of activated leukocyte cell adhesion molecule: implication for increased monocyte adhesion and migration in the CNS</span></div><div class="casAuthors">Yao, Honghong; Kim, Keejun; Duan, Ming; Hayashi, Teruo; Guo, Minglei; Morgello, Susan; Prat, Alexander; Wang, John; Su, Tsung-Ping; Buch, Shilpa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5942-5955</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Human immunodeficiency virus (HIV)-assocd. increase in monocyte adhesion and trafficking is exacerbated by cocaine abuse.  The underlying mechanisms involve cocaine-mediated upregulation of adhesion mols. with subsequent disruption of the blood-brain barrier (BBB).  Recently, a novel activated leukocyte cell adhesion mol. (ALCAM) has been implicated in leukocyte transmigration across the endothelium.  We now show that upregulation of ALCAM in the brain endothelium seen in HIV+/cocacine drug abusers paralleled increased CD68 immunostaining compared with HIV+/no cocaine or uninfected controls, suggesting the important role of ALCAM in promoting leukocyte infiltration across the BBB.  Furthermore, ALCAM expression was increased in cocaine-treated mice with concomitant increase in monocyte adhesion and transmigration in vivo, which was ameliorated by pretreating with the neutralizing antibody to ALCAM, lending addnl. support to the role of ALCAM.  This new concept was further confirmed by in vitro expts.  Cocaine-mediated induction of ALCAM in human brain microvascular endothelial cells through the translocation of σ receptor to the plasma membrane, followed by phosphorylation of PDGF-β (platelet-derived growth factor-β) receptor.  Downstream activation of mitogen-activated protein kinases, Akt, and NF-κB (nuclear factor-κB) pathways resulted in induced expression of ALCAM.  Functional implication of upregulated ALCAM was confirmed using cell adhesion and transmigration assays.  Neutralizing antibody to ALCAM ameliorated this effect.  Together, these findings implicate cocaine-mediated induction of ALCAM as a mediator of increased monocyte adhesion/transmigration into the CNS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD8BTVSKcjTbVg90H21EOLACvtfcHk0lioQ_yiurT9EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsFSqs7s%253D&md5=541db055042aaa42c28119937e73ac26</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.5618-10.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.5618-10.2011%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DDuan%26aufirst%3DM.%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DGuo%26aufirst%3DM.%26aulast%3DMorgello%26aufirst%3DS.%26aulast%3DPrat%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DSu%26aufirst%3DT.%2BP.%26aulast%3DBuch%26aufirst%3DS.%26atitle%3DCocaine%2520hijacks%2520sigma1%2520receptor%2520to%2520initiate%2520induction%2520of%2520activated%2520leukocyte%2520cell%2520adhesion%2520molecule%253A%2520implication%2520for%2520increased%2520monocyte%2520adhesion%2520and%2520migration%2520in%2520the%2520CNS%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D5942%26epage%3D5955%26doi%3D10.1523%2FJNEUROSCI.5618-10.2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Almansa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vela, J. M.</span><span> </span><span class="NLM_article-title">Selective sigma-1 receptor antagonists for the treatment of pain</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1179</span><span class="NLM_x">–</span> <span class="NLM_lpage">1199</span><span class="refDoi"> DOI: 10.4155/fmc.14.54</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.4155%2Ffmc.14.54" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=25078137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVyjurjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1179-1199&author=C.+Almansaauthor=J.+M.+Vela&title=Selective+sigma-1+receptor+antagonists+for+the+treatment+of+pain&doi=10.4155%2Ffmc.14.54"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Selective sigma-1 receptor antagonists for the treatment of pain</span></div><div class="casAuthors">Almansa, Carmen; Vela, Jose Miguel</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1179-1199</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The sigma-1 receptor (σ1R) is located in areas of the CNS key for pain control and belongs to a unique target class with chaperoning functions over different mol. targets involved in transmission and amplification of nociceptive messages.  Preclin. evidence supports a role for σ1R antagonists in the treatment of pain states where hypersensitivity develops as hyperalgesia and allodynia, two common symptoms encountered in neuropathic and other chronic pain conditions.  Addnl., σ1R antagonists increase opioid analgesia without increasing opioid-related unwanted effects, which point to their potential use as opioid adjuvant therapy.  This review summarizes the structure and function of the σ1R as well as the medicinal chem. and pharmacol. studies directed to the identification of σ1R antagonists for the treatment of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQ0qGYS21i37Vg90H21EOLACvtfcHk0lioQ_yiurT9EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVyjurjK&md5=3ced452012e44f478a377f0fa52995d4</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.4155%2Ffmc.14.54&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.14.54%26sid%3Dliteratum%253Aachs%26aulast%3DAlmansa%26aufirst%3DC.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26atitle%3DSelective%2520sigma-1%2520receptor%2520antagonists%2520for%2520the%2520treatment%2520of%2520pain%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2014%26volume%3D6%26spage%3D1179%26epage%3D1199%26doi%3D10.4155%2Ffmc.14.54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Nguyen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucke-Wold, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mookerjee, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavendish, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scandinaro, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, R. R.</span><span> </span><span class="NLM_article-title">Role of sigma-1 receptors in neurodegenerative diseases</span> <span class="citation_source-journal">J. Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span><span class="refDoi"> DOI: 10.1016/j.jphs.2014.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.1016%2Fj.jphs.2014.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=25704014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BC28XislaksLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2015&pages=17-29&author=L.+Nguyenauthor=B.+P.+Lucke-Woldauthor=S.+A.+Mookerjeeauthor=J.+Z.+Cavendishauthor=M.+J.+Robsonauthor=A.+L.+Scandinaroauthor=R.+R.+Matsumoto&title=Role+of+sigma-1+receptors+in+neurodegenerative+diseases&doi=10.1016%2Fj.jphs.2014.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Role of sigma-1 receptors in neurodegenerative diseases</span></div><div class="casAuthors">Nguyen, Linda; Lucke-Wold, Brandon P.; Mookerjee, Shona A.; Cavendish, John Z.; Robson, Matthew J.; Scandinaro, Anna L.; Matsumoto, Rae R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Sciences (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-29</span>CODEN:
                <span class="NLM_cas:coden">JPSTGJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-8613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Neurodegenerative diseases with distinct genetic etiologies and pathol. phenotypes appear to share common mechanisms of neuronal cellular dysfunction, including excitotoxicity, calcium dysregulation, oxidative damage, ER stress and mitochondrial dysfunction.  Glial cells, including microglia and astrocytes, play an increasingly recognized role in both the promotion and prevention of neurodegeneration.  Sigma receptors, particularly the sigma-1 receptor subtype, which are expressed in both neurons and glia of multiple regions within the central nervous system, are a unique class of intracellular proteins that can modulate many biol. mechanisms assocd. with neurodegeneration.  These receptors therefore represent compelling putative targets for pharmacol. treating neurodegenerative disorders.  In this review, we provide an overview of the biol. mechanisms frequently assocd. with neurodegeneration, and discuss how sigma-1 receptors may alter these mechanisms to preserve or restore neuronal function.  In addn., we speculate on their therapeutic potential in the treatment of various neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdBzbVUAlU9rVg90H21EOLACvtfcHk0lhZjO2OLksubg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XislaksLY%253D&md5=1aa1ab1a9eb49ef2d69eef975a568a2d</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.jphs.2014.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jphs.2014.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DL.%26aulast%3DLucke-Wold%26aufirst%3DB.%2BP.%26aulast%3DMookerjee%26aufirst%3DS.%2BA.%26aulast%3DCavendish%26aufirst%3DJ.%2BZ.%26aulast%3DRobson%26aufirst%3DM.%2BJ.%26aulast%3DScandinaro%26aufirst%3DA.%2BL.%26aulast%3DMatsumoto%26aufirst%3DR.%2BR.%26atitle%3DRole%2520of%2520sigma-1%2520receptors%2520in%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2015%26volume%3D127%26spage%3D17%26epage%3D29%26doi%3D10.1016%2Fj.jphs.2014.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Urfer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moebius, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skoloudik, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santamarina, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mita, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muir, K. W.</span><span> </span><span class="NLM_article-title">Cutamesine Stroke Recovery Study, G. Phase II trial of the Sigma-1 receptor agonist cutamesine (SA4503) for recovery enhancement after acute ischemic stroke</span> <span class="citation_source-journal">Stroke</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">3304</span><span class="NLM_x">–</span> <span class="NLM_lpage">3310</span><span class="refDoi"> DOI: 10.1161/STROKEAHA.114.005835</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.1161%2FSTROKEAHA.114.005835" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2014&pages=3304-3310&author=R.+Urferauthor=H.+J.+Moebiusauthor=D.+Skoloudikauthor=E.+Santamarinaauthor=W.+Satoauthor=S.+Mitaauthor=K.+W.+Muir&title=Cutamesine+Stroke+Recovery+Study%2C+G.+Phase+II+trial+of+the+Sigma-1+receptor+agonist+cutamesine+%28SA4503%29+for+recovery+enhancement+after+acute+ischemic+stroke&doi=10.1161%2FSTROKEAHA.114.005835"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1161%2FSTROKEAHA.114.005835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FSTROKEAHA.114.005835%26sid%3Dliteratum%253Aachs%26aulast%3DUrfer%26aufirst%3DR.%26aulast%3DMoebius%26aufirst%3DH.%2BJ.%26aulast%3DSkoloudik%26aufirst%3DD.%26aulast%3DSantamarina%26aufirst%3DE.%26aulast%3DSato%26aufirst%3DW.%26aulast%3DMita%26aufirst%3DS.%26aulast%3DMuir%26aufirst%3DK.%2BW.%26atitle%3DCutamesine%2520Stroke%2520Recovery%2520Study%252C%2520G.%2520Phase%2520II%2520trial%2520of%2520the%2520Sigma-1%2520receptor%2520agonist%2520cutamesine%2520%2528SA4503%2529%2520for%2520recovery%2520enhancement%2520after%2520acute%2520ischemic%2520stroke%26jtitle%3DStroke%26date%3D2014%26volume%3D45%26spage%3D3304%26epage%3D3310%26doi%3D10.1161%2FSTROKEAHA.114.005835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Jin, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X. Y.</span><span> </span><span class="NLM_article-title">Roles of sigma-1 receptors in Alzheimer’s disease</span> <span class="citation_source-journal">Int. J. Clin. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">4808</span><span class="NLM_x">–</span> <span class="NLM_lpage">4820</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=26131055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A280%3ADC%252BC2MbptFynsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2015&pages=4808-4820&author=J.+L.+Jinauthor=M.+Fangauthor=Y.+X.+Zhaoauthor=X.+Y.+Liu&title=Roles+of+sigma-1+receptors+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of sigma-1 receptors in Alzheimer's disease</span></div><div class="casAuthors">Jin Jia-Li; Fang Min; Zhao Yan-Xin; Liu Xue-Yuan</div><div class="citationInfo"><span class="NLM_cas:title">International journal of clinical and experimental medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">4808-20</span>
        ISSN:<span class="NLM_cas:issn">1940-5901</span>.
    </div><div class="casAbstract">Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the leading cause of senile dementia all over the world.  Still no existing drugs can effectively reverse the cognitive impairment.  However, Sigma-1 (σ-1) receptors have been long implicated in multiple neurological and psychiatric conditions over these years.  In this review, we discuss the current understanding of σ-1 receptor functions.  Through regulation of lipid rafts, secretases, kinases, neuroceptors and ion channels, σ-1 receptors can influence cellular signal transduction, TCA cycle, oxidative stress, neuron plasticity and neurotransmitter release etc.  Based on this, we suggest the key cellular mechanisms linking σ-1 receptor to Alzheimer's disease.  Besides, we detail the evidences showing that σ-1 receptors agonists, being the promising compounds for treatment of cognitive dysfunction, exhibit robust neuroprotection and anti-amnesia effect against Aβ neurotoxicity in the progress of Alzheimer's disease.  The evidence comes from animal models, preclinical studies in humans and full clinical trials.  In addition, the questions to be solved regarding this receptor are also presented.  When concerned with NMDAR, σ-1 receptor activation may result in two totally different influences on AD.  Utilization of σ-1 agents early in AD remains an overlooked therapeutic opportunity.  This article may pave the way for further studies about sigma-1 receptor on Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQtgNNdI_x_xG52AMpI4GK2fW6udTcc2ebjEHz5r7yv57ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MbptFynsQ%253D%253D&md5=9a885f6b442e658b1037e96c4fabdfa1</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DJ.%2BL.%26aulast%3DFang%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DY.%2BX.%26aulast%3DLiu%26aufirst%3DX.%2BY.%26atitle%3DRoles%2520of%2520sigma-1%2520receptors%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DInt.%2520J.%2520Clin.%2520Exp.%2520Med.%26date%3D2015%26volume%3D8%26spage%3D4808%26epage%3D4820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Haiman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratt, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, A.</span><span> </span><span class="NLM_article-title">Effects of dextromethorphan/quinidine on auditory event-related potentials in multiple sclerosis patients with pseudobulbar affect</span> <span class="citation_source-journal">J. Clin. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">444</span><span class="NLM_x">–</span> <span class="NLM_lpage">452</span><span class="refDoi"> DOI: 10.1097/JCP.0b013e3181b5ae5c</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.1097%2FJCP.0b013e3181b5ae5c" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=19745644" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFWhtbjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=444-452&author=G.+Haimanauthor=H.+Prattauthor=A.+Miller&title=Effects+of+dextromethorphan%2Fquinidine+on+auditory+event-related+potentials+in+multiple+sclerosis+patients+with+pseudobulbar+affect&doi=10.1097%2FJCP.0b013e3181b5ae5c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of Dextromethorphan/Quinidine on Auditory Event-Related Potentials in Multiple Sclerosis Patients With Pseudobulbar Affect</span></div><div class="casAuthors">Haiman, Guy; Pratt, Hillel; Miller, Ariel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychopharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">444-452</span>CODEN:
                <span class="NLM_cas:coden">JCPYDR</span>;
        ISSN:<span class="NLM_cas:issn">0271-0749</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The purpose of this study was to characterize the brain activity and assocd. cortical structures involved in pseudobulbar affect (PBA), a condition characterized by uncontrollable episodes of laughing and/or crying in patients with multiple sclerosis before and after treatment with dextromethorphan/quinidine (DM/Q).  Behavioral responses and event-related potentials (ERPs) in response to subjectively significant and neutral verbal stimuli were recorded from 2 groups: 6 multiple sclerosis patients with PBA before (PBA-preTx) and after (PBA-DM/Q) treatment with DM/Q and 6 healthy control (HC) subjects.  Statistical nonparametric mapping comparisons of ERP source c.d. distributions between groups were conducted for subjectively significant and neutral stimuli sep. before and after treatment with DM/Q.  Treatment with DM/Q had a normalizing effect on the behavioral responses of PBA patients.  Event-related potential waveform comparisons of PBA-preTx and PBA-DM/Q with HC, for both neutral and subjectively significant stimuli, revealed effects on early ERP components.  Comparisons between PBA-preTx and HC, in response to subjectively significant stimuli, revealed both early and late effects.  Source anal. comparisons between PBA-preTx and PBA-DM/Q indicated distinct activations in areas involved in emotional processing and high-level and associative visual processing in response to neutral stimuli and in areas involved in emotional, somatosensory, primary, and premotor processing in response to subjectively significant stimuli.  In most cases, stimuli evoked higher c.d. in PBA-DM/Q compared with the other groups.  In conclusion, differences in brain activity were obsd. before and after medication.  Also, DM/Q administration resulted in normalization of behavioral and electrophysiol. measures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm3vDkTNZP3rVg90H21EOLACvtfcHk0lhZjO2OLksubg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFWhtbjM&md5=662d1fab46aa12d39fd01fb276dc75a0</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1097%2FJCP.0b013e3181b5ae5c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FJCP.0b013e3181b5ae5c%26sid%3Dliteratum%253Aachs%26aulast%3DHaiman%26aufirst%3DG.%26aulast%3DPratt%26aufirst%3DH.%26aulast%3DMiller%26aufirst%3DA.%26atitle%3DEffects%2520of%2520dextromethorphan%252Fquinidine%2520on%2520auditory%2520event-related%2520potentials%2520in%2520multiple%2520sclerosis%2520patients%2520with%2520pseudobulbar%2520affect%26jtitle%3DJ.%2520Clin.%2520Psychopharmacol.%26date%3D2009%26volume%3D29%26spage%3D444%26epage%3D452%26doi%3D10.1097%2FJCP.0b013e3181b5ae5c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Kulkarni, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhir, A.</span><span> </span><span class="NLM_article-title">sigma-1 receptors in major depression and anxiety</span> <span class="citation_source-journal">Expert Rev. Neurother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1021</span><span class="NLM_x">–</span> <span class="NLM_lpage">1034</span><span class="refDoi"> DOI: 10.1586/ern.09.40</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.1586%2Fern.09.40" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=19589051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BD1MXos1egtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=1021-1034&author=S.+K.+Kulkarniauthor=A.+Dhir&title=sigma-1+receptors+in+major+depression+and+anxiety&doi=10.1586%2Fern.09.40"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">σ-1 receptors in major depression and anxiety</span></div><div class="casAuthors">Kulkarni, Shrinivas K.; Dhir, Ashish</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Neurotherapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1021-1034</span>CODEN:
                <span class="NLM_cas:coden">ERNXAR</span>;
        ISSN:<span class="NLM_cas:issn">1473-7175</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Major depression and anxiety are two of the major psychiatric disorders that have some overlapping pathophysiologies, the most significant being the dysfunction in the monoaminergic, GABAergic and glutamatergic systems.  A large no. of drugs that alter these neurotransmitter levels/systems are effective in the treatment of major depression and anxiety.  However, full remission of the clin. symptoms has not been achieved, perhaps owing to the complex pathophysiol. of the diseases.  Thus, the search for newer targets and target-specific drugs continues.  Recently, the role of σ-receptors, particularly the σ-1 receptor subtype, has been identified as a target for the pathophysiol. of neuropsychiatric disorders, and σ-1 receptor modulators are considered to be the drugs of the future for the treatment of major depression and anxiety.  The present review attempts to discuss the role of σ-1 receptors in the pathophysiol. of major depression and anxiety and also tries to position the use of its receptor modulators in the treatment of these two major disorders.  The role of σ-1 receptors in the mechanism of antidepressant action of venlafaxine, bupropion, neurosteroids and one of the herbal antidepressants, berberine, is reviewed.  Although, σ-1 receptor modulators may be future therapeutic options, either as individual agents or adjuvants in the treatment of mental disorders, the topic needs further preclin. and clin. exploration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSBtnV2P59xLVg90H21EOLACvtfcHk0lhPfh_tfwM2lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXos1egtL0%253D&md5=a26dd8928fbbb21fa2f137c4b6b4bc29</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1586%2Fern.09.40&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fern.09.40%26sid%3Dliteratum%253Aachs%26aulast%3DKulkarni%26aufirst%3DS.%2BK.%26aulast%3DDhir%26aufirst%3DA.%26atitle%3Dsigma-1%2520receptors%2520in%2520major%2520depression%2520and%2520anxiety%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2009%26volume%3D9%26spage%3D1021%26epage%3D1034%26doi%3D10.1586%2Fern.09.40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Cendan, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pujalte, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portillo-Salido, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montoliu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baeyens, J. M.</span><span> </span><span class="NLM_article-title">Formalin-induced pain is reduced in sigma(1) receptor knockout mice</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">511</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">74</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2005.01.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.1016%2Fj.ejphar.2005.01.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=15777781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitlCjsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=511&publication_year=2005&pages=73-74&author=C.+M.+Cendanauthor=J.+M.+Pujalteauthor=E.+Portillo-Salidoauthor=L.+Montoliuauthor=J.+M.+Baeyens&title=Formalin-induced+pain+is+reduced+in+sigma%281%29+receptor+knockout+mice&doi=10.1016%2Fj.ejphar.2005.01.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Formalin-induced pain is reduced in σ1 receptor knockout mice</span></div><div class="casAuthors">Cendan, Cruz Miguel; Pujalte, Jose Miguel; Portillo-Salido, Enrique; Montoliu, Lluis; Baeyens, Jose M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">511</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-74</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The role of σ1 receptors in non-acute pain has not been explored.  In this study we show that both phases of formalin-induced pain were reduced by approx. 55% in σ1 receptor knockout mice in comparison to wild-type animals.  These results suggest that the tonic pain induced by formalin is altered in mice lacking σ1 receptors, and highlight the potential usefulness of further studies of the role of σ1 receptors in models of non-acute pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLfs5SOcqYY7Vg90H21EOLACvtfcHk0lhPfh_tfwM2lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitlCjsLs%253D&md5=71d93bc7957c3f85824ab4a63d174a6b</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2005.01.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2005.01.036%26sid%3Dliteratum%253Aachs%26aulast%3DCendan%26aufirst%3DC.%2BM.%26aulast%3DPujalte%26aufirst%3DJ.%2BM.%26aulast%3DPortillo-Salido%26aufirst%3DE.%26aulast%3DMontoliu%26aufirst%3DL.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26atitle%3DFormalin-induced%2520pain%2520is%2520reduced%2520in%2520sigma%25281%2529%2520receptor%2520knockout%2520mice%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2005%26volume%3D511%26spage%3D73%26epage%3D74%26doi%3D10.1016%2Fj.ejphar.2005.01.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Entrena, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cobos, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieto, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cendan, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gris, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Pozo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamanillo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baeyens, J. M.</span><span> </span><span class="NLM_article-title">Sigma-1 receptors are essential for capsaicin-induced mechanical hypersensitivity: studies with selective sigma-1 ligands and sigma-1 knockout mice</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">252</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span><span class="refDoi"> DOI: 10.1016/j.pain.2009.03.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.1016%2Fj.pain.2009.03.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=19375855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BD1MXls1Ortr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2009&pages=252-261&author=J.+M.+Entrenaauthor=E.+J.+Cobosauthor=F.+R.+Nietoauthor=C.+M.+Cendanauthor=G.+Grisauthor=E.+Del+Pozoauthor=D.+Zamanilloauthor=J.+M.+Baeyens&title=Sigma-1+receptors+are+essential+for+capsaicin-induced+mechanical+hypersensitivity%3A+studies+with+selective+sigma-1+ligands+and+sigma-1+knockout+mice&doi=10.1016%2Fj.pain.2009.03.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma-1 receptors are essential for capsaicin-induced mechanical hypersensitivity: Studies with selective sigma-1 ligands and sigma-1 knockout mice</span></div><div class="casAuthors">Entrena, Jose Manuel; Cobos, Enrique Jose; Nieto, Francisco Rafael; Cendan, Cruz Miguel; Gris, Georgia; Del Pozo, Esperanza; Zamanillo, Daniel; Baeyens, Jose Manuel</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">252-261</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">We evaluated the role of σ1 receptors on capsaicin-induced mech. hypersensitivity and on nociceptive pain induced by punctate mech. stimuli, using wild-type and σ1 receptor knockout (σ1-KO) mice and selective σ1 receptor-acting drugs.  Mutation in σ1-KO mice was confirmed by PCR anal. of genomic DNA and, at the protein level, by [3H](+)-pentazocine binding assays.  Both wild-type and σ1-KO mice not treated with capsaicin showed similar responses to different intensities of mech. stimuli (0.05-8 g force), ranging from innocuous to noxious, applied to the hind paw.  This indicates that σ1 gene inactivation does not modify the perception of punctate mech. stimuli.  The intraplantar (i.pl.) administration of capsaicin induced dose-dependent mech. allodynia in wild-type mice (markedly reducing both the threshold force necessary to induce paw withdrawal and the latency to paw withdrawal induced by a given force).  In contrast, capsaicin was completely unable to induce mech. hypersensitivity in σ1-KO mice.  The high-affinity and selective σ1 antagonists BD-1063, BD-1047 and NE-100, administered s.c. dose-dependently inhibited mech. allodynia induced by capsaicin (1 μg,i.pl.), yielding ED50 (mg/kg) values of 15.80 ± 0.93, 29.31 ± 1.65 and 40.74 ± 7.20, resp.  The effects of the σ1 antagonists were reversed by the σ1 agonist PRE-084 (32 mg/kg, s.c.).  None of the drugs tested modified the responses induced by a painful mech. punctate stimulus (4 g force) in nonsensitized animals.  These results suggest that σ1 receptors are essential for capsaicin-induced mech. hypersensitivity, but are not involved in mech. nociceptive pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxwYUgwwMlprVg90H21EOLACvtfcHk0lhPfh_tfwM2lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXls1Ortr0%253D&md5=e51c7b76ea146ba992c7d1768e1da9a3</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2009.03.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2009.03.011%26sid%3Dliteratum%253Aachs%26aulast%3DEntrena%26aufirst%3DJ.%2BM.%26aulast%3DCobos%26aufirst%3DE.%2BJ.%26aulast%3DNieto%26aufirst%3DF.%2BR.%26aulast%3DCendan%26aufirst%3DC.%2BM.%26aulast%3DGris%26aufirst%3DG.%26aulast%3DDel%2BPozo%26aufirst%3DE.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26atitle%3DSigma-1%2520receptors%2520are%2520essential%2520for%2520capsaicin-induced%2520mechanical%2520hypersensitivity%253A%2520studies%2520with%2520selective%2520sigma-1%2520ligands%2520and%2520sigma-1%2520knockout%2520mice%26jtitle%3DPain%26date%3D2009%26volume%3D143%26spage%3D252%26epage%3D261%26doi%3D10.1016%2Fj.pain.2009.03.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Chien, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasternak, G. W.</span><span> </span><span class="NLM_article-title">Selective antagonism of opioid analgesia by a sigma system</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x">, </span> <span class="NLM_fpage">1583</span><span class="NLM_x">–</span> <span class="NLM_lpage">1590</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=7996472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADyaK2MXislelu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1994&pages=1583-1590&author=C.+C.+Chienauthor=G.+W.+Pasternak&title=Selective+antagonism+of+opioid+analgesia+by+a+sigma+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Selective antagonism of opioid analgesia by a sigma system</span></div><div class="casAuthors">Chien, Chih-Cheng; Pasternak, Gavril W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1583-90</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">(+)-Pentazocine antagonizes morphine analgesia as potently as its (-) isomer, ruling out an opioid receptor mechanism of action and suggesting a role for sigma1 receptors.  Systemic (+)-pentazocine also reverses supraspinal or spinal morphine analgesia.  1,3-Di(2-tolyl)guanidine, a sigma ligand with no appreciable opioid receptor affinity, antagonizes morphine analgesia.  The actions of both (+)-pentazocine and 1,3-di(2-tolyl)guanidine are reversed by haloperidol, which has high affinity for both sigma and D2 receptors, but not by the D2-selective antagonist (-)-sulpiride, which lacks activity at sigma sites.  The antiopioid sigma system is tonically active.  Haloperidol, but not (-)-sulpiride, decreases morphine ED50 almost 2-fold.  The antiopioid system modulates only mu analgesia.  Unlike analgesia, (+)-pentazocine does not influence morphine's inhibition of gastrointestinal transit or lethality.  (+)-Pentazocine also antagonizes kappa1, kappa3 and delta analgesia through sigma mechanisms in a haloperidol-sensitive manner.  (-)-Sulpiride is inactive.  Alone, haloperidol enhances kappa1, kappa3 and delta analgesia more dramatically than morphine, which indicates that the sigma system is active against all opioid analgesic systems.  Sigma systems are responsible for some strain differences in kappa receptor sensitivity.  Unlike CD-1 mice, BALB-C mice are relatively insensitive toward the kappa1 agent U50,488H and the kappa3 analgesic naloxone benzoylhydrazone.  Blockade of the sigma system with haloperidol eliminates these strain differences.  In conclusion, sigma1 systems functionally antagonize opioid analgesia without affecting morphine's effects on gastrointestinal transit or lethality.  The antiopioid sigma system is tonically active and is more active against kappa analgesia than mu.  The level of this tonic activity plays a significant role in strain differences in analgesic sensitivity toward opioid analgesia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPi-tKcGCFM7Vg90H21EOLACvtfcHk0lj2UQ9amxmvTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXislelu7k%253D&md5=d1314dcf06a32a48599975aa5208c4b8</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DC.%2BC.%26aulast%3DPasternak%26aufirst%3DG.%2BW.%26atitle%3DSelective%2520antagonism%2520of%2520opioid%2520analgesia%2520by%2520a%2520sigma%2520system%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1994%26volume%3D271%26spage%3D1583%26epage%3D1590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Cendan, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pujalte, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portillo-Salido, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baeyens, J. M.</span><span> </span><span class="NLM_article-title">Antinociceptive effects of haloperidol and its metabolites in the formalin test in mice</span> <span class="citation_source-journal">Psychopharmacology (Heidelberg, Ger.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">182</span><span class="NLM_x">, </span> <span class="NLM_fpage">485</span><span class="NLM_x">–</span> <span class="NLM_lpage">493</span><span class="refDoi"> DOI: 10.1007/s00213-005-0127-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.1007%2Fs00213-005-0127-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=16075285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFahtbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=2005&pages=485-493&author=C.+M.+Cendanauthor=J.+M.+Pujalteauthor=E.+Portillo-Salidoauthor=J.+M.+Baeyens&title=Antinociceptive+effects+of+haloperidol+and+its+metabolites+in+the+formalin+test+in+mice&doi=10.1007%2Fs00213-005-0127-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Antinociceptive effects of haloperidol and its metabolites in the formalin test in mice</span></div><div class="casAuthors">Cendan, Cruz M.; Pujalte, Jose M.; Portillo-Salido, Enrique; Baeyens, Jose M.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">182</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">485-493</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Rationale: Formalin-induced pain is reduced in sigma-1 (σ1) receptor knockout mice; therefore, the authors hypothesized that haloperidol and its metabolites I and II, which have affinity for σ1 receptors, may modulate formalin-induced pain.  Results: Intraplantar administration of formalin (2.5%) to CD-1 mice produced a biphasic period of pain.  Haloperidol (0.03-1 mg/kg, s.c.) and reduced haloperidol (metabolite II, 0.25-8 mg/kg, s.c.) dose-dependently inhibited both phases of formalin-induced pain.  Haloperidol metabolite I (4-128 mg/kg, s.c.) also produced dose-dependent antinociception in the second phase of the formalin test, but was less potent and effective against first-phase pain.  Haloperidol metabolite III (16 and 128 mg/kg) and (-)sulpiride (200 mg/kg), which have no affinity for σ1 receptors, did not produce significant antinociception in either phase of the formalin test.  The order of potency of the drugs to produce their antinociceptive effect [haloperidol > metabolite II > metabolite I » metabolite III= (-)sulpiride=inactive] correlated with their affinity for σ1 receptors, but not with their affinity for σ2 or dopamine D2 receptors.  Naloxone (1 mg/kg, s.c.) did not antagonize the antinociception induced by haloperidol and its metabolites.  None of the antinociceptive drugs in the formalin test produced any antinociception in the tail flick test.  Conclusion: These results suggest that the antinociceptive effect of haloperidol and its metabolites in the formalin test is not due to unspecific/generalized inhibition of nociception or modulation of opioid receptors, and that it may be related, at least partially, to the ability of these drugs to interact with σ1 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFuqvqHXFzk7Vg90H21EOLACvtfcHk0lj2UQ9amxmvTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFahtbzP&md5=3d55ac20e082e77f70769659224994f1</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2Fs00213-005-0127-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-005-0127-z%26sid%3Dliteratum%253Aachs%26aulast%3DCendan%26aufirst%3DC.%2BM.%26aulast%3DPujalte%26aufirst%3DJ.%2BM.%26aulast%3DPortillo-Salido%26aufirst%3DE.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26atitle%3DAntinociceptive%2520effects%2520of%2520haloperidol%2520and%2520its%2520metabolites%2520in%2520the%2520formalin%2520test%2520in%2520mice%26jtitle%3DPsychopharmacology%2520%2528Heidelberg%252C%2520Ger.%2529%26date%3D2005%26volume%3D182%26spage%3D485%26epage%3D493%26doi%3D10.1007%2Fs00213-005-0127-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Vela, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almansa, C.</span><span> </span><span class="NLM_article-title">Investigational sigma-1 receptor antagonists for the treatment of pain</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">883</span><span class="NLM_x">–</span> <span class="NLM_lpage">896</span><span class="refDoi"> DOI: 10.1517/13543784.2015.1048334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.1517%2F13543784.2015.1048334" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2015&pages=883-896&author=J.+M.+Velaauthor=M.+Merlosauthor=C.+Almansa&title=Investigational+sigma-1+receptor+antagonists+for+the+treatment+of+pain&doi=10.1517%2F13543784.2015.1048334"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1517%2F13543784.2015.1048334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2015.1048334%26sid%3Dliteratum%253Aachs%26aulast%3DVela%26aufirst%3DJ.%2BM.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DAlmansa%26aufirst%3DC.%26atitle%3DInvestigational%2520sigma-1%2520receptor%2520antagonists%2520for%2520the%2520treatment%2520of%2520pain%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2015%26volume%3D24%26spage%3D883%26epage%3D896%26doi%3D10.1517%2F13543784.2015.1048334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Vidal-Torres, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de la Puente, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocasalbas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tourino, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bura, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez-Pastor, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Codony, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamanillo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buschmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baeyens, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maldonado, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vela, J. M.</span><span> </span><span class="NLM_article-title">Sigma-1 receptor antagonism as opioid adjuvant strategy: enhancement of opioid antinociception without increasing adverse effects</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">711</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2013.04.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.1016%2Fj.ejphar.2013.04.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=23632394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptVyksLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=711&publication_year=2013&pages=63-72&author=A.+Vidal-Torresauthor=B.+de+la+Puenteauthor=M.+Rocasalbasauthor=C.+Tourinoauthor=S.+A.+Buraauthor=B.+Fernandez-Pastorauthor=L.+Romeroauthor=X.+Codonyauthor=D.+Zamanilloauthor=H.+Buschmannauthor=M.+Merlosauthor=J.+M.+Baeyensauthor=R.+Maldonadoauthor=J.+M.+Vela&title=Sigma-1+receptor+antagonism+as+opioid+adjuvant+strategy%3A+enhancement+of+opioid+antinociception+without+increasing+adverse+effects&doi=10.1016%2Fj.ejphar.2013.04.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma-1 receptor antagonism as opioid adjuvant strategy: Enhancement of opioid antinociception without increasing adverse effects</span></div><div class="casAuthors">Vidal-Torres, Alba; de la Puente, Beatriz; Rocasalbas, Maria; Tourino, Clara; Andreea Bura, Simona; Fernandez-Pastor, Begona; Romero, Luz; Codony, Xavier; Zamanillo, Daniel; Buschmann, Helmut; Merlos, Manuel; Manuel Baeyens, Jose; Maldonado, Rafael; Vela, Jose Miguel</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">711</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">63-72</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">While opioids are potent analgesics widely used in the management of pain, a no. of well-known adverse effects limit their use.  The sigma-1 receptor is a ligand-regulated mol. chaperone involved in pain processing, including modulation of opioid antinociception.  However, data supporting the potential use of sigma-1 receptor ligands as suitable opioid adjuvants are based on studies that use non selective ligands.  Also, safety issues derived from combination therapy are poorly addressed.  In this study we used the new selective sigma-1 receptor antagonist S1RA (E-52862) to characterize the effect of selective sigma-1 receptor blockade on opioid-induced efficacy- and safety-related outcomes in mice.  S1RA (40 mg/kg) had no effect in the tail-flick test but did enhance the antinociceptive potency of several opioids by a factor between 2 and 3.3.  The potentiating effect of S1RA on morphine antinociception did not occur in sigma-1 receptor knockout mice, which supports the selective involvement of the sigma-1 receptor.  Interestingly, S1RA co-administration restored morphine antinociception in tolerant mice and reverted the reward effects of morphine in the conditioned place preference paradigm.  In addn., enhancement of antinociception was not accompanied by potentiation of other opioid-induced effects, such as the development of morphine analgesic tolerance, phys. dependence, inhibition of gastrointestinal transit, or mydriasis.  The use of sigma-1 receptor antagonists as opioid adjuvants could represent a promising pharmacol. strategy to enhance opioid potency and, most importantly, to increase the safety margin of opioids.  S1RA is currently in phase II clin. trials for the treatment of several pain conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVTGE08MufobVg90H21EOLACvtfcHk0lj2UQ9amxmvTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptVyksLc%253D&md5=c2cd0eb6fe5a9232bff11fe1539f74d4</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2013.04.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2013.04.018%26sid%3Dliteratum%253Aachs%26aulast%3DVidal-Torres%26aufirst%3DA.%26aulast%3Dde%2Bla%2BPuente%26aufirst%3DB.%26aulast%3DRocasalbas%26aufirst%3DM.%26aulast%3DTourino%26aufirst%3DC.%26aulast%3DBura%26aufirst%3DS.%2BA.%26aulast%3DFernandez-Pastor%26aufirst%3DB.%26aulast%3DRomero%26aufirst%3DL.%26aulast%3DCodony%26aufirst%3DX.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DBuschmann%26aufirst%3DH.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26aulast%3DMaldonado%26aufirst%3DR.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26atitle%3DSigma-1%2520receptor%2520antagonism%2520as%2520opioid%2520adjuvant%2520strategy%253A%2520enhancement%2520of%2520opioid%2520antinociception%2520without%2520increasing%2520adverse%2520effects%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D711%26spage%3D63%26epage%3D72%26doi%3D10.1016%2Fj.ejphar.2013.04.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Diaz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christmann, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrens, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Port, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascual, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgueno, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monroy, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balada, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vela, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almansa, C.</span><span> </span><span class="NLM_article-title">Synthesis and structure-activity relationship study of a new series of selective sigma(1) receptor ligands for the treatment of pain: 4-aminotriazoles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2441</span><span class="NLM_x">–</span> <span class="NLM_lpage">2451</span><span class="refDoi"> DOI: 10.1021/jm501920g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501920g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitlWms78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2441-2451&author=J.+L.+Diazauthor=U.+Christmannauthor=A.+Fernandezauthor=A.+Torrensauthor=A.+Portauthor=R.+Pascualauthor=I.+Alvarezauthor=J.+Burguenoauthor=X.+Monroyauthor=A.+Monteroauthor=A.+Baladaauthor=J.+M.+Velaauthor=C.+Almansa&title=Synthesis+and+structure-activity+relationship+study+of+a+new+series+of+selective+sigma%281%29+receptor+ligands+for+the+treatment+of+pain%3A+4-aminotriazoles&doi=10.1021%2Fjm501920g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Structure-Activity Relationship Study of a New Series of Selective σ1 Receptor Ligands for the Treatment of Pain: 4-Aminotriazoles</span></div><div class="casAuthors">Diaz, Jose Luis; Christmann, Ute; Fernandez, Ariadna; Torrens, Antoni; Port, Adriana; Pascual, Rosalia; Alvarez, Ines; Burgueno, Javier; Monroy, Xavier; Montero, Ana; Balada, Ariadna; Vela, Jose Miguel; Almansa, Carmen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2441-2451</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis and pharmacol. activity of a new series of 4-aminotriazoles I [R1 = 4-Cl-C6H4, 3,4-Cl2-C6H3, benzyl, cyclohexyl, etc; R2 = H, COMe, SO2Me, etc; R3 = piperidin-1-yl, morpholin-1-yl, 4-cyclohexylpiperizin-1-yl, etc; n = 1, 2] as potent σ1 receptor (σ1R) ligands are reported.  The compds. were prepd. using a 4-5-step process, involving as a key step a click chem. reaction between ynamides and azides.  The most active compds. exhibited nanomolar potency for the σ1R, and the selectivity over the σ2R was improved on decreasing the central amine basicity.  It was concluded that in order to achieve good σ1R potency a min. lipophilicity was required, while limiting to a defined range of cLogP avoided human ether-a-go-go-related gene channel inhibition.  This made the most interesting derivs. to be concd. in a narrow margin of lipophilicity.  Among them, compd. I [R1 = 2,3-Cl2-benzyl, R2 = H, R3 = morpholin-1-yl, n = 1] exhibited the most potent in vivo antinociceptive properties, which are indicative of its antagonist character.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxmyKI9YzVhbVg90H21EOLACvtfcHk0lgdZlnNG2YCGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitlWms78%253D&md5=7dc178db143bbce4f8c7f33e62a062b6</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm501920g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501920g%26sid%3Dliteratum%253Aachs%26aulast%3DDiaz%26aufirst%3DJ.%2BL.%26aulast%3DChristmann%26aufirst%3DU.%26aulast%3DFernandez%26aufirst%3DA.%26aulast%3DTorrens%26aufirst%3DA.%26aulast%3DPort%26aufirst%3DA.%26aulast%3DPascual%26aufirst%3DR.%26aulast%3DAlvarez%26aufirst%3DI.%26aulast%3DBurgueno%26aufirst%3DJ.%26aulast%3DMonroy%26aufirst%3DX.%26aulast%3DMontero%26aufirst%3DA.%26aulast%3DBalada%26aufirst%3DA.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26aulast%3DAlmansa%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationship%2520study%2520of%2520a%2520new%2520series%2520of%2520selective%2520sigma%25281%2529%2520receptor%2520ligands%2520for%2520the%2520treatment%2520of%2520pain%253A%25204-aminotriazoles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2441%26epage%3D2451%26doi%3D10.1021%2Fjm501920g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Diaz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christmann, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luengo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bordas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enrech, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascual, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgueno, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benet-Buchholz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceron-Bertran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramirez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinoso, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez de Henestrosa, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vela, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almansa, C.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of a new series of hexahydro-2H-pyrano[3,2-c]quinolines as novel selective sigma1 receptor ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3656</span><span class="NLM_x">–</span> <span class="NLM_lpage">3665</span><span class="refDoi"> DOI: 10.1021/jm400181k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400181k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3656-3665&author=J.+L.+Diazauthor=U.+Christmannauthor=A.+Fernandezauthor=M.+Luengoauthor=M.+Bordasauthor=R.+Enrechauthor=M.+Carroauthor=R.+Pascualauthor=J.+Burguenoauthor=M.+Merlosauthor=J.+Benet-Buchholzauthor=J.+Ceron-Bertranauthor=J.+Ramirezauthor=R.+F.+Reinosoauthor=A.+R.+Fernandez+de+Henestrosaauthor=J.+M.+Velaauthor=C.+Almansa&title=Synthesis+and+biological+evaluation+of+a+new+series+of+hexahydro-2H-pyrano%5B3%2C2-c%5Dquinolines+as+novel+selective+sigma1+receptor+ligands&doi=10.1021%2Fjm400181k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm400181k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400181k%26sid%3Dliteratum%253Aachs%26aulast%3DDiaz%26aufirst%3DJ.%2BL.%26aulast%3DChristmann%26aufirst%3DU.%26aulast%3DFernandez%26aufirst%3DA.%26aulast%3DLuengo%26aufirst%3DM.%26aulast%3DBordas%26aufirst%3DM.%26aulast%3DEnrech%26aufirst%3DR.%26aulast%3DCarro%26aufirst%3DM.%26aulast%3DPascual%26aufirst%3DR.%26aulast%3DBurgueno%26aufirst%3DJ.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DBenet-Buchholz%26aufirst%3DJ.%26aulast%3DCeron-Bertran%26aufirst%3DJ.%26aulast%3DRamirez%26aufirst%3DJ.%26aulast%3DReinoso%26aufirst%3DR.%2BF.%26aulast%3DFernandez%2Bde%2BHenestrosa%26aufirst%3DA.%2BR.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26aulast%3DAlmansa%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520a%2520new%2520series%2520of%2520hexahydro-2H-pyrano%255B3%252C2-c%255Dquinolines%2520as%2520novel%2520selective%2520sigma1%2520receptor%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3656%26epage%3D3665%26doi%3D10.1021%2Fjm400181k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Lan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of novel sigma-1 receptor antagonists based on pyrimidine scaffold as agents for treating neuropathic pain</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">10404</span><span class="NLM_x">–</span> <span class="NLM_lpage">10423</span><span class="refDoi"> DOI: 10.1021/jm501207r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501207r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFOhsbbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10404-10423&author=Y.+Lanauthor=Y.+Chenauthor=X.+Caoauthor=J.+Zhangauthor=J.+Wangauthor=X.+Xuauthor=Y.+Qiuauthor=T.+Zhangauthor=X.+Liuauthor=B.+F.+Liuauthor=G.+Zhang&title=Synthesis+and+biological+evaluation+of+novel+sigma-1+receptor+antagonists+based+on+pyrimidine+scaffold+as+agents+for+treating+neuropathic+pain&doi=10.1021%2Fjm501207r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of Novel Sigma-1 Receptor Antagonists Based on Pyrimidine Scaffold As Agents for Treating Neuropathic Pain</span></div><div class="casAuthors">Lan, Yu; Chen, Yin; Cao, Xudong; Zhang, Juecheng; Wang, Jie; Xu, Xiangqing; Qiu, Yinli; Zhang, Tan; Liu, Xin; Liu, Bi-Feng; Zhang, Guisen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10404-10423</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery and synthesis of a new series of pyrimidines as potent sigma-1 receptor (σ1R) antagonists, assocd. with pharmacol. antineuropathic pain activity, are the focus of this article.  The new compds. were evaluated in vitro in σ-1 and σ-2 receptor binding assays.  The nature of the pyrimidine scaffold was crucial for activity, and a basic amine was shown to be necessary according to the known pharmacophoric model.  The most promising deriv. was 5-chloro-2-(4-chlorophenyl)-4-methyl-6-(3-(piperidin-1-yl)propoxy)pyrimidine (I), which exhibited a high binding affinity to σ1R receptor (Ki σ1 = 1.06 nM) and good σ-1/2 selectivity (1344-fold).  In in vivo tests, I exerted dose-dependent antinociceptive effects in mice formalin model and rats CCI models of neuropathic pain.  In addn., no motor impairments were found in rotarod tests; acceptable pharmacokinetic properties were also noted.  These data suggest I may constitute a novel class of drugs for the treatment of neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-dkiomNDrPLVg90H21EOLACvtfcHk0lgdZlnNG2YCGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFOhsbbE&md5=bd003488b014b40e739cc42c825424ce</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm501207r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501207r%26sid%3Dliteratum%253Aachs%26aulast%3DLan%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DB.%2BF.%26aulast%3DZhang%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520sigma-1%2520receptor%2520antagonists%2520based%2520on%2520pyrimidine%2520scaffold%2520as%2520agents%2520for%2520treating%2520neuropathic%2520pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10404%26epage%3D10423%26doi%3D10.1021%2Fjm501207r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Yu, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunosewoyo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span> </span><span class="NLM_article-title">From alpha4beta2 nicotinic ligands to the discovery of sigma1 receptor ligands: pharmacophore analysis and rational design</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1054</span><span class="NLM_x">–</span> <span class="NLM_lpage">1058</span><span class="refDoi"> DOI: 10.1021/ml3002715</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml3002715" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFamtr3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=1054-1058&author=L.+F.+Yuauthor=H.+K.+Zhangauthor=H.+Gunosewoyoauthor=A.+P.+Kozikowski&title=From+alpha4beta2+nicotinic+ligands+to+the+discovery+of+sigma1+receptor+ligands%3A+pharmacophore+analysis+and+rational+design&doi=10.1021%2Fml3002715"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">From α4β2 Nicotinic Ligands to the Discovery of σ1 Receptor Ligands: Pharmacophore Analysis and Rational Design</span></div><div class="casAuthors">Yu, Li-Fang; Zhang, Han-Kun; Gunosewoyo, Hendra; Kozikowski, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1054-1058</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Comparative analyses of the pharmacophoric elements required for σ1 and nicotinic ligands led to the identification of a potent and selective σ1 ligand (15, I).  Compd. 15 displayed high selectivity for the σ1 receptor (Ki, σ1 = 4.1 nM; Ki, σ2 = 1312 nM) with moderate binding affinity for the DAT (Ki = 373 nM) and NET (Ki = 203 nM) in the PDSP broad screening panel of common CNS neurotransmitter transporters and receptors.  The key finding in this present work is that a subtle structural modification could be used as a tool to switch a ligand's selectivity between nAChRs and sigma receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp00SphSwYKLrVg90H21EOLACvtfcHk0lhQloL4IHof8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFamtr3K&md5=908dc6a13498beb6e751249b33d35e71</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fml3002715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml3002715%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DL.%2BF.%26aulast%3DZhang%26aufirst%3DH.%2BK.%26aulast%3DGunosewoyo%26aufirst%3DH.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DFrom%2520alpha4beta2%2520nicotinic%2520ligands%2520to%2520the%2520discovery%2520of%2520sigma1%2520receptor%2520ligands%253A%2520pharmacophore%2520analysis%2520and%2520rational%2520design%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D1054%26epage%3D1058%26doi%3D10.1021%2Fml3002715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Yu, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuckmantel, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eaton, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldarone, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedolak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanania, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span> </span><span class="NLM_article-title">Identification of novel alpha4beta2-nicotinic acetylcholine receptor (nAChR) agonists based on an isoxazole ether scaffold that demonstrate antidepressant-like activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">812</span><span class="NLM_x">–</span> <span class="NLM_lpage">823</span><span class="refDoi"> DOI: 10.1021/jm201301h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201301h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=812-823&author=L.+F.+Yuauthor=W.+Tuckmantelauthor=J.+B.+Eatonauthor=B.+Caldaroneauthor=A.+Fedolakauthor=T.+Hananiaauthor=D.+Brunnerauthor=R.+J.+Lukasauthor=A.+P.+Kozikowski&title=Identification+of+novel+alpha4beta2-nicotinic+acetylcholine+receptor+%28nAChR%29+agonists+based+on+an+isoxazole+ether+scaffold+that+demonstrate+antidepressant-like+activity&doi=10.1021%2Fjm201301h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm201301h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201301h%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DL.%2BF.%26aulast%3DTuckmantel%26aufirst%3DW.%26aulast%3DEaton%26aufirst%3DJ.%2BB.%26aulast%3DCaldarone%26aufirst%3DB.%26aulast%3DFedolak%26aufirst%3DA.%26aulast%3DHanania%26aufirst%3DT.%26aulast%3DBrunner%26aufirst%3DD.%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DIdentification%2520of%2520novel%2520alpha4beta2-nicotinic%2520acetylcholine%2520receptor%2520%2528nAChR%2529%2520agonists%2520based%2520on%2520an%2520isoxazole%2520ether%2520scaffold%2520that%2520demonstrate%2520antidepressant-like%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D812%26epage%3D823%26doi%3D10.1021%2Fjm201301h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="note"><p class="first last"><i>K</i><sub>i</sub> determinations were generously provided by the National Institute of Mental Health’s Psychoactive Drug Screening Program, contract no. HHSN-271-2008-00025-C (NIMH PDSP). The NIMH PDSP is directed by Bryan L. Roth M.D., Ph.D., at the University of North Carolina at Chapel Hill and Project Officer Jamie Driscol at NIMH, Bethesda, MD, USA.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Narayanan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesangeau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupaert, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCurdy, C. R.</span><span> </span><span class="NLM_article-title">Early development of sigma-receptor ligands</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span><span class="refDoi"> DOI: 10.4155/fmc.10.279</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.4155%2Ffmc.10.279" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=21428827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1WgtbzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=79-94&author=S.+Narayananauthor=R.+Bhatauthor=C.+Mesangeauauthor=J.+H.+Poupaertauthor=C.+R.+McCurdy&title=Early+development+of+sigma-receptor+ligands&doi=10.4155%2Ffmc.10.279"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Early development of sigma-receptor ligands</span></div><div class="casAuthors">Narayanan, Sanju; Bhat, Rohit; Mesangeau, Christophe; Poupaert, Jacques H.; McCurdy, Christopher R.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">79-94</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Sigma receptors (σ-1 and σ-2) are non-opioid proteins implicated in the pathophysiol. of various neurol. disorders and cancer.  The σ-1 subtype is a chaperon protein widely distributed in the CNS and peripheral tissues.  These receptors are involved in the modulation of K+- and Ca2+-dependent signaling cascades at the endoplasmic reticulum and modulation of neurotransmitter release. σ-1 receptors are emerging targets for the treatment of neurophychiatric diseases (schizophrenia and depression) and cocaine addiction. σ-2 receptors are lipid raft proteins.  They are highly expressed on many tumor cells and hence considered potential targets for anticancer drugs. σ receptors bind to a diverse class of pharmacol. compds. like cocaine, methamphetamine, benzomorphans like (±)-pentazocine, (±)-SKF-10,047 and endogenous neurosteroids and sphingolipids.  In this review we focus on the early development of σ receptor-specific ligands and radiolabeling agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraY6MpL93nLbVg90H21EOLACvtfcHk0lhQloL4IHof8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1WgtbzE&md5=d9bfcd36c9ebbaaa1223b7eec923e061</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.4155%2Ffmc.10.279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.10.279%26sid%3Dliteratum%253Aachs%26aulast%3DNarayanan%26aufirst%3DS.%26aulast%3DBhat%26aufirst%3DR.%26aulast%3DMesangeau%26aufirst%3DC.%26aulast%3DPoupaert%26aufirst%3DJ.%2BH.%26aulast%3DMcCurdy%26aufirst%3DC.%2BR.%26atitle%3DEarly%2520development%2520of%2520sigma-receptor%2520ligands%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2011%26volume%3D3%26spage%3D79%26epage%3D94%26doi%3D10.4155%2Ffmc.10.279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Clark, D. E.</span><span> </span><span class="NLM_article-title">Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">815</span><span class="NLM_x">–</span> <span class="NLM_lpage">21</span><span class="refDoi"> DOI: 10.1021/js980402t</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.1021%2Fjs980402t" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10430548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADyaK1MXjvFGitbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1999&pages=815-21&author=D.+E.+Clark&title=Rapid+calculation+of+polar+molecular+surface+area+and+its+application+to+the+prediction+of+transport+phenomena.+2.+Prediction+of+blood-brain+barrier+penetration&doi=10.1021%2Fjs980402t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid Calculation of Polar Molecular Surface Area and Its Application to the Prediction of Transport Phenomena. 2. Prediction of Blood-Brain Barrier Penetration</span></div><div class="casAuthors">Clark, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">815-821</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This paper describes the derivation of a simple QSAR model for the prediction of log BB from a set of 55 diverse org. compds.  The model contains two variables: polar surface area (PSA) and calcd. logP, both of which can be rapidly computed.  It therefore permits the prediction of log BB for large compd. sets, such as virtual combinatorial libraries.  The performance of this QSAR on two test sets taken from the literature is illustrated and compared with results from other reported computational approaches to log BB prediction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHa3ieLzy0RbVg90H21EOLACvtfcHk0lgN2zy82zMuqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjvFGitbk%253D&md5=949f8bf41525d8d04694e1288f24b626</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjs980402t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjs980402t%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DD.%2BE.%26atitle%3DRapid%2520calculation%2520of%2520polar%2520molecular%2520surface%2520area%2520and%2520its%2520application%2520to%2520the%2520prediction%2520of%2520transport%2520phenomena.%25202.%2520Prediction%2520of%2520blood-brain%2520barrier%2520penetration%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1999%26volume%3D88%26spage%3D815%26epage%3D21%26doi%3D10.1021%2Fjs980402t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ablordeppey, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ismaiel, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">el-Ashmawy, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howie, K. B.</span><span> </span><span class="NLM_article-title">Structural features important for sigma 1 receptor binding</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1214</span><span class="NLM_x">–</span> <span class="NLM_lpage">1219</span><span class="refDoi"> DOI: 10.1021/jm00034a020</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00034a020" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADyaK2cXksV2lsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=1214-1219&author=R.+A.+Glennonauthor=S.+Y.+Ablordeppeyauthor=A.+M.+Ismaielauthor=M.+B.+el-Ashmawyauthor=J.+B.+Fischerauthor=K.+B.+Howie&title=Structural+features+important+for+sigma+1+receptor+binding&doi=10.1021%2Fjm00034a020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Features Important for σ1 Receptor Binding</span></div><div class="casAuthors">Glennon, Richard A.; Ablordeppey, Seth Y.; Ismaiel, Abd M.; El-Ashmawy, Mahmoud B.; Fischer, James B.; Howie, Kathleen Burke</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1214-19</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Two problems that have hampered σ receptor research are a lack of high-affinity agents and the recent identification of multiple populations of σ receptors (i.e., σ1 and σ2 sites).  Recently, several high-affinity σ ligands have been identified, and the term superpotent σ ligands has been coined to describe agents with Ki values of <1 nM.  It was previously shown that appropriately N-substituted phenylalkylamines bind at σ receptors with high affinity.  The structure-affinity relationships of these phenylalkylamine derivs. for σ1 binding are examd. and some of the first superpotent σ1 ligands described.  A binding model was developed to account for the structural features of the phenylalkylamines that appear to be important for the interaction of these agents with σ1 sites.  Some of the amines were prepd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6nnZHspQ0MLVg90H21EOLACvtfcHk0lgN2zy82zMuqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXksV2lsrY%253D&md5=3c9b4ff203d7c304da3779a874837bf5</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm00034a020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00034a020%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DAblordeppey%26aufirst%3DS.%2BY.%26aulast%3DIsmaiel%26aufirst%3DA.%2BM.%26aulast%3Del-Ashmawy%26aufirst%3DM.%2BB.%26aulast%3DFischer%26aufirst%3DJ.%2BB.%26aulast%3DHowie%26aufirst%3DK.%2BB.%26atitle%3DStructural%2520features%2520important%2520for%2520sigma%25201%2520receptor%2520binding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D1214%26epage%3D1219%26doi%3D10.1021%2Fjm00034a020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Diaz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuberes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berrocal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contijoch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christmann, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Port, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holenz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buschmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laggner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serafini, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgueno, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamanillo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vela, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almansa, C.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of the 1-arylpyrazole class of sigma(1) receptor antagonists: identification of 4-{2-[5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yloxy]ethyl}morpholine (S1RA, E-52862)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">8211</span><span class="NLM_x">–</span> <span class="NLM_lpage">8224</span><span class="refDoi"> DOI: 10.1021/jm3007323</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3007323" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVWht7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8211-8224&author=J.+L.+Diazauthor=R.+Cuberesauthor=J.+Berrocalauthor=M.+Contijochauthor=U.+Christmannauthor=A.+Fernandezauthor=A.+Portauthor=J.+Holenzauthor=H.+Buschmannauthor=C.+Laggnerauthor=M.+T.+Serafiniauthor=J.+Burguenoauthor=D.+Zamanilloauthor=M.+Merlosauthor=J.+M.+Velaauthor=C.+Almansa&title=Synthesis+and+biological+evaluation+of+the+1-arylpyrazole+class+of+sigma%281%29+receptor+antagonists%3A+identification+of+4-%7B2-%5B5-methyl-1-%28naphthalen-2-yl%29-1H-pyrazol-3-yloxy%5Dethyl%7Dmorpholine+%28S1RA%2C+E-52862%29&doi=10.1021%2Fjm3007323"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of the 1-Arylpyrazole Class of σ1 Receptor Antagonists: Identification of 4-{2-[5-Methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yloxy]ethyl}morpholine (S1RA, E-52862)</span></div><div class="casAuthors">Diaz, Jose Luis; Cuberes, Rosa; Berrocal, Joana; Contijoch, Montserrat; Christmann, Ute; Fernandez, Ariadna; Port, Adriana; Holenz, Jorg; Buschmann, Helmut; Laggner, Christian; Serafini, Maria Teresa; Burgueno, Javier; Zamanillo, Daniel; Merlos, Manuel; Vela, Jose Miguel; Almansa, Carmen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8211-8224</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis and pharmacol. activity of a new series of 1-arylpyrazoles as potent σ1 receptor (σ1R) antagonists are reported.  The new compds. were evaluated in vitro in human σ1R and guinea pig σ2 receptor (σ2R) binding assays.  The nature of the pyrazole substituents was crucial for activity, and a basic amine was shown to be necessary, in accordance with known receptor pharmacophores.  A wide variety of amines and spacer lengths between the amino and pyrazole groups was tolerated, but only the ethylenoxy spacer and small cyclic amines provided compds. with sufficient selectivity for σ1R vs σ2R.  The most selective compds. were further profiled, and 4-{2-[5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yloxy]ethyl}morpholine (S1RA, E-52862, I), which showed high activity in the mouse capsaicin model of neurogenic pain, emerged as the most interesting candidate.  In addn., compd. I exerted dose-dependent antinociceptive effects in several neuropathic pain models.  This, together with its good physicochem., safety, and ADME properties, led compd. I to be selected as clin. candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreQxd7-vnvc7Vg90H21EOLACvtfcHk0lgjHnLFGUyzeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVWht7bI&md5=0d6a5c8008d27635117c3901ec1db3c4</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm3007323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3007323%26sid%3Dliteratum%253Aachs%26aulast%3DDiaz%26aufirst%3DJ.%2BL.%26aulast%3DCuberes%26aufirst%3DR.%26aulast%3DBerrocal%26aufirst%3DJ.%26aulast%3DContijoch%26aufirst%3DM.%26aulast%3DChristmann%26aufirst%3DU.%26aulast%3DFernandez%26aufirst%3DA.%26aulast%3DPort%26aufirst%3DA.%26aulast%3DHolenz%26aufirst%3DJ.%26aulast%3DBuschmann%26aufirst%3DH.%26aulast%3DLaggner%26aufirst%3DC.%26aulast%3DSerafini%26aufirst%3DM.%2BT.%26aulast%3DBurgueno%26aufirst%3DJ.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26aulast%3DAlmansa%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520the%25201-arylpyrazole%2520class%2520of%2520sigma%25281%2529%2520receptor%2520antagonists%253A%2520identification%2520of%25204-%257B2-%255B5-methyl-1-%2528naphthalen-2-yl%2529-1H-pyrazol-3-yloxy%255Dethyl%257Dmorpholine%2520%2528S1RA%252C%2520E-52862%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8211%26epage%3D8224%26doi%3D10.1021%2Fjm3007323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Cobos, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baeyens, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Pozo, E.</span><span> </span><span class="NLM_article-title">Phenytoin differentially modulates the affinity of agonist and antagonist ligands for sigma 1 receptors of guinea pig brain</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">192</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span><span class="refDoi"> DOI: 10.1002/syn.20103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.1002%2Fsyn.20103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=15635593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Cgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2005&pages=192-195&author=E.+J.+Cobosauthor=J.+M.+Baeyensauthor=E.+Del+Pozo&title=Phenytoin+differentially+modulates+the+affinity+of+agonist+and+antagonist+ligands+for+sigma+1+receptors+of+guinea+pig+brain&doi=10.1002%2Fsyn.20103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Phenytoin differentially modulates the affinity of agonist and antagonist ligands for σ1 receptors of guinea pig brain</span></div><div class="casAuthors">Cobos, Enrique J.; Baeyens, Jose M.; Del Pozo, Esperanza</div><div class="citationInfo"><span class="NLM_cas:title">Synapse (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">192-195</span>CODEN:
                <span class="NLM_cas:coden">SYNAET</span>;
        ISSN:<span class="NLM_cas:issn">0887-4476</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The authors evaluated the effects of phenytoin (DPH) on the affinity for sigma-1 (σ1) receptors of agonist or antagonist σ1 ligands in guinea pig brain.  Heterologous competition expts. showed that DPH (250 μM and 1 mM) concn.-dependently increased the affinity of the σ1 agonists dextromethorphan, (+)-SKF-10,047, (+)-3-PPP, and PRE-084.  However, neither DPH 250 μM nor 1 mM increased (in fact, they slightly decreased) the affinity of the σ1 receptor antagonists haloperidol, BD 1063, NE-100, progesterone, and BD 1047.  These findings suggest that allosteric modulation by DPH of the affinity of σ1 receptor ligands depends on the agonist or antagonist characteristics of the ligand.  Therefore, detg. in vitro the differential modulation by DPH of σ1 ligand affinity appears to constitute a procedure that can predict the pharmacol. profile of different σ1 ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoossDgzqW_ibVg90H21EOLACvtfcHk0lgjHnLFGUyzeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Cgtb4%253D&md5=2243891ce029ec03b1910ce6bd4e49c8</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fsyn.20103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fsyn.20103%26sid%3Dliteratum%253Aachs%26aulast%3DCobos%26aufirst%3DE.%2BJ.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26aulast%3DDel%2BPozo%26aufirst%3DE.%26atitle%3DPhenytoin%2520differentially%2520modulates%2520the%2520affinity%2520of%2520agonist%2520and%2520antagonist%2520ligands%2520for%2520sigma%25201%2520receptors%2520of%2520guinea%2520pig%2520brain%26jtitle%3DSynapse%26date%3D2005%26volume%3D55%26spage%3D192%26epage%3D195%26doi%3D10.1002%2Fsyn.20103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Tjolsen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berge, O. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunskaar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosland, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hole, K.</span><span> </span><span class="NLM_article-title">The formalin test: an evaluation of the method</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span><span class="refDoi"> DOI: 10.1016/0304-3959(92)90003-T</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.1016%2F0304-3959%2892%2990003-T" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1454405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A280%3ADyaK3s%252FoslSnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1992&pages=5-17&author=A.+Tjolsenauthor=O.+G.+Bergeauthor=S.+Hunskaarauthor=J.+H.+Roslandauthor=K.+Hole&title=The+formalin+test%3A+an+evaluation+of+the+method&doi=10.1016%2F0304-3959%2892%2990003-T"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">The formalin test: an evaluation of the method</span></div><div class="casAuthors">Tjolsen Arne; Berge Odd-Geir; Hunskaar Steinar; Rosland Jan Henrik; Hole Kjell</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-17</span>
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    </div><div class="casAbstract">The formalin test for nociception, which is predominantly used with rats and mice, involves moderate, continuous pain generated by injured tissue.  In this way it differs from most traditional tests of nociception which rely upon brief stimuli of threshold intensity.  In this article we describe the main features of the formalin test, including the characteristics of the stimulus and how changes in nociceptive behaviour may be measured and interpreted.  The response to formalin shows an early and a late phase.  The early phase seems to be caused predominantly by C-fibre activation due to the peripheral stimulus, while the late phase appears to be dependent on the combination of an inflammatory reaction in the peripheral tissue and functional changes in the dorsal horn of the spinal cord.  These functional changes seem to be initiated by the C-fibre barrage during the early phase.  In mice, the behavioural response in the late phase depends on the ambient temperature.  We argue that the peripheral tissue temperature as well as other factors influencing the peripheral inflammation may affect the response, possibly confounding the results obtained with the test.  Furthermore, we discuss the methods of recording the response and the value of observing more than one aspect of behaviour.  Scoring of several behavioural variables provides a means of assessing motor or sensorimotor function as possible causes for changes in behaviour.  In conclusion, the formalin test is a valuable addition to the battery of methods available to study nociception.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSEPstJUQcfvkEksK8CslK8fW6udTcc2eY2xhmSkCTZu7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3s%252FoslSnsA%253D%253D&md5=d56dc5eb88d109dd30d319dcf580c781</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2F0304-3959%2892%2990003-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3959%252892%252990003-T%26sid%3Dliteratum%253Aachs%26aulast%3DTjolsen%26aufirst%3DA.%26aulast%3DBerge%26aufirst%3DO.%2BG.%26aulast%3DHunskaar%26aufirst%3DS.%26aulast%3DRosland%26aufirst%3DJ.%2BH.%26aulast%3DHole%26aufirst%3DK.%26atitle%3DThe%2520formalin%2520test%253A%2520an%2520evaluation%2520of%2520the%2520method%26jtitle%3DPain%26date%3D1992%26volume%3D51%26spage%3D5%26epage%3D17%26doi%3D10.1016%2F0304-3959%2892%2990003-T" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Mogil, J. S.</span><span> </span><span class="NLM_article-title">Animal models of pain: progress and challenges</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span><span class="refDoi"> DOI: 10.1038/nrn2606</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.1038%2Fnrn2606" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=19259101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisFCntLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=283-294&author=J.+S.+Mogil&title=Animal+models+of+pain%3A+progress+and+challenges&doi=10.1038%2Fnrn2606"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Animal models of pain: progress and challenges</span></div><div class="casAuthors">Mogil, Jeffrey S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">283-294</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Many are frustrated with the lack of translational progress in the pain field, in which huge gains in basic science knowledge obtained using animal models have not led to the development of many new clin. effective compds.  A careful re-examn. of animal models of pain is therefore warranted.  Pain researchers now have at their disposal a much wider range of mutant animals to study, assays that more closely resemble clin. pain states, and dependent measures beyond simple reflexive withdrawal.  However, the complexity of the phenomenon of pain has made it difficult to assess the true value of these advances.  In addn., pain studies are importantly affected by a wide range of modulatory factors, including sex, genotype and social communication, all of which must be taken into account when using an animal model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFMgN3i1-8BbVg90H21EOLACvtfcHk0lgjHnLFGUyzeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisFCntLY%253D&md5=364f8c94a9fa144fe4ea13c6f1f6641f</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnrn2606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn2606%26sid%3Dliteratum%253Aachs%26aulast%3DMogil%26aufirst%3DJ.%2BS.%26atitle%3DAnimal%2520models%2520of%2520pain%253A%2520progress%2520and%2520challenges%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2009%26volume%3D10%26spage%3D283%26epage%3D294%26doi%3D10.1038%2Fnrn2606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerns, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConnell, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, G. T.</span><span> </span><span class="NLM_article-title">High throughput artificial membrane permeability assay for blood-brain barrier</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span><span class="refDoi"> DOI: 10.1016/S0223-5234(03)00012-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=10.1016%2FS0223-5234%2803%2900012-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=12667689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=223-232&author=L.+Diauthor=E.+H.+Kernsauthor=K.+Fanauthor=O.+J.+McConnellauthor=G.+T.+Carter&title=High+throughput+artificial+membrane+permeability+assay+for+blood-brain+barrier&doi=10.1016%2FS0223-5234%2803%2900012-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">High throughput artificial membrane permeability assay for blood-brain barrier</span></div><div class="casAuthors">Di, Li; Kerns, Edward H.; Fan, Kristi; McConnell, Oliver J.; Carter, Guy T.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">223-232</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">The recent advances in high throughput screening for biol. activities and combinatorial chem. have greatly expanded the no. of drug candidates.  Rapid screening for BBB penetration potential early in drug discovery programs provides important information for compd. selection and guidance of synthesis for desirable CNS properties.  In this paper, we discuss a modification of the parallel artificial membrane permeation assay (PAMPA) for the prediction of blood-brain barrier penetration (PAMPA-BBB).  The assay was developed with 30 structurally diverse com. drugs and validated with 14 Wyeth Research compds.  The PAMPA-BBB assay has the advantages of: predicting passive blood-brain barrier penetration with high success, high throughput, low cost, and reproducibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZCg9Ka4mziLVg90H21EOLACvtfcHk0libRjnXgB5bGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D&md5=d228d5808ba8df23deed92c5e2bf3863</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2FS0223-5234%2803%2900012-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0223-5234%252803%252900012-6%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DMcConnell%26aufirst%3DO.%2BJ.%26aulast%3DCarter%26aufirst%3DG.%2BT.%26atitle%3DHigh%2520throughput%2520artificial%2520membrane%2520permeability%2520assay%2520for%2520blood-brain%2520barrier%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2003%26volume%3D38%26spage%3D223%26epage%3D232%26doi%3D10.1016%2FS0223-5234%2803%2900012-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i90"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00571">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_01124"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b00571">10.1021/acs.jmedchem.6b00571</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline"><sup>1</sup>H and <sup>13</sup>C NMR spectra of all final compounds, PAMPA permeability of selected compounds, and functional profile of compound <b>53</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00571/suppl_file/jm6b00571_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00571/suppl_file/jm6b00571_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00571/suppl_file/jm6b00571_si_001.pdf">jm6b00571_si_001.pdf (4.5 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00571/suppl_file/jm6b00571_si_002.csv">jm6b00571_si_002.csv (3.28 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-13%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b00571" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b00571" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679917efea853cac","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
